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 4 | Abstract 
Abstract 
   The first public draft of a genome from Chinese hamster ovary (CHO) cells was published in 
2011, an entire decade after the first draft of the human genome. This publication of a relevant CHO 
reference genome, in combination with the fact that the cost for DNA sequencing has dropped more 
than 10,000 fold over the last couple of years due to the revolution of next-generation sequencing 
(NGS), has dramatically accelerated CHO-omics from virtually non-existent to a vibrant growing 
field.  
   The aim of this thesis was to investigate the impact of coagulation factor VIII (FVIII) production 
in CHO cells using omics tools. A wide range of methods were applied including whole-genome 
sequencing, targeted genome sequencing, mRNA sequencing, miRNA sequencing and mass 
spectrometry  based shotgun proteomics on a number of clones in order to get a more holistic 
picture of the inner workings of these CHO transfectants.  
   From the whole-genome sequencing of two CHO genomes (CHO DXB11 and the FVIII 
producing transfectant: F435) it was observed that roughly 20% of the genes in the genome were 
haploid and roughly 10% had a copy number of three or higher indicating extensive rearrangements 
compared to the Chinese hamster origin. The transcriptome of 14 clones producing a dynamic range 
of FVIII was analyzed using RNA sequencing revealing an unexpected degree of 5’ truncations of 
the transgene in 11 of the 14 clones. These truncations were validated using targeted genome 
sequencing, which also mapped the transgene insertion site in a number of clones. Furthermore, the 
RNA sequencing data was combined with proteomics data to investigate which impact FVIII 
biosynthesis exerts on the CHO cells. This revealed a dose-dependent induction of the unfolded-
protein response, endoplasmic reticulum stress and oxidative stress which further lead to 
degradation of FVIII by the endoplasmic-reticulum-associated protein degradation pathway. This is 
to our knowledge, the first time that such extensive omics tools have been applied to a broad panel 
of CHO cells producing a very complex protein. The holistic view obtained for the FVIII producing 
cells provide a much clearer picture of the metabolic burden associated with FVIII secretion, than 
could be obtained using previous indirect methods.  
   The data and methods presented in this thesis suggest initial steps, which may be refined towards 
full utilization of omics technologies for analysis and engineering of industrially relevant CHO 
cells. Full implementation of such tools for generating specifically engineered CHO production cell 
lines may allow significant cost-reductions in production of complex biopharmaceuticals such as 
FVIII. 
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Dansk sammenfatning 
  Det første offentligt tilgængelige genom fra Chinese hamster ovary (CHO) celler blev frigivet i 
2011, et helt årti efter frigivelsen af det humane genom. Tilgængelighed af dette relevante CHO 
reference genom, i kombination med et fald på mere end 10.000 gange i prisen for DNA 
sekventering over de sidste par år, har på dramatisk vis accelereret CHO-omics fra at være stort set 
ikke-eksisterende, til et felt i kraftig vækst. 
   Formålet med denne afhandling var at benytte omics værktøjer til at undersøge den påvirkning, 
som produktion af koagulationsfaktor VIII (FVIII) har på CHO-celler. Et bredt udvalg af værktøjer 
blev brugt der iblandt fuld-genom sekventering, målrettet genomsekventering af transgenområder, 
mRNA-sekventering, miRNA-sekventering og massespektrometri-baseret shotgun proteomics til 
analyse af en række kloner, for at danne et mere holistisk billede af disse CHO transfektanters 
karakteristika. 
   Fra fuld-genom sekventeringen af to CHO genomer (CHO DXB11 og en FVIII producerende 
transfektant: F435) blev det observeret, at omkring 20% af generne i genomet var haploide og ca. 
10% havde et kopinummerantal på tre eller højere, hvilket indikerer omfattende ændringer i 
genomet i forhold til det oprindelige genom fra en kinesisk hamster. Transkriptomet af 14 kloner, 
der producerer FVIII over et stort spænd, blev analyseret med RNA-sekventering og dette viste en 
uventet grad af 5’ trunkeringer af transgenet i 11 ud af 14 kloner. Disse trunkeringer blev valideret 
ved brug af målrettet genomsekventering, som også blev brugt til at kortlægge 
transgenintegrationsområdet i en række af klonerne. RNA-sekventeringsdataen blev desuden 
kombineret med proteomdata med det formål, at undersøge den effekt FVIII biosyntese har på CHO 
cellerne. Denne analyse viste en dosisafhængig induktion af unfolded-protein response, 
endoplasmatisk reticulum stress og oxidativt stress i cellerne som resulterede i endoplasmic-
reticulum-associated protein degradation. Så vidt vides, er dette første gang at så omfattende 
værktøjer er benyttet til analyse af et bredt panel af CHO celler, der producerer et komplekst 
protein. Det holistiske billede, der males af de FVIII producerende celler ud fra disse analyser, giver 
et klarere billede af den metaboliske byrde, der er associeret med FVIII sekretion, end hvad der kan 
opnås med mere indirekte metoder.  
   Data og metoder, der præsenteres i denne tese, udgør de første skridt mod fuld anvendelse af 
omics værktøjer til analyse og udvikling af industrielt betydningsfulde CHO celler. Fuldstændig 
implementering af sådanne værktøjer vil kunne bruges til at udarbejde specialdesignede CHO 
produktionscellelinjer, der måske vil tillade signifikante reduktioner i produktionsprisen for 
komplekse lægemidler som fx FVIII. 
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Abbreviations 
AEC adenylate energy charge  
BDD-FVIII B-domain deleted Coagulation 
Factor VIII 
CDS coding DNA sequence  
CGCDB CHO gene co-expression database  
CHO Chinese Hamster Ovary 
CN copy number  
CNV copy number variation  
DE differentially expressed 
EMS Ethyl methanesulfonate  
ER endoplasmic reticulum  
ERAD Endoplasmic-reticulum-associated 
protein degradation  
FASP Filter aided sample prep 
Fc fold-change  
FPKM Fragments per kilobase of exon per 
million fragments mapped 
FVIIa activated Factor VII  
FVIII Coagulation Factor VIII 
FVIIIa Activated Coagulation Factor VIII  
GEM genome-scale metabolic model  
GO Gene Ontology  
GOI gene of interest  
HCP host cell proteins  
IRES an internal ribosomal entry site  
iTRAQ isobaric tags for relative and absolute 
quantification 
IPA Ingenuity Pathway Analysis   
IVC integral of viable cells 
LT Mouse Polyomavirus large T  
mAbs monoclonal antibodies  
MALDI TOF matrix-assisted laser 
desorption/ionization time of flight  
MS mass spectrometry  
MTX methotrexate  
NGS Next-Generation Sequencing  
OPLS ortho-phospho-l-serine  
PacBio Pacific Biosciences  
PDI Protein disulfide isomerase 
PEG polyethylene glycol 
qP specific productivity  
qPCR quantitative Polymerase 
Chain Reaction  
qRT-PCR quantitative Reverse 
Transcription Polymerase 
Chain Reaction  
RNAseq RNA sequencing 
ROS reactive oxygen species 
SDS Sodium dodecyl sulfate  
SILAC stable isotope labeling with amino 
acids in culture  
SNPs single nucleotide polymorphisms  
TLA Targeted Locus Amplification 
TMT tandem mass tags  
UPR unfolded protein response  
UTR untranslated regions  
VCP Valosincontaining protein  
vWF von Willebrand factor  
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Structure of the thesis 
   In order to provide a framework for the reader, the following structure of the thesis was chosen: 
Chapter 1 provides the background knowledge, which will be necessary in order to grasp the 
concepts utilized in this thesis. In Chapter 2 the data from whole-genome sequencing of two CHO 
genomes are presented and compared to the genomes, which are currently publicly available, 
specifically in relation to changes in gene copy numbers. In Chapter 3 the focus turns more 
specifically on the F8 transgene in 14 CHO transfectants and how RNA sequencing data was mined 
in order to discover significant truncations on the transgene. Chapter 4 focuses on the knowledge 
gained from proteomics and RNA sequencing in characterizing CHO cell lines producing FVIII. 
Furthermore, attempts for finding targets for improving the FVIII productivity on signatures from 
RNA sequencing were investigated. In Chapter 5 an overview of the current state of CHO 
proteomics are given. The topic of Chapter 6 is the utilization of omics data from CHO for 
generation of genome-scale metabolic models. Chapter 7 contains an introduction into analyses of 
CHO NGS data also available at http://wiki.bio.dtu.dk/CHOomics and finally Chapter 8 lists the 
conclusions and future perspectives of the work presented in this thesis.  
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Chapter 1 - Introduction and Background 
1.1 Hemophilia A 
   Approximately 350,000 males world-wide suffer from hemophilia A, which is caused by genetic 
abnormalities of the F8 gene encoding coagulation factor VIII (FVIII). The gene is located on 
chromosome X and is comprised of 26 exons spanning more than 180kb. The most commonly 
found genetic defects are an inversion of intron 22 [1] and an inversion of intron 1 [2] constituting 
30-50% and 2-5% respectively of the cases of severe hemophilia A.  The remaining polymorphisms 
found are a diverse spread of different nonsense, missense, splice-site mutations and 
deletions/insertions [3].  
   Without proper treatment of severe hemophilia A a person will have a life expectancy of 11 years. 
A doctor [4] describing patients with hemophilia A in the late 1960ies wrote: “The typical 
hemophiliacs whom I saw … were children who looked severely crippled. They had terrible joint contractures of 
their elbows, knees, and ankles from repeated hemorrhages and all the inflammatory reaction of the joints to get 
the blood out of there. They were terribly scarred. The cartilage was gone in most cases, and they had bone 
rubbing against bone.”. “Virtually all of those who made it into their late teens and adulthood had so much 
chronic joint pain that they were addicted, for good reason, to Demerol and other narcotic pain medicines.” It 
was not until the 1970s that successful treatment with FVIII purified from blood donors were used 
to treat patients, but due to the low levels of FVIII in the blood, samples from up to 30,000 donors 
were pooled to make one vial of FVIII used for treatment [4]. The treatment was a success and the 
patients were able to live near-normal lives, but between 1981 and 1985 more than half of the 
members of the hemophilia community in the United States (approximately 20,000 people) became 
infected by human immunodeficiency virus due to lack of screening of blood donors [5]. Because of 
this disaster there was a huge push to develop a recombinant FVIII treatment in order to avoid 
donor blood in hemophilia A treatment.  
   The F8 cDNA sequence was identified and the gene was heterologously expressed in 1984 [6,7]. 
Since then, the global FVIII marked has reached a value of 6.2 billion USD in 2013 of which 76% 
was from recombinant FVIII. Recombinant FVIII is sold under different names by Baxter, Wyeth, 
Aventis Behring and since 2013: Novo Nordisk. Out of the 350,000 patients estimated world-wide 
approximately 70,000 receive treatment. The main barrier for treatment is the cost which is  
approximately 100,000 USD per year per patient [5].   
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1.2 Expression of the FVIII protein 
   Following the identification of the F8 cDNA sequence the biosynthesis of FVIII has been studied 
extensively with the aim of optimizing recombinant FVIII production and gaining a better 
understanding of the underlying cause of hemophilia A. FVIII is produced by a variety of cell types 
in vivo, but the primary source for FVIII production appear to occur in the liver by hepatocytes and 
sinusoidal endothelial cells [8,9]. There is currently no established cell line that naturally expresses 
FVIII and thus the knowledge gained concerning the expression and secretion of the protein is 
found solely from analysis of various mammalian cell lines transfected with F8 cDNA [10]. 
Heterologous expression of human FVIII are though found to be at levels three order of magnitude 
lower than similarly sized secreted glycoproteins [11,12]. 
 
Figure 1 Synthesis and post-translational modification of FVIII 
F8 mRNA is transcribed (1) and translated into the endoplasmic reticulum (2) where N-glycans are added and 
disulphide bridges are formed (3). The protein is shipped (4) from the endoplasmic reticulum to the Golgi apparatus (5) 
where it is cleaved and sulphanations are added before secretion from the cell (6). Upon secretion the FVIII protein can 
be processed by thrombin to yield activated FVIII (7) which subsequently lead to inactivated FVIII (8) by several 
different routes. Cleavage patterns of FVIII from [13], and disulfide bridges from [14]. 
 
   The knowledge gathered concerning the expression and secretion of FVIII can be summarized as 
follows (see Figure 1): After transcription of the F8 gene, the translation is directed into the 
endoplasmic reticulum (ER) due to the presence of a 19 amino acid-long signal peptide encoded in 
the 5’ end of the mRNA. Following removal of this signal peptide, a single-chain protein of 2332 
amino acids is synthesized with the domain structure A1-a1-A2-a2-B-a3-A3-C1-C2. The A 
domains share 40% amino acid identity with each other and likewise 40% amino acid identity is 
seen among the C domains. The B-domain consists of 908 amino acids and is without amino acid 
homology to any other known protein [13].  N-glycans are added to the FVIII peptide chain in order 
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membrane protein calnexin to interact with it. More than 75% of the N-glycans attachment sites of 
FVIII are located to the B-domain and attachment of N-glycans are found to be critical for FVIII 
secretion, as inhibition of N-glycosylation using tunicamycin dramatically reduced secretion [15]. 
FVIII is found to cycle through interactions with calnexin/calreticulin and the chaperone 
immunoglobulin-binding protein (BiP) possibly aiding in catalyzing correct folding [12,16]. The 
calnexin/calreticulin cycle function as a quality control step for glycoproteins by retaining proteins 
in the ER until they are correctly folded [17]. Unfortunately, it appears that approximately a third of 
the translated FVIII accumulate as non-disulfide-linked aggregates in the ER due to ATP depletion 
[18]. This furthermore activates the unfolded protein response (UPR) in the cell and cause oxidative 
stress [19]. In the case of incorrect folding after several cycles of calnexin/calreticulin interaction, 
the protein is sent for degradation by proteasomes in the cytoplasm by Endoplasmic-reticulum-
associated protein degradation (ERAD) [17]. These implications of FVIII productions are further 
elaborated in Chapter 4. 
   After the protein is correctly folded it is able to interact with the soluble protein: multiple 
coagulation factor deficiency protein 2 (MCDF2). The transmembrane protein partner: Mannose-
binding lectin 1 (LMAN1) binds MCDF2 and selectively package FVIII into vesicles, which are 
subsequently transported to the Golgi apparatus. It has been found that mutations in LMAN1 or 
MCFD2 cause combined deficiency of Coagulation Factor V and FVIII associated with the plasma 
levels of 5%-30% of normal levels [20]. Thus, the selective transport of FVIII from ER to the Golgi 
relies on the function of these proteins. 
   Upon arrival to the Golgi apparatus the FVIII protein is cleaved into a heavy chain (200 kDa) and 
a light chain (80 kDa), which are held together by a divalent metal ion. The protein furthermore 
undergo modification of the N-glycans, is O-glycosylated and furthermore sulphated on specific 
tyrosine residues.  
   Following release into circulation, FVIII binds a protein called von Willebrand factor (vWF). This 
allows the proteins to form a tight non-covalent complex, which shield FVIII from premature 
activation and clearance. FVIII becomes activated upon cleavage by thrombin by proteolysis at 
three residues: Arg372, Arg740 and Arg1689 thus releasing the full B-domain and a3 region (binding 
vWF) from the protein [21]. Activated FVIII (FVIIIa) is subsequently able to act as a cofactor in the 
blood clotting cascade by interacting with coagulation factor IXa on the surface of activated 
platelets.  
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   The activity of FVIIIa is rapidly lost either due to dissociation of the A2 domain from the rest of 
the subunits or by degradation due to cleavage by proteases such as thrombin, activated Coagulation 
Factor IX, activated Coagulation Factor X or activated protein C [13]. 
1.3 Engineering FVIII for recombinant protein production  
   In order to produce FVIII recombinantly at a competitive price compared to FVIII from donor 
blood, extensive efforts were undertaken in order to optimize production of FVIII from the cDNA 
sequence. It was found that the F8 coding region contained stretches, which had a deleterious effect 
on F8 mRNA accumulation and caused transcriptional silencing [22,23]. As the B-domain was 
found not to be essential for FVIII procoagulant activity [24], yet constituted 40% of the transcript, 
it was attempted to replace the fragment with a smaller region, which still ensure cleavage. It was 
seen that by removing the B-domain, the level of F8 mRNA could be increased 20-fold compared 
to full-length F8 mRNA. Unfortunately, the yield of secreted B-domain deleted (BDD) FVIII only 
doubled compared to secretion of full-length FVIII [13,25]. This indicates that the B-domain 
somehow have an effect on efficient biosynthesis of the protein, as higher levels of mRNA did not 
drastically increase the level of secreted protein. The recombinant FVIII investigated in this thesis is 
a FVIII protein with a B-domain, which has been truncated from 908 to only 21 amino acid residues 
[26]. In other attempts to optimize the protein for improved yields, Swaroop et al created a missense 
mutation (F309S) in order to decrease affinity for BiP binding in the ER. This was found to lead to 
more efficient secretion, although the interaction of heavy and light chain was also weakened [27]. 
   A major obstacle for using FVIII variants, as the one created by Swaroop [27], for actual FVIII 
therapy in humans, is the risk that the hemophilia A patient will develop inhibiting antibodies. The 
FVIII protein has been found to be very immunogenic in hemophilia A patients, with a tendency for 
patients with a large deletions in the F8 gene to often develop inhibitors (40% chance) and less so in 
patients with only small missense mutations in the F8 gene (5% chance) [3]. Once a patient has 
developed antibodies against FVIII, additional FVIII administered to the blood will be rendered 
inactive and removed within minutes. This currently leave only one viable solution to stop the 
bleeding in a patient who has developed inhibiting antibodies: circumventing the steps of the blood 
coagulation cascade involving FVIII by administering activated Factor VII (FVIIa) [28] or FEIBA 
[29]. Unfortunately, this treatment is very costly as 250,000  USD worth of FVIIa can routinely be 
used during a single surgical operation on a hemophilia A patient with inhibitors [30]. As the FVIII 
drugs on the marked have a proven track record in regard to inhibitor development, it would be 
detrimental for a new FVIII drug if the levels were only slightly higher. It would thus be of much 
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lower risk to optimize the cell line for better production of FVIII compared to changing the protein 
only to fail in a costly clinical trial several years down the road. This way several iterations can be 
run quickly in order to gain a better understanding of what constitute a good FVIII cell line. A 
prime example for this strategy is seen in the two-fold optimization of the cellular FVIII 
productivity [31] by co-expression of the chaperone: heat shock protein 70 (Hsp70). This caused a 
significant delayed induction of apoptosis and furthermore improved the percentage of correctly 
folded FVIII secreted into the media (the specific activity). It was observed that less FVIII was 
found sequestered on the surface of these cells compared to normal FVIII producing cells [32].  
   The problem of FVIII bound to the surface of production cells are most profound when cells are 
grown in a serum-free setting where up to 90% of the FVIII can be found bound to the cells [34], 
but have been found to be alleviated by co-expression of vWF [35]. A successful strategy for 
keeping FVIII in the media and off the cell membrane is the addition of ortho-phospho-l-serine 
(OPLS). This molecule, which binds FVIII, is able to keep FVIII from binding the cell surface. It 
was found that addition of OPLS, 24 hours prior to harvesting FVIII from a culture of CHO cells, 
lead to a 50% increase in yield [36]. The idea was further developed by creating a cell line co-
expressing a protein called lactadherin, which bind the cell surface competing with FVIII. This lead 
to improved yields by increasing the amount of FVIII found in the media compared to on the cell 
surface [37].  
   Purified FVIII injected into a patient has a half-life of approximately 8-12 hours, thus requiring 
three injections per week in order to sustain a plasma level of FVIII of 1% compared to that of a 
normal person [38]. The next generation of recombinant FVIII therapy entering the marked the 
years to come, are specifically aiming at improving the half-life of FVIII in the patient, thus 
reducing the amount of FVIII needed per patient per week. Biogen Idec is aiming for improved 
half-life through covalently linking FVIII to a human IgG1 Fc domain [39] whereas the strategy of 
Bayer, Baxter and Novo Nordisk is anchoring a large polyethylene glycol (PEG) molecule [40-42]. 
Using this strategy the half-life of FVIII was increased from 8.3 to 18 hours in Cynomolgus 
monkeys [41], which could bring down the number of weekly dosages from three to two per patient.  
   Finally, ongoing attempts are being made to effectively cure hemophilia A using gene therapy. 
The efforts are hindered by 1) the relatively large size of the BDD-F8 coding region of 4.4kb, 
compared to the packaging capacity of the popular adeno-associated viruses, 2) the inefficient 
biosynthesis of FVIII mentioned above and 3) the problem of gene therapy of viral capsid-mediated 
cytotoxicity [11]. The problem of capsid induced cytotoxicity is further intensified by the general 
issue of inhibitor development, even when administered directly as purified protein from 
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recombinant sources [3]. The hypothesis is that infected cells might present misfolded FVIII at cell 
surface and elicit an immune response [43,44]. Headway has though been achieved with gene 
therapy of Factor IX for hemophilia B patients. Six patients have for more than two years 
successfully been producing Factor IX at 1-6% of normal levels [45,46]. 
   For the time being gene therapy might not be considered the safe choice even though it might 
present itself at one point as the cheaper choice. For this reason gaining a better understanding of 
what constitutes an efficient cell line for FVIII production will benefit recombinant FVIII therapy 
on the short timeline, but could also shed light on optimizing gene therapy on the longer time line as 
well. Due to the extensive post-translational modifications required for production of active FVIII, 
the protein needs to be produced in a complex mammalian cell line, of which Chinese Hamster 
Ovary (CHO) cells are by far the most popular cell factory. Gaining a better understanding of CHO 
cells producing FVIII will therefore be the most straightforward approach for effectively reducing 
the production cost for hemophilia A therapy. 
1.4 The Chinese Hamster Ovary cells 
   The global market for biopharmaceuticals is currently 140 billion USD of which the majority of 
proteins requiring post-translational modifications are produced in CHO cells [47]. The Chinese 
hamster (Cricetulus griseus) was originally brought to the USA to be used instead of mice for 
typing pneumococci [48]. Theodore Puck found in 1957 that a cell line of near diploid karyotype 
could be generated with relative ease, from a trypsinized sample of ovarian tissue from Chinese 
hamsters [49]. The cell line immortalized by an unknown spontaneous mechanism and was able to 
grow for months without showing signs of senescence, which are normally seen in cell lines derived 
from humans  [50]. They were widely distributed to many laboratories around the world and 
described as “hardy” and growing well even with very low fetal bovine serum concentrations in the 
medium [51].  The first CHO cell line adapted to growth in media completely without serum was 
obtained in 1977 [52], thus paving the way for growth in cheap defined media and easing 
downstream purification of secreted proteins. It was later found that CHO happened to produce 
proteins with a glycosylation pattern similar to that of humans [53] and is not infected by a wide 
range of viruses dangerous to humans [54]. This has led to CHO cells being the de facto standard 
for protein production in mammalian cells. CHO is currently used for production of more than 40 
biopharmaceuticals including monoclonal antibodies, hormones, cytokines and blood-coagulation 
factors. The history of the different lineages of CHO are excellently summarized in a recent review 
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[51] and shown in Figure 2 below. The genome sequencing of CHO DXB11 and F435 is described 
in Chapter 2 of this thesis. 
 
Figure 2 Overview of the lineages of the most commonly used CHO cell lines. 
Cell lines which have been genome sequenced at the time of writing have been highlighted. ATCC: American Type 
Culture Collection. ECACC: European Collection of Cell Cultures. Figure redrawn from [55]. 
 
   Another advantage of CHO cells is several well characterized methods for transfection such as 
calcium phosphate transfection, electroporation, lipofection or polymer-mediated gene transfer 
[56,57]. Upon transfection a selection system is advantageous in order to enrich the cellular 
population of desired transfectants. One of the most commonly used selection markers for cell line 
generation in CHO cells is the dhfr-selection system, which is used in chapter 3 and 4 of this thesis. 
Dihydrofolate reductase (DHFR) is an enzyme, which is able to catalyze the conversion of 
dihydrofolic acid to tetrahydrofolic acid – an essential cofactor carrier. Inhibition of DHFR, or 
knockout of the dhfr gene (as in the CHO DXB11 and CHO DG44 cell lines), thus leads to 
auxotrophy for glycine, hypoxanthine and thymidine. A favorable approach for heterologous 
expression of a gene of interest (GOI), would therefore be to couple expression of the GOI with the 
dhfr gene from one biscistronic mRNA by placing an internal ribosomal entry site (IRES) in 
between the two genes. Following transfection of DHFR
-/-
 cells, only cells producing DHFR (and 
thus the protein of interest) will be able to survive the selection pressure from the media lacking 
glycine, hypoxanthine and thymidine [58]. As the transfected DNA, encoding dhfr, is not 
propagated in the cells, it will be diluted out over time (Figure 3A). In the case a copy of the 
transgene is integrated into the genome of the cell and expression of DHFR is high enough to 
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sustain viability for the cell, a stable cell line can be isolated (Figure 3B). By adding the folic acid 
analog methotrexate (MTX) to the growth media, the level of DHFR required to sustain viability for 
the cell go up as MTX will bind DHFR inhibiting its activity. As the gene of interest and dhfr are 
coupled that will lead to selection for clones with high expression levels of transgene. The MTX 
concentration can be increased for several rounds of selection leading to cells with many copies of 
the inserted transgene and dhfr, thus allowing the cells to produce sufficient levels of DHFR to 
survive [58] (Figure 3C). Transient transfection can thus be used for a short burst of production 
lasting a few days before the transgene is diluted out, whereas an amplified cell line with high 
productivity can sustain production for a much longer period of time, but it usually requires several 
months of selection pressure from transfection until the cell line can be isolated.  
 
 
Figure 3 Transient transfection versus generation of a stable cell line.  
(A) In a transient transfection the transgenic DNA is transcribed but not replicated within the cell, which leads to the 
transgene being diluted at each cell division. (B) In rare instances the transgene is inserted into the genome leading to a 
stable cell line. (C) By addition of MTX clones can be selected for, which has undergone amplification of the transgene. 
1.5 CHO Systems biology by omics technologies 
   Over the course of the past three decades massive improvements have been achieved within 
media and process optimization of the CHO cells leading to typical antibody yields in 1986 of 0.05 
g/L compared to 5-10 g/L today [57].  Although such results are impressive, they are most often 
product specific and are thus very labor intensive [59]. In contrast, only very limited success stories 
have been published within genetically engineering CHO through metabolic engineering towards 
higher protein productivities [60,61], compared to the results seen in microbial cell factories where 
entire metabolic pathways have been engineered [62-64]. A major reason for CHO lacking behind 
microbial cell factories in cell line engineering, is the fact that until recently the omics toolbox 
available to study the cell has been virtually empty. “Omics” as a term are typically defined as the 
bioinformatics study of all constituents of a biological system considered collectively, e.g., all genes 
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of an organism – genomics. A list of the most commonly investigated omics is given in Figure 4. 
As proteomics will be covered at lengths in chapter 5 of this thesis the two main omics which will 
be covered in detail will be CHO genomics and transcriptomics 
 
 
Figure 4 Different layers of cellular processes, the corresponding omics field and suggested research strategies 
for investigation of the given omics field. Figure modified from [59]. 
 
1.5.1 The current state of CHO genomics 
   Not a single CHO genome was publicly available until 2011, where two different groups released 
sequence from CHO-K1 [54] of ~100x coverage and a CHO DXB11 transfectant at ~1x coverage 
[65]. This was an entire decade after the publication of the first draft of the human genome [66] and 
15 years after the genome of the first eukaryote, Saccharomyces cerevisiae [67]. Prior to the 
publication of the CHO-K1 genome most early genome-based studies of CHO cells were performed 
using the genome sequences from other mammals, for example, human, mouse or rat [68,69], which 
generally limited the possible experiments and interpretation of the results. From the genome 
sequence of CHO-K1, it was found that the cell line contained 24,383 genes associated with 21 
chromosomes with a total of 2.45 Gb of genomic sequence. The genome sequence has been made 
accessible at the online database www.CHOgenome.org [70,71] as well as download from 
Genbank. One of the main advantages of expressing heterologous protein in CHO has been the 
possibility of human like post-translational modifications of recombinant proteins [53]. Analysis of 
the CHO-K1 genome revealed that homologs existed for 99% of the genes in the human genome 
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associated with glycosylation. Of these genes, merely 53% were detected to be transcribed. 
Furthermore, analysis of the transcriptome revealed that numerous genes associated with viral entry 
were not expressed, thus explaining the resistance of CHO cells to viral infection [54].  
   In 2013 two groups [55,72] published the genomic sequence of the Chinese hamster, from which 
the CHO cell line was originally extracted in 1957 [49]. The data from the two independent 
sequencing efforts are at the time of writing being merged with 3
rd
 generation sequencing data from 
Pacific Biosciences [73] into a single well-characterized genome. The hope is that this genome will 
be able to be used for the future study of CHO cells lines as a standard reference. The current 
version of the Chinese hamster genome is composed of 53,000 separate fragments (scaffolds) and 
the hope is that by merging the sequencing data, that this number of fragments can be dramatically 
reduced in order to get a more holistic view on the localization of each gene in in genome. 
   The genomic sequence from a number of CHO cell lines including the industrially relevant CHO-
S and CHO DG44 were also published in 2013 [55]. The genomic sequences for these cell lines are 
currently only available as raw sequence reads at the NCBI Short Read Archive. Analysis showed 
that more than 3.7 million point mutations were identified in these cell lines compared to the 
Chinese hamster [55] highlighting the fact that CHO genomes and the Chinese hamster are not 
identical and a need exist for further sequencing of genomes from additional popular CHO cell 
lines.  
1.5.2 State of CHO transcriptomics 
   In order to analyze the portion of the genome that is actively transcribed under a specific set of 
conditions, methods such as quantitative Reverse Transcription PCR  (qRT-PCR), microarrays and 
more recently RNA sequencing can be used. As stated above the possibilities for studying the 
transcriptome were limited prior to the publication of the genome although microarrays did exist, 
which covered a subset of the CHO transcripts. In an interesting study, Clarke et al [74] analyzed 
microarray data from 121 different conditions run by Pfizer on pre-genome microarrays. From the 
massive dataset it was possible to identify several gene clusters, which were associated with culture 
growth rate and productivity. The first large scale RNA sequencing paper covering CHO cells came 
out just two months after the CHO-K1 genome in 2011 [75]. By sequencing CHO samples from 
different genetic backgrounds and several cultivation conditions, they were able to de novo 
assemble the reads into 29,184 different transcripts. The transcripts identified in this paper are at the 
time of writing the source for CHO genes at Genbank and not the sequence from the CHO genomes. 
A transcriptome database for CHO RNA sequencing data has recently been developed and is 
available at https://gendbe.cebitec.uni-bielefeld.de/cho.html [76].  
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   The CHO microRNA transcriptome has been thoroughly mapped [77] and the first papers 
analyzing the impact on apoptosis, growth and protein expression based on overexpression of 
different miRNAs have been published [78-80]. Notably it was found that 184 different miRNAs 
were able to induce up to two-fold improvements in protein expression of their transgene (secreted 
alkaline phosphatase) [80]. Due to the small size of miRNAs it is possible to synthesize the oligos 
and conduct large scale screens for a fraction of the price of mRNA overexpression. Due to these 
advantages and the results published so far, the strategy for cell line optimization through miRNA 
modulation hold great promise. A problem though still facing this area of research is the difficulty 
of predicting the miRNA target sites in the transcriptome. miRNA typically bind to the untranslated 
regions (UTR) of transcripts and these regions are currently very poorly annotated. Headway has 
though recently been achieved with a study conducting 5’ enriched RNA sequencing for 
identification of transcriptional start sites, which should improve the knowledge of UTR positions 
in the CHO transcriptome [81]. 
1.6 Next-generation sequencing 
   The reason for the sudden increase in CHO sequencing data in the last couple of years can be 
explained by the revolution of Next-generation Sequencing (NGS) which has reduced the 
sequencing cost per megabase with more than 10,000 fold over the past 14 years (Figure 5). 
  
Figure 5 Sequencing before and now 
Left: Cost of sequencing one megabase of DNA over the course of the last 14 years.  Image from 
www.genome.gov/sequencingcosts. Right: One sequenced read using original Sanger sequencing. Figure from [82]   
 
   The rapid cost-reduction for sequencing has allowed project to be carried out today at a cost only 
a tiny fraction of what it would have been a few years earlier. First-generation sequencing was 
invented back in 1970s by Frederick Sanger [82,83] and relied on DNA polymerase extending a 
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sequencing primer annealing to a DNA fragment of interest. By splitting the reaction into several 
lanes and adding different nucleotide mixtures, the limiting nucleotide for a given lane could be 
used to deduce the base pair at that given position (Figure 5). The interpretation of the gel was fairly 
complex so it was common practice that one person would read the sequence from the combination 
of the lanes and another person would write down the sequence. This is why a sequenced DNA 
fragment is commonly referred to as a read. In 1986 Smith et al. [84] made a significant 
improvement by replacing the radioactive labels used in the Sanger method with fluorescent tags. 
This allowed the reaction to be run in a single vial sequencing up to 500–800bp allowing for high-
throughput sequencing. The sequencing of the human genome was done using this approach, which 
was the predominant way for small and large scale DNA sequencing until a publication in Nature in 
2005 [85], which described the whole genome sequencing of Mycoplasma genitalium in one four-
hour run yielding a 40-fold coverage of the genome with 99% or better accuracy carried out by the 
454 Life sciences Corporation. This technology was further made obsolete by the advent of 
Illumina Solexa solid state sequencing allowing for sequencing of 600 Gbp in a single run [86]. 
 
Figure 6 A schematic overview of Illumina sequencing  
1) Samples consisting of RNA are reverse transcribed into cDNA and 2) subsequently standardized adapters are added. 
3) The DNA fragments are seeded on a flow cell, 4) amplified using primers found attached to the flow cell and 5) 
sequenced in parallel one bp of the time by release of a flourophor. 6) The color of each polony is registered for each 
cycle and 7) the sequence for each fragment is deduced from the color. 8) Each fragment is sequenced from each end 
resulting in two paired reads from the same fragment. Figure inspired by [87].  
 
   The method of Illumina sequencing can be summarized as follows (see Figure 6).  
1. For genome sequencing, the DNA sample is digested into small DNA fragments of only a 
couple of hundred bps (in the case of sequencing of mRNA or miRNA samples, several steps 
precede purifying the desired sample and reverse transcribing it to cDNA). 
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2. Standardized adapters are added to the fragments. 
3. Following addition of adapters the fragments are added to a flow cell containing oligos 
complimentary to the adapters, which have been added to the fragments. 
4. The sample fragments are then amplified by PCR in order to get a stronger signal. In contrast to 
a regular PCR reaction the primers are in this case found on the flow cell in the vicinity of the 
fragment attached to the glass surface. By only being able to amplify using adapters found near 
the fragment, the PCR products are found in a localized area of the flow cell called a polony of 
approximately 1 million copies (like a bacterial colony that amplify on an agar plate from a 
single bacterium to an entire colony within a confined area).  
5. Sequencing is carried out by adding all four nucleotides at the same time containing chain 
terminators so only one nucleotide can be added to each fragment in each cycle. Each nucleotide 
is labelled with a dye that can subsequently be read and following removal of the chain 
terminator the cycle is repeated.  
6. For each cycle a high resolution picture is taken monitoring the color of each polony.  
7. By using image analysis collecting the color of each 2D position on the flow cell the identity of 
the nucleotide is sequenced at each cycle can be deduced and thus allowing for approximately 
~100bp of 1 billion template fragments to sequenced on the flow cell in parallel.  
8. After the first round of sequencing the chemicals are washed off and then a new sequencing 
primer is added which align to the adapter in the other end of the fragment. Subsequently, 
~100bp of the other end is sequenced yielding two read pairs originating from the same 
fragment with a read pair distance between them depending upon the length of the original 
fragment. The two reads from a single fragment is called paired reads.  
 
   A significant advantage of this technology compared to competing technologies, is found in the 
fact that all fragments are read in parallel without getting out of synchronization allowing large 
stretches of the same nucleotide to be read with large confidence. The vast majority of the NGS 
papers that are published these years have been done using the Illumina technology. 
   Third generation sequencing technologies such as the technique invented by Pacific Biosciences 
(PacBio) are currently gaining adoption by allowing sequencing without PCR amplification in the 
library preparation and producing reads that are up to 20kb in length contrast to the 100bp on the 
Illumina platform [86]. The reads can be assembled with much higher level of confidence if larger 
overlaps exists between the fragments and thus longer reads allow for better assembly of regions 
containing repeats. The price for sequencing using the PacBio technology is  approximately 10x 
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higher per megabase than Illumina sequencing and for this reason it is common practice to get raw 
sequence with high depth coverage for each bp on the genome using the Illumina technology and 
then a low coverage of the expensive PacBio data in order to reliably assemble the genome getting 
the best of both worlds on a limited budget.  
1.6.1 Analysis of NGS data 
   A typical workflow for analysis of raw data from a transcriptome and genome sequencing 
experiment are shown in Figure 7. In both cases, the reads are aligned to a reference genome and 
the number of reads aligning to a given gene is monitored.  
 
 
Figure 7 Representation of NGS workflows 
A) An Ilumina read from a RNA sequencing experiment is shown in the fastq format: first a line containing a unique 
identified, then a line containing the sequenced fragment  and finally a line containing the quality score for each 
sequenced base. Sequenced reads are aligned to genomic reference sequence and reads spanning an intron are seen 
aligning to exonic sequence on both sides of the intron. Following alignment the number of read pairs aligning to each 
gene in the genome is counted and used, after normalization, to identify genes, which are differentially expressed. B) 
Illumina reads from a genome sequencing experiment. SNPS are detected as discrepancies between the reference 
genome and several reads. From the sequencing depth it can be seen which genes have reduced or amplified copy 
number in the genome.  
 
   In the case of RNA sequencing special algorithms, such as Tophat [88], are used allowing for 
efficient alignment of reads that span over introns, which are not observed in genome sequencing 
data. After alignment, the number of reads that have aligned to each gene in the genome can be 
counted. In order to compare expression levels between samples, the number of reads counted for a 
given gene is normalized [89] between samples and subsequently used for deduction of which genes 
are differentially expressed. For alignment of reads from a genome sequencing experiment (Figure 
7B), the alignment is more straightforward as gaps are not expected. After alignment of the reads 
single nucleotide polymorphisms (SNPs) can be found as discrepancies between multiple reads and 
the reference genome at a given position. Depending on how many reads agree with the reference 
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genome and the alternate sequence it can be deduced whether the mutation is homozygous or 
heterozygous. With a similar method as for detection of differentially expressed genes, copy 
number changes can de spotted based on differences in the read depth from gene to gene. In chapter 
7 detailed descriptions are given on the bioinformatics pipelines used in this thesis. 
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In this chapter, the conclusions generated from whole-genome-sequencing (WGS) of two CHO 
genomes (CHO DXB11 and a FVIII producing cell line called F435) will be presented with specific 
focus on the detection of copy number changes in the genome. It was shown that the copy number 
directly correlated with the sequencing depth revealing an unexpected degree of haploidy. 
Furthermore, when analyzing the genes from each chromosome separately, it was found to reveal 
unique signatures for each chromosome. Following the published work from BMC genomics, a 
short update is provided concerning the importance of the 3
rd
 generation sequencing efforts of the 
C. griseus genome currently underway. 
  
   
     
     

           

                 
                    
   
                  
                
                 
                 
                      
                  
                  
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              
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        
       
         
       
            
        
         
      
          
   
       
          
       
          
          
       
          
       
       
          
     
          
        
       
  
          
         
       
         
        
         
       
          
        
        

       

          
         
       
         
      
         
        
       
       
        
          
        
          
         
         
       
         
            
            
          
          
        
      
         
             
          
         
        
        
      
         
        
         
         
        
        
            
      
   
       

       
          
         
         
         
          
        
         
        
         
  
         
         
         
        
        
         
         
        
      
         
     

        
        
           
         
            
        
         
         
          
        
       
        
       
         
       
           
      
         
        
         
       
       
          
    
       
       
        
         
          
        
       
          
         
        
          
          
        
          
         
         
      
       




        
         
           
            
             
             
           
          
          
            
            
          
           
          
          
   
    
  
   
     
   
  
     
   
         
        
          
          
        
   
       
       
         
         
       
         
         
          
      
        
          
            
         




















                     
                      
                      











        
  
         
         
          


         
       
          
          
        
          
     
        
        
           
         
        
       
       












                   
                      
               
        
  
           
     
     
     
     
     
     
    
     
    
    
         
          
         
           
          
        
            
         
        
      
         

        
       
        
         
       
         
           
          
         
          
         
          
         
        
        
         
        
        
        
         
         
          
         
           
         
          

         
        
        
           
         
          
           
         
       
          
        
           
        
       
         
       
       
        
         
        
           
        
         
      
     
        
         
         
          
         
        
         
         
       
         
         
        
           
         
       
    
         
        
         
      
         
         
       
         
           
        
         
       
            
         
     
       
         
      
         
         
      
      
        
        
         
          
       
      
   
         
        
         
           
         
        
       
          
        
       
          
        
            
         
        
        
        
        
       
      
         
       
          
        
          
          
         
         
          
          
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         
      

          
       
     
         
        
         
         
          
           
          
         
       
          
        
        
          
    
 
       
        
       
         
        
           
     
          
          
         
           
         
          
       
        
      
       
       
        
       
  
     
        
        
         
        
         
         
         
       
        
         
       
        
 
  
         
        
         
             
            
         
         
        
          
       
    
 
       
      
      
       
      
       
       
          
     
 
         
         
         
       
     
       
       
       
    
     
      
        
     
  
          
    
     
       
        
        
       
      
     
         
      
    
         

 
        
    

         
         
          
         
         
         
         
         
 
 
           
          
       
             
            
            
             
            
            
         
            
          
          
         
          
        
           
            
    
 
        
 
             
         
        

           
           
             
        
 
        
         
        
      
         
    
       

       

             
        
 
                
          

           
          
            
           
 
            
          
            
        

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         
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2.2 Outlook and future perspectives 
   Following the work published in BMC Genomics [1], the method used for deduction of copy 
numbers has been further improved making identification of local changes in copy number 
detectable (Figure 1). At the time of writing, the final stage of sequencing is taking place at Johns 
Hopkins and the University of Delaware (personal communication: Kelley Heffner), in order to 
update the assembly of the C. griseus genome using 3
rd
 generation sequencing reads [2].  This 
assembly is expected to combine most of the 53,000 scaffolds currently making up the C. griseus 
genome into a more coherent representation. If this is achieved, an unprecedented level of detail 
will be able to be detected for copy number changes and will allow identification of which 
chromosomal regions have been amplified and reduced.  
 
Figure 1 Copy number across four scaffolds from chromosome 2 
Local differences in copynumber can be detected with relative ease providing  an estimate for the number of 
rearrangement events in the different CHO genomes. Blue line indicate a detected difference in copy number. X-axis 
represent the position on the scaffold given with a scale of 10,000bp. 
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   From the data presented previously [1] it was apparent that large regions of the CHO genomes are 
present in a copy number higher than two, which to some extent can explain the large number of 
scaffolds in the CHO-K1 ATCC sequencing project [3]. The reason why the scaffolds cannot be 
assembled is probably not solely a matter of assembly of short reads in regions containing repeats, 
but also a matter of trying to assemble a complex quadroploid stretch of DNA and demand a 
haploid representation in fasta format. This also reveals the need for creation of a well annotated C. 
griseus genome, because it is probably the closest organism we can sequence, which is stable in 
terms of copy number. This will allow for a haploid representation in fasta-format with the lowest 
number of scaffolds and thus provide a better overview.  
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Chapter 3 – Transgene expression in CHO 
   In this chapter, the focus will be moved from the genome as a whole to specifically the F8 
transgene in CHO transfectants producing FVIII. Transcriptomics data has most commonly been 
achieved using microarrays: predefined oligos, which based on annealing with sample, can be used 
to deduce expression level. One of the advantages of RNA sequencing is that whatever is in the 
sample will be sequenced, thus allowing for insights into the composition and expression of the 
transgene used for transfection of the cell line in addition to the general transcriptome. First, the 
paper: “Deep sequencing reveals different compositions of mRNA transcribed from the F8 gene in a 
panel of FVIII-producing CHO cell lines” is attached and next data from the characterization of the 
F8 transgene in the Clone 1 genome (also referred to as F435 in this thesis) is shown. Finally, data 
is presented from co-expression of the F8 transgene and three different protein disulfide isomerases 
in the Icosagen system revealing substantial selection pressure in the cell pools against the F8 
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    
 
        
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3.2 Composition of the transgene composition in the genome of Clone 1  
3.2.1 Introduction 
Following transfection of a transgene into CHO cells the gene can be incorporated into the genome. 
By applying selection pressure over longer periods of time only the cells having incorporated the 
transgene and actively transcribing the selection marker are able to survive. In the case of the 
DHFR selection system, MTX addition can be used to increase the cellular need for DHFR inducing 
higher transcription levels of the transgene and the selection marker. This is mostly achieved by the 
cell through amplification of the transgene copy number in the genome [1]. Here we present an 
analysis in the composition and location of the F8 transgene in the Clone 1 genome, which is a 
CHO DXB11 cell line, which after transfection underwent amplification with MTX.  
3.2.2 Results and Discussion 
In the pursuit of identifying the location of the inserted transgene in the Clone 1 genome (also 
referred to as F435 in a recent paper [2]) the raw WGS reads were aligned to the CHO-K1 ATCC 
genome and subsequently the alignment file was searched for break-spanning reads, which are 
paired reads aligning to the transgene with one pair and on the genome with the other pair.  
 
Table 1 List of scaffolds found to have break-spanning reads aligning to the transgene and the genome. 
Ranking Reads Scaffold name   Ranking Reads Scaffold name 
1 260 NW_003613906.1   6 3 NW_003613600.1 
2 34 NW_003614308.1   7 3 NW_003613653.1 
3 5 NW_003613609.1   8 3 NW_003613658.1 
4 4 NW_003613585.1   9 3 NW_003613679.1 
5 3 NW_003613583.1   10 3 NW_003613683.1 
 
In Table 1 it is seen that scaffold NW_003613906.1, found on the C. griseus chromosome 2, holds 
the largest number of break-spanning reads and was thus investigated more thoroughly.    
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Figure 1 Sequencing depth for 40kb flanking the two suggested insertion locations.  
It is seen that the 2.5kb flanking the insertion are found in much higher depth indicating amplification of this region. 
 
From the depth distribution (Figure 1) it is seen that reads aligning to a 2.5kb region on 
NW_003613906.1 (pos 140800-143300) are vastly overrepresented in sequencing results from the 
Clone 1 genome compared to the CHO DXB11 genome with a median depth of 27.7 in this region 
compared to 2.0 in the rest of the scaffold. The 260 break-spanning reads found to align to this 
scaffold was de novo assembled and the contigs were searched against NW_003613906.1 and the 
transgene sequence. One contig revealed the transition from position 7664 on the plasmid on the 
minus strand into pos 143061 on NW_003613906.1 indicating that 114bp of the plasmid had been 
trimmed away from the site used for linearization compared to what was found in the genome. 
Another contig surprisingly revealed the transition from 1.2kb into the FVIII CDS onto the genome 
at pos 140979 indicating the integration of a truncated plasmid only containing promoter and 1.2kb 
of the FVIII CDS. 
 
Copy number analysis of the transgene 
In order to get a better picture of the transgene, the depth of coverage was calculated for F8 and 
dhfr transgene regions (Table 2).  
 
Table 2 The normalized read count for F8 and dhfr listing the minimum, maximum, median, mean and standard 
deviation of read depth measured spanning their CDS 
  min max median mean st.dev st.dev/mean 
F8 26.8 103.6 55.6 63.1 17.4 27.6% 
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Due to the large standard deviation for the depth of the F8 coding region the entire region was 
plotted and it was seen that the first 1,200bp of the F8 CDS had a copy number of 90 whereas the 
rest of the F8 CDS only have a copy number of 54 (Figure 2A). All of dhfr has a copy number of 
92. The mRNA depth distribution is seen to be uniform over the entire transcript, which indicates 
that both F8 and dhfr are only expressed in the form covering the entire transcript (Figure 2B). 
Thus, the extra copies of dhfr and the start of F8 either transcriptionally silent or degraded quickly. 
The insertion event described in the previous section showed that the left insertion was from 2.8kb 
into the plasmid on the minus strand, which then explain why the first 1.2kb of FVIII are found in a 
higher copy number than the rest of the gene. As to dhfr we know that the insertion on the right side 
of the 2.5kb span of genomic sequence held the dhfr sequence and this is needed to be transcribed 
in order to select by MTX inducing amplification of this region of the genome. This consequently 
indicates that full length transgene are also present on the left side of the amplified region. The 
remaining copies might be present next to the truncated F8 gene as they are found in almost 
identical number of copies. It could be speculated that the second insertion 2.5kb from the full 
length transgene might aid in some way at keeping the region open and e.g. function as promoter 
decoys which the cell can methylate without affecting FVIII production.  
Figure 2 Sequencing depth for the transgene sequence  
A) Depth measured from WGS genome sequencing data from Clone 1 and B) from RNAseq data  
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In combination with the work published earlier [3] Clone 1 was sent for targeted sequencing [4]. 
The coverage of the transgene is visualized in Figure 3A. Two libraries were made enriching for 
fragments centered on position 5110 and another on position 6760, in both cases the enrichment of 
these positions in the sequencing data is apparent (Figure 3B). The two libraries both validated the 
integration from pos 1-7776 seen from WGS (with a small exception for coverage of the region 
5707-6476 due to a technical bias).  
 
Figure 3 Sequencing depth for the transgene sequence in the targeted sequencing data of Clone 1.  
A) sequencing reads are seen to cover pos 1-7776 of the transgene. B) Two libraries were made primed for sequence 
from position 5110 and another on position 6760 and reads covering these positions are seen to be vastly 
overrepresented compared to reads aligning to the rest of the transgene. Library A shown in black and library B shown 
in grey. 
 
As to the insertion site, the targeted sequencing data detected the same insertion site as by WGS, 
but due to the nature of the TLA targeted sequencing method, it would be expected that the 
surrounding region of the scaffold would be heavily sequenced, as it is found flanking the primed 
DNA [4]. In contrast, only the 2.5 kb found in between the two inserts are seen in the targeted 
sequencing data and no reads align to other regions of the scaffold (Figure 4A). From each of the 
two libraries approximately 350 mio reads were sequenced, allowing accurate investigation of the 
transgene and the suggested insertion site with 600 times less sequenced reads as when used for 
WGS. SNP detection can be carried out by high accuracy due to the very high coverage of the 
transgene in targeted sequencing compared to WGS, but only pos 710 and 878 of the promoter 
region was found to contain mutations. It has recently been shown by Zhang et al [5] that using 
standard SNP detection tools on RNAseq data, that they were able to detect point mutations in the 
IgG transgene of clones and thus use RNAseq data for cell line screening early in the process.   
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Figure 4 Sequencing depth on scaffold NW_003613906.1 using targeted sequencing data 
A) Depth measured at scaffold NW_003613906.1 and B) transgene. Reads aligning to position are shown in black and 
break-spanning reads aligning to position shown in dashed grey. 
 
The transcriptomics landscape of the suggested insertion site 
The area suggested as integration site is found in an intron between exon 7 and 8 of the gene 
LOC100774471 (sodium- and chloride-dependent glycine transporter 1-like), which is a 
transcriptionally active gene (Figure 5B). Looking specifically into transcription of each of the 
exons no difference is seen in the transcription of the gene in Clone 1 compared to other FVIII 
clones. If the transgene had been inserted and amplified 30 times in one location the combined 
length would be more than 600 kb and would thus expect to impact the transcription level from 
exon 8-13 compared to 1-7. 
 
 
Figure 5 Transcription of the gene harboring the suggested integration site.  
A) The site is found in the gene: LOC100774471 between exon 7 and 8. B) The gene is not differentially expressed in 
the Clone 1 and the C) The expression of each exon is similar in Clone 1 compared to other FVIII clones with no 
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3.2.3 Conclusion 
Based on the knowledge gained from WGS, mRNAseq and targeted sequencing data, the most 
likely explanation is that the 2.5kb fragment from scaffold NW_003613906.1 was integrated into 
the genome somewhere else with transgenes flanking it: one side with a truncated and a complete 
transgene and one complete on the other side (see Figure 6). After insertion, selection by MTX 
induced amplification of the region in the genome. Due to the stoichiometric relationship of the 
model it would be expected to find a sequencing depth of 30x for the NW_003613906.1 fragment, 
60x for the majority of the F8 transgene and 90x for the start of the transgene and dhfr, which 
correspond quite well with the depths measured. As the targeted sequencing data did not yield any 
reads aligning to the NW_003613906.1 scaffold outside the 2.5 kb region and the transcriptome did 
not show any sign of disruption in Clone 1 it would appear that the insertion has occurred 
somewhere else. Due to the short fragments sequenced using the Illumina technology it is not 
possible to conclude more at the present time, but sequencing with PacBio or southern blots might 
provide further insights. SNP detection did not prove to be relevant in this given case, but all three 
omics technologies allow for such analysis. Though, SNP detection by WGS require high depth 
over the entire genome and would thus be the most expensive option of the three to answer that 
question. 
 
Figure 6 a model of the transgene composition in the Clone 1 genome 
 
3.2.4 Materials and methods 
Deduction of sequencing depth 
Genomic DNA was extracted from Clone 1 cells, sequenced and aligned to the CHO-K1 ATCC 
genome as described elsewhere [2]. From the alignment bam file reads were extracted aligning to 
the heterologous sequence and CHO scaffolds by a custom script. The depth of sequencing 
coverage was measured for the transgene and the NW_003613906.1 and normalized as described 
elsewhere [2]. Break-spanning reads were assembled de novo into contigs using CLC genomic 
workbench (CLC Bio, version 7.5) under standard settings. The contigs were exported and blasted 








Orientation not known Transcriptionally silent
Unknown 
insertion site(s)
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Targeted sequencing  
Targeted sequencing of the transgene in the Clone 1 genome was carried out as described elsewhere 
[3]. The reads were aligned to the CHO-K1 ATCC genome and break-spanning reads were 
extracted. The sequencing depth was measured using genomeCoverageBed from BEDTools 
(version 2.16.2) measuring both the depth for all aligned reads and for a subset only containing 
break-spanning reads.  
 
RNA sequencing 
RNA was extracted from Clone 1 cells in the exponential growth phase, sequenced and aligned to 
the CHO-K1 ATCC genome out as described elsewhere [3]. The location of the suggested insertion 
site was visualized using CLC genomic workbench (CLC Bio, version 7.5). The depth of 
sequencing was measured using genomeCoverageBed from BEDTools (version 2.16.2) specifically 
for the exon sequences and visualized using Microsoft Excel.  
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3.3 Semi-stable expression of transgenes in the Icosagen system 
3.3.1 Introduction and Background 
In order to study targets for cell line engineering, the gene of interest are generally co-expressed in a 
cell line to investigate the impact on the productivity or product quality. This can be achieved either 
by 1) transiently expressing one or several genes until the plasmids containing the genes are diluted 
out of the cellular population or 2) spending months generating a stable cell line with the target 
gene(s) stably integrated into the genome. In order to introduce an alternative, the QMCF system 
from Icosagen promises to generate a pool of semi-stable cells expressing a gene of interest within 
two weeks of transfection [1]. The system rely on the mouse polyomavirus large T (LT) antigen to 
initiate replication of the plasmid containing the transgene and the EBNA-1 protein (from the 
Epstein-Barr virus) to bind the plasmid to the host chromosome ensuring approximately equal 
distribution of plasmid from mother to daughter cells [2]. The CHOEBNALT85 cell line is derived 
from CHO-S and has been engineered to stably express the EBNA-1 protein allowing for binding of 
plasmids, containing the EBNA binding site, to CHO host chromosomes (Figure 1).  
  
 
Figure 1 Viral genome propagated into both daughter cells following mitosis due to direct binding of viral genome to 
host chromosomes by the Epstein-Barr E2 protein. The mechanism above was used for development of the Icosagen 
system. Figure rearranged from [3].   
 
   Protein folding in the cell is assisted by several chaperones able to catalyze the reactions so that 
correct folding is induced within a short timeframe. Secreted and cell-surface proteins are 
commonly stabilized by disulfide bonds and the construction of these are catalyzed by Protein 
disulfide isomerases (PDIs) [4]. It has previously been shown that overexpression of PDI in CHO 
cells lead to an increase in antibody productivity of 15-37% [5,6], whereas it did not impact the 
productivity of thrombopoietin [5] and caused reduction in productivity when co-expressed with 
tumor necrosis factor receptor:Fc fusion protein by retaining the protein in the ER [7]. To my 
knowledge, the co-expression of PDI with FVIII has not been described in literature. Here data is 
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presented on FVIII production co-expressed with combinations of three different PDI’s (PDI, 
PDIA3 and PDIA6) using the Icosagen system in order to investigate the robustness of the system 
for high throughput hypothesis testing and investigate the impact of PDI co-expression for 
improved FVIII production.  
3.3.2 Results and Discussion 
   In order to investigate the impact of co-expressing PDI, PDIA3 and PDIA6 in CHO cells 
producing FVIII, the genes were synthesized and inserted into a plasmid compatible with the 
Icosagen CHOEBNALT85 system. Cells were transfected with different combination of plasmids 
and the expression of transgenes was validated using western blotting (Figure 2). 
 
Figure 2 Western blots showing overexpression of PDIs and FVIII  
A) Information regarding the amount and plasmid(s) used for transfection of cells. Western blotting staining for B) PDI  C) PDIA3 
D) PDIA6 E) FVIII and F) Beta-actin. Picture rearranged with permission from [8] 
 
   Following four days of production the productivity was calculated and compared to the plasmids 
levels in the cell measured by qPCR and F8 expression levels measured by qRT-PCR (Figure 3A). 
Pool 11 only transfected with plasmid containing F8 were found to yield the highest level of F8 on 
DNA, RNA and expressed FVIII compared to the other ten pools. Interestingly, Pool 9 expressing 
F8 as well as PDI and PDIA6, was found to have a FVIII productivity of 87% to Pool 11 but only 
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containing a third of the F8 DNA and RNA-level observed in Pool 11. It has been shown previously 
that the F8 expression level does not appear to correlate with FVIII productivity [9]. Due to the 
severe fluctuations in F8 expressions levels among the pools it cannot be concluded whether or not 
the PDIs elicit a significant difference in FVIII productivity.  
 
Figure 3 Fluctuations in the F8 plasmid levels following transfection. 
A) Productivity was calculated as ng of FVIII per cell per day relative to the highest producing pool. DNA levels were 
estimated based on F8 levels from genomic DNA extraction normalized to pool 11. Diameter of circles indicates F8 
expression levels based on qRT-PCR normalized to pool 11. B) Levels of F8, PDI, PDIA3 and PDIA6 transgene 
plasmid measured by qPCR from extracted genomic DNA. 
 
   The ratios of transfected plasmid found in the end of the production phase were found to differ 
markedly from the ratios used for transfection (Figure 3B). It was seen that plasmids encoding PDI 
and to a lesser extent PDIA6 and PDIA3 dominated in pools co-expressing these genes and only in 
Pool 11 encoding only FVIII did the F8 plasmid dominate. It thus appears based on the differences 
between the two time points, that a clear selection pressure exists to avoid plasmids encoding F8. 
This is found to be in contrast to data from earlier work in our lab co-expressing antibodies and 
chaperones of similar size as the PDIs in the same cell lines, where the antibody productivities did 
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selection marker is available at the present time for the Icosagen CHOEBNALT85 system. In the 
case more selection markers had been available, one could have been used for the F8 transgene and 
another for the PDIs, but that would probably also have led to different equilibria being set from 
pool to pool within the PDIs. Another solution would be to insert all relevant genes into one 
plasmid, but that would require several time-consuming cloning steps, and it might prove to be 
unstable due to the size of the plasmid.    
3.3.3 Conclusions 
The concentration of episomal F8 transgene as well as the F8 expression level was seen to fluctuate 
noticeably from cell line to cell line showing a clear selection pressure favoring one plasmid over 
the other, in the case of transfecting multiple plasmids at the same time with the same selection 
marker. For this reason the Icosagen system cannot be recommended for co-expression studies of 
F8. 
3.3.4 Acknowledgements 
I would like to acknowledge Anahita Zamani Mohammadian for carrying out the majority of the 
experimental work described in this section further described in [8]. 
3.3.5 Materials and Methods 
Gene synthesis and generation of transfectants 
The CHO genes encoding: PDI, PDIA3 and PDIA6 were synthesised codon optimized for CHO and 
inserted directly into the QMCF-5 vector (Icosagen, Estonia) by the synthesis vendor (Genescript, 
NJ, USA). CHOEBNALT85 cells were transfected by electroporation (GenePulser Xcell, Biorad) 
with 4µg of plasmid encoding FVIII, Herring Sperm DNA Solution and the following 
concentrations of PDI plasmids: Pool 1: 0.3µg plasmid encoding PDI, Pool 2: 0.3µg plasmid 
encoding PDIA3, Pool 3: 0.3µg plasmid encoding PDIA6, Pool 4: 1.5µg plasmid encoding PDI, 
Pool 5: 1.5µg plasmid encoding PDIA3, Pool 6: 1.5µg plasmid encoding PDIA6, Pool 7: 0.3µg 
Plasmids encoding PDI/PDIA3/PDIA6, Pool 8: 0.3µg Plasmids encoding PDI/PDIA3, Pool 9: 
0.3µg Plasmids encoding PDI/PDIA6, Pool 10: 0.3µg Plasmids encoding PDIA3/PDIA6, Pool 11: 
N/A. Cells were transferred to 1:1 CD CHO and SFM II media (Gibco) with puromycine, and 
selection with G418 was added after 24 hours. The cells were passaged every 4 days for 16 days 
until transferred to a 30 ml culture seeded with 3x10
5
 cells/ml in an orbital shaker at 36.5˚C at a 
shaking speed of 125 rpm and 8.0% CO2. Following three days of growth the incubation 
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temperature was lowered to 30°C and after 4 days of growth samples were taken for DNA 
purification, RNA purification, western blotting and FVIII quantification.   
 
Western blotting 
Protein lysates for Western blotting were prepared by spinning down 10e6 cells and resuspending 
the pellet in 200 μl of Mammalian Protein Extraction Reagent (M-PER) (Thermo) following 
manufacturer’s instructions. 30 μg of each sample was used for Western blotting. Gels were 
submitted to western blotting using Novex/NuPage blotting system (Invitrogen). Primary antibodies 
used were 1:500 dilution of sheep polyclonal anti-human factor VIII (CL20035AP, Cedarlane labs, 
Burlington, ON, Canada), 1:1000 dilution of PDI, mAb (1D3) Mouse IgG1  (Enzo® Life Sciences, 
Farmingdale, Ny, USA), 1:167 dilution of Goat anti-Human PDI A3 (RayBiotech, Inc., Norcross, 
Ga, USA), 1:100 dilution of Rabbit anti-PDI A6 antibody (Pierce Biotechnology , Rockford, Il 
USA) and 1:1000 dilution of rabbit anti-beta-actin antibody (Cell Signaling Technology, Danvers, 
Ma, USA). Secondary antibodies used were 1:20000 dilution of Donkey anti-Rabbit IRDye® 800 
CW (LI-COR® Biosciences, Lincoln, Ne, USA) 1:20000 dilution of Donkey anti-Mouse IR-Dye® 
680 LT (LI-COR® Biosciences, incoln, Ne, USA ), 1:15000 dilution of Donkey anti-Goat IRDye® 
800 CW (LI-COR® Biosciences, Lincoln, Ne, USA) and 1:10000 dilution of Alexa Fluor® 680 
donkey anti-sheep IgG (Invitrogen, Carlsbad, Ca, USA). The ladders used were Full Range 
Rainbow™ recombinant protein molecular weight marker (GE lifescience, Piscataway, NJ, USA) 
 
Estimation of plasmid and expression levels 
Genomic and plasmid DNA purification was extracted from 2x10
6
 cells using DNeasy Blood & 
Tissue Kit (Qiagen, Germantown, Md, USA) following the manufacturer´s instructions. RNA was 
extracted from 2x10
6
 cells using TRIzol (Invitrogen) the RNeasy Cleanup kit (Qiagen) following 
the manufacturer’s instructions. RNA integrity was confirmed on an Agilent 2100 Bioanalyzer 
using total RNA nano chips (Agilent Technologies, Santa Clara, Ca, USA). RNA concentration was 
measured using a NanoDrop spectrophotometer (NanoDrop Technologies). cDNA was produced 
from 1µg RNA using SuperScript III first-strand synthesis supermix (Invitrogen, Carlsbad, CA). 
Primers used for F8 ORF (transgene position 1676-1695 and 1752-1775), gapdh (Forward: 
AACTTTGGCATTGTGGAAGG and reverse: ACACGTTGGGGGTAGGAACA), PDI (Forward: 
CTGCAGCCGAAACACTGA and reverse: CACATCCTTAAAGAATCCGATGA), PDIA3 
(Forward: TCCCTTCTCCATACGAGGTG and reverse: CAGTTTCTTGTTGGCAGGACT), 
PDIA6 (Forward: GGAGGATTCGGATCACCAG and reverse: CAGCAGTGCGAATTTCATCT), 
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QMCF-5 plasmid backbone (Forward: CATCAGCCATGATGGATACTTTC and reverse: 
GGCAGGATCTCCTGTCATCT) 
The qPCR reactions were run as 20µl reaction using Quantifast SYBR green PCR Master Mix 
(QIAGEN, Germany) following manufacturer’s instructions on a Stratagene MX3000P real-time 
PCR system (Stratagene). Primer efficiencies were calculated based on 5 consecutive 5-fold 
dilutions of cDNA samples and used to calculate relative expression ratio for each gene relative to 
gapdh and normalized compared to pool 11 as described elsewhere [10]. For calculation of plasmid 
ratios the total level of plasmid was deduced based on primers binding to the plasmid backbone 
normalized to gapdh and compared to levels of relevant transgenes normalized to gapdh.  
 
Specific productivity 
FVIII antigen was measured using an ELISA kit (VisuLize, FVIII Antigen Kit) from Affinity 
Biologicals (Ancaster, ON, USA) as described by the manufacturer. The titer was normalised to the 
number of viable cells at the time of FVIII extraction as measured on a Vicell XR system (Beckman 
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Chapter 4 – Impact of FVIII production on the CHO cell 
In this chapter, the general transcriptome and proteome of the 14 CHO transfectants producing 
FVIII described in the previous chapter will be investigated. It was found that expression of the F8 
transgene has a severe impact on the state of the cells causing them to respond to the pressure by 
upregulating the unfolded protein response, the oxidative stress pathway and degrade the FVIII 
protein through the Endoplasmic-reticulum-associated protein degradation pathway. The 
preliminary manuscript attached is aimed for submission to Biotechnology and Bioengineering in 
the autumn of 2015.  
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4.1 Manuscript 1: Characterization of Chinese Hamster Ovary cells 
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4.1.1 Abstract 
Coagulation factor VIII (FVIII) is one of the most complex proteins produced heterologously in 
large scale as a biopharmaceutical. There is currently no established cell line that naturally 
expresses FVIII and thus the knowledge gained concerning the expression and secretion of the 
protein is found solely from analyses of various mammalian cell lines transfected with F8 cDNA. 
We have recently published RNA sequencing data from 14 CHO DXB11 clones expressing a 
dynamic range of recombinant FVIII, characterizing the transgene composition of the clones. Here 
we attempt to characterize the global impact FVIII biosynthesis exerts on the transcriptome and 
proteome of a number of CHO transfectants producing FVIII.  A FVIII dose-dependent induction of 
the unfolded protein response, the NRF2-mediated oxidative stress response and the endoplasmic 
reticulum stress pathway is observed. Xbp1 were found to be spliced in the FVIII producing cells 
causing induction of the unfolded protein response. Proteomic data from three clones were found to 
correlate with a Pearson’s correlation coefficient of 0.38, but a correlation of 0.84 was found 
between the two methods when analysing the subset of genes correlating with the FVIII 
productivity.  Finally it was attempted to overexpress targets based on the data. Overexpression of 
PDI, NRF2, Bach1, LAMN1, Calr, PDI/PDIA6, and Calr/PDIA3 was found in all instances to yield 
significant reductions in FVIII productivity when co-expressed, but a minor increase in FVIII 
productivity were seen by co-expression of PDIA6, FKBP2 and the miRNA: let-7f-2 in a transient 
setting. 
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4.1.2 Introduction and background 
Approximately 350,000 males world-wide suffer from hemophilia A, which is caused by genetic 
abnormalities of the F8 gene encoding coagulation factor VIII (FVIII). There is currently no 
established cell line that naturally expresses FVIII and thus the knowledge gained concerning the 
expression and secretion of the protein is found solely from analysis of various mammalian cell 
lines transfected with F8 cDNA (Plantier et al.  2005). Heterologous expression of human FVIII are 
though found to be at levels three order of magnitude lower than similarly sized secreted 
glycoproteins (Brown et al.  2014;Kaufman et al.  1997).  
 
Following transcription of the F8 gene, the translation is directed into the endoplasmic reticulum 
(ER) where it upon folding binds ER chaperones, such as immunoglobulin-binding protein (BiP) 
(Marquette et al.  1995), calreticulin and calnexin (Pipe et al.  1998). The calnexin/calreticulin cycle 
function as a quality control step for glycoproteins by retaining proteins in the ER until they are 
correctly folded (Ellgaard and Helenius, 2003). Unfortunately, it appears that a substantial portion 
of the translated FVIII accumulate as aggregates in the ER probably due to ATP depletion 
(Tagliavacca et al.  2000). This further activates the unfolded protein response (UPR) in the cell and 
cause oxidative stress (Malhotra et al.  2008). 
 
We have previously described selection and growth characterization of 14 CHO DXB11 
transfectants producing FVIII in a dynamic range (Kaas et al.  2015). The 14 clones were grown in 
batch cultures and samples for RNA sequencing were drawn 48 hours into the cultivation when all 
cultures were in the exponential growth phase. No correlation was seen between expression of the 
F8 transcript and the level of functional secreted FVIII. The transgene compositions of the clones 
were thoroughly characterized revealing severe truncations of the transgene in clone 12-14 
explaining the lack of FVIII production and Clone 3-11 were found not to transcribe a tripartite 
leader in the 5’ end of the transcript expected to impact the level of FVIII protein produced from 
each F8 transcript. Here we present, to our knowledge, the first description of the global impact that 
FVIII biosynthesis exert on the transcriptome and proteome of CHO cells. 
4.1.3 Results and Discussion 
Characterization of expression patterns from FVIII cell lines 
14 CHO DXB11 transfectants (named based on descending FVIII productivity) were grown under 
batch conditions, RNA was extracted 48 hours into the cultivations and used for RNA sequencing 
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(RNAseq). The overall variation within the dataset was visualized based on multidimensional 
scaling of the entire RNAseq dataset (Figure 8A). It is seen that the three top producing clones 
separate on the first dimension from the rest, which can be explained by the fact that these three 
clones did not originate from the same transfection reaction from the rest of the clones. On the 
second dimension clone 12 and 13 separate from the rest as controls versus the FVIII producers. 




Figure 8 Characterization of the RNAseq dataset. 
A) Multidimensional scaling of the biological coefficient of variation for the RNAseq dataset from all samples. B) A histogram 
showing the distribution of pearson's correlation coefficients for each gene to the FVIII productivity of the cell line. Lines mark one 
standard deviation from the mean. 
 
By mapping the Pearson's correlation coefficient for the expression level of each gene to the amount 
of secreted FVIII found at the time of RNA extraction, a list of 504 genes with a correlation higher 
than one standard deviations from the mean (Figure 8B) and a fold change higher than two from 
control to high producer were extracted (Supplementary table 1-2).  Notably, BiP (HSPA5), which 
is known to bind FVIII in the ER, was found to be upregulated 3.3 fold from the top FVIII producer 
(Clone 1) versus a control (Clone 12) with a p-value of 7.6E-108. BiP was furthermore found to 
correlate with a Pearson correlation coefficient of 0.87 indicating a dose-dependent induction of the 
expression. In contrast, the BiP level did not correlate to the level of F8 mRNA (the Pearson's 
correlation coefficient = 0.08), which could indicate that the translational efficiency is different 
from clone to clone. It has previously been found that overexpression of BiP decreased FVIII 
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(Brown et al.  2011), which represent a complex interplay between FVIII productivity and BiP 
expression. 
 
The Ingenuity Pathway Analysis (IPA) software package was used to identify biological pathways 
significantly enriched for the 504 genes correlating with productivity (Table I, full table in 
Supplementary Table 3). Notably, the three highest ranking pathways are the unfolded protein 
response (UPR), the endoplasmic reticulum stress pathway and the NRF2-mediated oxidative stress 
response indicating a dose dependent relationship between induction of these pathways and the 
amount of FVIII that successfully pass through the secretion machinery of the CHO cell.  
 
Table I List of the top 10 enriched pathways as found by IPA for genes correlating with FVIII 
productivity. 






1 Unfolded protein response 1.66E-07 10 42 
Calr, Edem1, Traf2, Dnajc3, Srebf1, Hsp90b1,  
Hspa5 (BiP) , Ppp1r15a, Sel1l, LOC103163461   
2 
Endoplasmic Reticulum Stress 
Pathway 
6.31E-05 5 19 Calr, Traf2, Dnajc3, Hsp90b1, Hspa5 (BiP) 
3 
NRF2-mediated Oxidative Stress 
Response 
1.23E-04 13 133 
Chcr1, Acta2, Ppib, Pik3cb, LOC100753467, 
Dnajc3, LOC100750937, LOC100766772, Dnajb11, 
Ephx1, Gclm, Dnajb14, Herpud1 
4 
Amyotrophic Lateral Sclerosis 
Signaling 
2.29E-04 9 51 
Grin3b, Akt3, Grin2d, Xiap, Bcl2l1, Gria4, Vegfb, 
Pik3cb, Birc3 
5 TNFR2 Signaling 3.24E-04 5 29 Traf2, Tnfaip3, Xiap, Nfkbie, Birc3 
6 
Role of Osteoblasts, Osteoclasts and 
Chondrocytes in Rheumatoid 
Arthritis 
8.13E-04 13 219 
Nfatc4, Traf2, Akt3, Dkk3, Itga3, Nfkbie, Pik3cb, 
Birc3, Il18, Csf1, Xiap, Il33, Apc2  
7 PI3K Signaling in B Lymphocytes 1.58E-03 9 128 
Nfatc4, Akt3, Fcgr2b, C3, Pdia3, Blnk, Atf5, 
Nfkbie, Pik3cb    
8 
Agranulocyte Adhesion and 
Diapedesis 
2.34E-03 11 189 
Il18, LOC100763261, Mmp9, Itga3, Cxcl3, Acta2, 
Sdc4, Cxcl1, Mmp17, Il33, LOC100769029   
9 CD40 Signaling 2.45E-03 6 65 Traf2, Fcer2, Tnfaip3, Ptgs2, Nfkbie, Pik3cb     
10 Molybdenum Cofactor Biosynthesis 2.57E-03 2 4 Mocs3, Nfs1       
 
Xbp1 splicing  
There were seen to be a significant overlap (p-value 6.09E-10) between 21 genes found to correlate 
with productivity (Srebf1, Sec11c, Sdf2l1, Rpn2, Ppib, Piga, Pdia3, Pdia4, Pdia6, Hyou1, Hspa5 
(BiP), Hsp90b1, Herpud1, Fkbp2, Fkbp11, Edem1, Dnajc3, Dnajb11, Ddost, Calr, Cxcl1), and 
genes found to be up-regulated by the transcription factor Xbp1(s) (Sriburi, 2007). The transcription 
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factor Xbp1 is normally translated into an in-active isoform but in the case unfolded proteins 
accumulate in the ER lumen, BiP will bind the proteins and no longer bind sequester IRE1α 
(encoded by Ern1). Once liberated from BiP, IRE1α will homodimerize and use its RNase activity 
to splice the transcript of Xbp1 by removal of a 26bp intron inside exon3 causing the translation of 
spliced Xbp1 (called Xbp1(s)) (Zhang and Kaufman, 2006). The ratio of  Xbp1(s) versus total Xbp1 
transcripts is shown in Figure 9 to be a mean of 40±13% in FVIII producing cell lines versus 
14±10% in control cells (p-value 5.6E-06) indicating that the majority of BiP is indeed bound in the 
FVIII producing cell lines (Clone 1-11) causing induction of the unfolded protein response. Earlier 
work showed that overexpression of Xbp1(s) in CHO-K1 cells lead to an increase in SEAP 
production (2x) (Tigges and Fussenegger, 2006), but overexpression in a FVIII cell line has been 
shown to yield conflicting results with no impact (Campos-da-Paz et al.  2008) or positive impact 
on FVIII biosynthesis (Brown et al.  2011).  
  
Figure 9 Ratio of spliced Xbp1(s) versus total expression of Xbp1.   
Ratios shown of Xbp1(s) compared to total Xbp1 transcript from FVIII producing clones (Clone 1-11) 
versus the controls (Clone 12-13). See Supplementary Figure 1 for further details. 
 
 
Network-based analysis of transcriptional response to FVIII expression 
In order to gain a better insight into the specific impact that FVIII expression puts on the CHO 
secretion machinery, a CHO-specific reconstruction of the secretion network (Lund et al, 
manuscript in preparation) was used to evaluate the data (shown in Figure 10A and listed in 
Supplementary Table 4). The network consists of 654 genes known to be relevant for secretion 
linked by 166 functions. Only genes known to be present in the CHO-K1 genome (Xu et al.  2011) 
were included in the network. When analysing the subnetwork associated with the function 
“recognition of misfolding” (Figure 10B) it is seen that the CRT/CNX-complex consisting of 
Calreticulin/ERP57 (PDIA3)/Calnexin is up-regulated. This complex is essential for quality control 
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productivity whereas Calnexin is only slightly induced (as Calr and PDIA3 expression is induced 
by Xbp1(s)). PDIA3 has been shown to be vital in assembly of the HMC complex (Garbi et al.  
2006) and furthermore have been found to mediate the substrate recognition of the 
Calreticulin/PDIA3/Calnexin complex (Oliver et al.  1999). It would thus be interesting to 
investigate whether PDIA3 alone or in combination with calreticulin could be a limiting factor in 
FVIII biosynthesis. 
 
PDI expression and a possible link to oxidative stress 
Genes coding for PDI’s such as PDIA3 (ERP59), PDIA4 (ERP72) and PDIA6 (TXNDC7) were 
found to be up-regulated in FVIII cells as a part of the UPR (Figure 10B). This tendency is 
interesting as disulfide bond formation catalyzed by PDIs produce reactive oxygen species (ROS) 
and it has been shown that production of FVIII lead to oxidative stress due to ROS (Malhotra et al.  
2008). From the current dataset it is clear that there is not a single gene in the oxidative 
phosphorylation or glycolysis pathway that is seen to be differentially expressed in the FVIII 
producing cell lines (data not shown), which would otherwise be considered the primary source for 
ROS. It is estimated that approximately 25% of the ROS generated by the cell is a byproduct from 
disulfide bond formation in the ER (Malhotra and Kaufman, 2007) and due to the presence of the 
retained FVIII in the ER, overexpression of PDI could thus result in a futile cycle of disulfide bond 
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Figure 10 CHO specific secretion network overlaid with RNAseq data 
A) CHO secretion network consisting of 654 genes and 166 functions. B) Subnetwork consisting of genes 
relevant for detection of misfolded protein. C) Subnetwork consisting of genes relevant for ERAD. D) 
Subnetwork consisting of genes relevant for ER-Golgi transport. Colors indicate log2(Foldchange) 
between all FVIII producing clones (Clone1-11) versus controls (Clone 12-14).  
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Endoplasmic-reticulum-associated protein degradation actively degrade FVIII 
Several members of the endoplasmic-reticulum-associated protein degradation (ERAD) pathway 
such as EDEM1, EDEM2 and DERL2 were found to be significantly up-regulated in FVIII 
producing cells (Figure 10C). These findings correspond well with the fact that  
pulse chase experiments has previously shown that significant portions of synthesized FVIII is held 
back in the ER and degraded instead of being secreted (Pipe et al.  1998). EDEMs have been found 
to bind glycoproteins failing quality control from the Calreticulin/Calnexin/PDIA3 complex and 
delivering them for translocation to the cytosol and subsequent degradation by the 20S proteasome, 
by retrotranslocation channels such as the one encoded by DERL2 (Vembar and Brodsky, 2008;Oda 
et al.  2006). Overexpression of EDEM1 and DERL2 has previously been shown to result in 
decreased half-life of misfolded proteins in the ER (Molinari et al.  2003;Oda et al.  2006). Addition 
of lactacystin (an inhibitor of the 20S proteasome) resulted in successfully stalling ERAD and 
caused accumulation of FVIII in the ER, but it did not impact the secretion level of FVIII indicating 
that increasing the half-life of FVIII in the ER will not impact the productivity of a cell line (Pipe et 
al.  1998). 
 
Transport from the ER to the golgi reveal patterns different from IgG production 
Within the expression pattern of the genes known to be relevant for ER to Golgi transport it is seen 
that LMAN1 (ERGIC53) and MCFD2 are constitutively expressed showing no significant induction 
in high FVIII producing cell lines (Figure 10D). Previous studies showed that addition of 
cycloheximide (a strong inhibitor of protein biosynthesis) to a cell line producing FVIII-GFP lead 
to the majority of FVIII being contained in the ER close to exit sites for more than 6 hours, which is 
very slow compared to just GFP containing an ER-export signal sequence (Heinz et al.  2009). 
LAMN1 and MCFD2 are known to be essential for correct transport from the ER to the cis-golgi 
complex (Zhang et al.  2006) and it could thus be suggested that LMAN1 and MCFD2 constitute a 
bottleneck in FVIII biosynthesis as the production of FVIII must be expected to be several orders of 
magnitude higher in a stable FVIII producing cell line like Clone 1 compared to native expression 
of F8 in hepatocytes and sinusoidal endothelial cells (Hollestelle et al.  2001).  
 
Proteome data correspond well with transcriptomics data 
   In order to validate the results above the proteomes from clone 1, 7 and 12 were investigated. The 
clones were grown under the same experimental conditions as for the RNA extraction and protein 
lysates were extracted 48 hours into the cultivation when the cells were in the exponential growth 
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phase. There were no significant differences detected in neither growth rate nor productivity (data 
not shown). Following treatment and digestion the lysates were divided and measured over two 
mass spectrometry (MS) runs identifying 5062 and 6152 proteins with an FDR < 1% respectively 
(Supplementary Table 5). 4187 proteins were detected in both runs and used for further analysis. 
Notably, BiP were found to be upregulated by 2.8 fold from the Clone 12 to Clone 1, which 
correspond well with the results from RNAseq. The oxidative stress response (p-value 3.24E-07) 
was found to be the most significantly enriched pathway in the two FVIII producing clones (Clone 
1 and 7) versus the control (Clone 12). By comparing the 15 genes found to be differentially 
expressed in the oxidative stress pathway either by RNAseq (14 genes) or MS (11 genes) it is seen 
that the two methods generally agree in respect to fold-changes with some discrepancies for genes 
with low expression levels in the RNA sequencing data (Gstm3, GSTM1 and DNAJB13) (Table 2). 
   Among the 4187 proteins detected, there was found to be a correlation of 0.38 in fold-changes 
between Clone 1 and Clone 12 in RNAseq versus MS (Figure 4). By removing the 4% of the genes 
with very low expression levels in the RNAseq experiment the correlation between the two methods 
was raised to 0.50. The relation was fitted using least-square regression yielding a slope of 0.406 (p-
value < 2E-16), which is very close to the slope of 0.4 found earlier for the correlation between 
RNAseq expression levels and protein identities probably indicating translational regulation 
(Baycin-Hizal et al.  2012). Among the 504 genes correlating positively with productivity in the 
RNAseq data 101 were found in proteomics as well and among the 647 genes correlating negatively 
with the productivity, 163 proteins were found. These 264 genes correlated by 0.84 between the two 
methods revealing a large overlap in differentially expressed genes found through both methods and 
showing that discrepancies between the two methods to a large extent is found in the noise of 
housekeeping genes.  
 
Table II Overview of differentially expressed genes from the oxidative stress pathway as 
detected by transcriptomics and proteomics. 
    Transcriptome data   Proteome data 





Pearson cor   p-value 
Fold 
Change 
Gstm3 glutathione S-transferase, mu 3 3.4E-164 3.4 86.8 0.88 
 
4.9E-02 -1.3 
Gsta1 glutathione S-transferase alpha 1 3.1E-65 358.2 21.3 0.87 
 
5.5E-06 4.2 





reticulum stress-inducible, ubiquitin-like 
domain member 1 




epoxide hydrolase 1, microsomal 
(xenobiotic) 





kinase, catalytic subunit beta 
4.3E-28 23.6 2.7 0.87 
 
4.9E-03 1.6 
FTL ferritin, light polypeptide 3.6E-10 7.2 2.7 0.43 
 
#Not detected 
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DNAJC3 
DnaJ (Hsp40) homolog, subfamily C, 
member 3 
1.7E-44 109.3 2.4 0.92 
 
#Not detected 




v-maf avian musculoaponeurotic 
fibrosarcoma oncogene homolog F 




DnaJ (Hsp40) homolog, subfamily B, 
member 11 
3.2E-31 105.0 2.2 0.90 
 
3.1E-02 1.8 




v-maf avian musculoaponeurotic 
fibrosarcoma oncogene homolog K 
1.3E-10 21.5 2.0 0.37 
 
#Not detected 
GSTA2 glutathione S-transferase alpha 2 4.1E-33 239.8 2.0 0.75 
 
#Not detected 









DnaJ (Hsp40) homolog, subfamily C, 
member 16 




DnaJ (Hsp40) homolog, subfamily B, 
member 2 




aldo-keto reductase family 1, member A1 
(aldehyde reductase) 




v-akt murine thymoma viral oncogene 
homolog 1 
3.2E-52 233.5 -2.3 -0.88 
 
1.4E-03 -2.2 
PRDX1 peroxiredoxin 1 1.1E-47 1589.2 -2.3 -0.49 
 
3.6E-03 -2.0 
CUL3 cullin 3 5.0E-20 79.2 -2.4 -0.86 
 
2.6E-02 -1.4 




DnaJ (Hsp40) homolog, subfamily B, 
member 13 
3.0E-40 3.8 -8.2 -0.77   1.2E-01 2.0 
 
 
Figure 11 Correlation of transcriptomics and proteomic data. 
Fold change in expression of 4187 genes found in both the proteome and transcriptome datasets. 
Transcripts correlating positively with productivity shown in red and transcripts correlating negatively 
with the productivity in blue.  
 
Transient and stable overexpression of target genes 
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Based on the large number of chaperones found to correlate with the FVIII productivity, it was 
hypothesized that these might be limiting factors for successful folding of FVIII and they were thus 
chosen to be overexpressed. The PDIs: PDI (ERP59), PDIA3 (ERP57), PDIA6 (TXNDC7), two 
PPiases catalyzing proline cis-trans isomerization: FKBP13 (FKBP2) and FKBP11 as well as 
Calreticulin were chosen for overexpression. Furthermore, the inducer of the oxidative stress 
response, NRF2 (previously overexpressed in neurons by (Shih et al.  2003)), as well as two 
transcription factors with unknown targets (TGIF2 and Bach1) and the two ER-golgi transporters: 
LAMN1 and MCFD2 were overexpressed. Finally, miRNAseq was conducted from Clone 1, 7 and 
13 identifying 748 expressed miRNAs in all samples. 4 miRNAs (let-7d, let-7f-2, mir-181c and 
mir-34b) were found to be differentially expressed and correlated with the FVIII productivity and 
were overexpressed as short-hairpin RNAs coupled to GFP. 
 
 
Figure 12 Specific productivity of FVIII transient transfectants. 
A) Specific productivity made relative to the productivity in the negative control miRNA cell line after 72 
hours of growth in Clone 7 transiently co-expressing target genes. Specific productivity made relative to 
the productivity in the negative control miRNA cell line after in Clone 1 transiently co-expressing target 
genes for B) 48 hours and C) 72 hours. Error bars indicate standard deviation within biological 
triplicates. * p-value < 0.05. *** p-value < 0.01. 
 
Transient overexpression of the targets above in clone 7 did not yield any significant changes in 
FVIII productivity (Figure 2A), but it was found that overexpression of the miRNA let-7f-2 lead to 
a significant increase in specific productivity of 33% (Figure 5C) when overexpressed in Clone 1. 
Overexpression of PDIA6 and FKBP2 lead to an increases in productivity of 24% and 23% 
respectively, but was not significant due to a relatively high standard deviation for the productivity 
of the control. Overexpression of PDI, NRF2, Bach1, LAMN1, Calr, PDI/PDIA6, and Calr/PDIA3 
was found in all instances to yield significant reductions in FVIII productivity. In the cells 
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growth rate and cell size (data not shown). The transgene expression was measured using qRT-PCR 
showing clear induction of transgene in the relevant transfectants (Supplementary Figure 6). In 
order to validate the findings from the transient overexpression experiment, stable cell pools were 
generated by transfecting Clone 1with plasmids encoding PDIA6, FKBP2 and the miRNA let-7f-2.  
Furthermore, an IgG cell line and an EPO-producing cell line were also transfected with plasmid 
encoding the miRNA let-7f-2. The cell pools grew under selection with a growth rate unchanged 
from the untransfected mother cell line. The growth characteristics, product titer and specific 
productivity of the transfectants were unexpectedly unchanged compared to the mother cell line 
(Supplementary Figure 7).This difference might  It needs to be stated that the targets above were 
only co-expressed under the control of one strong CMV promoter and the targets might thus prove 
successful under the control of a weaker promoter bringing the dose into a more favorable region 
for the cell (Tagkopoulos, 2013). 
4.1.4 Conclusion 
Using both transcriptomics and proteomics we have, to our knowledge for the first time, described 
the cellular response to heterologous production of FVIII. The data indicate a dose-dependent 
induction of the UPR, ER-stress and oxidative stress pathways largely induced by BiP binding of 
unfolded FVIII. It was not seen to be possible to rescue unfolded FVIII solely by overexpression of 
single chaperones or proteins essential of transport from ER to the Golgi. It appears from the 
literature and from the data presented here that a bottleneck exists in the ER which is not able to 
promote folding of a significant portion of the F8-mRNA being translated. It is suggested from the 
data at hand that due to induction of the UPR, PDIs are overexpressed leading to generation of ROS 
due to a futile cycle of disulphide isomerization on the FVIII retained in the ER, which cause 
apoptosis.  
4.1.5 Materials and methods 
RNA sequencing data analysis 
14 CHO clones were grown and RNA was extracted 48 hours after seeding. See our earlier work for 
further information (Kaas et al.  2015). Following identification of the expression levels for all 
genes in the CHO genome, the pearson's correlation coefficient was calculated for each gene to the 
productivity (coagulation activity measured at 48 hours into the cultivation normalised by the viable 
cell count) using R (Ihaka and Gentleman, 1996). Genes were considered to correlate significantly 
with productivity with Persons's correlation > 0.81 or < -0.81 (constituting two standard deviations 
from the mean of all measured correlations). Determination of differentially expressed genes was 
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carried out by EdgeR as genes with a ± 2.0 fold changes, expression levels > 1 FPKM (as elsewhere 
(Mortazavi et al.  2008)) and a p-value < 0.01. 
 
Ingeniuity pathway analysis 
The proteome sequences from mouse, rat and human were downloaded from the Ensembl Biomart 
(Kinsella et al.  2011). Homologs were defined as the closest hit for each protein in CHO using 
blast+. FPKM-values, p-value, fold change ratio and the Ensembl-ID’s were introduced to IPA and 
the list of significantly enriched pathways was exported.  
 
Sample preparation for proteomics analysis 
Clone 1, 7 and 12 were grown in biological triplicates in 75 ml cultures with same experimental 
conditions and media as when extracting RNA samples for RNA sequencing (Kaas et al.  2015). 
After 48 hours of growth the cells 2-3e6 cells were spun down for 10 minutes at 1200RPM, washed 
with PBS twice followed by 5min of centrifugation at 5000RPM. The pellets were resuspended in 
SDS-lysis buffer made up by: 2% SDS (w/v), 0.1 mM phenylmethylsulfonyl fluoride (Sigma-
Aldrich) and 1 mM EDTA (Sigma-Aldrich), adjusted to pH=8 with triethylammonium bicarbonate 
(Sigma-Aldrich). The suspension was sonicated on ice for 60 seconds three times. The protein 
concentration was measured with the BCA assay (Thermo scientific). 200 µg of protein lysate was 
reduced in TCEP (final concentration of 10mM) at  
at 60°C for 1 hour with shaking at 750 rpm. The lysate is cooled to room temperature and a final 
concentration of 17.05 mM iodoacetamide is added in order to alkylate the sample. 90 microgram 
of lysate was diluted by 9M sequanol grade urea (Thermo Scientific) in order to decrease the SDS 
concentration to 0.09% and left to react in the dark for 1 hour.The sample was enriched on the 
membrane of a spin filter (Amicon Ultra-0.5 mL, Milipore) by centrifugation at 14000 xg for 10 
minutes retaining all fragments > 10kDa. The membrane was washed with 9M urea and spun down 
at 14000 xg for 10 minutes three times. The membrane was further washed two times with 50mM 
TEABC. The lysate on the membrane was digested by adding 8.5µg Trypsin/Lys-C mix (Promega) 
dissolved in 50mM TEABC, pH set to 7.8 and left to incubate over night at 37°C. The filter was 
turned around and the lysate was spun down at 1000 rpm for 2 minutes. The filer was subsequently 
turned back, 300µl TEABC was added and the filter was left for 5 minutes before the filter was 
spun down at 14,000 xg for 10 minutes. The two lysates were combined and digestion was 
validated using silver staining. Lysates were dried in a speed vac (Savant, Thermo Scientific) for 
~3hours until dry. The samples were resuspended in 80% anhydrous acetonitrile (Sigma-Aldrich) 
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and split into two samples of equal volume and dried using a speed vac. Samples were resuspended 
in 100µl 100mM TEABC and 40µl anhydrous acetonitrile. TMT labels were added to the samples 
using the TMT Mass Tagging Kits and Reagents kit (Thermo scientific) following manufacturer’s 
instructions. The nine lysates were run on two TMT runs. Run1: Clone1.1, Clone1.2, Clone7.1, 
Clone7.1, Clone12.1, Clone12.2. Run2: Clone1.1, Clone1.3, Clone7.1, Clone7.3, Clone12.1, 
Clone12.3. 
 
Fractionation of peptides and LC-MS/MS analysis 
TMT labeled peptides were fractionated on basic RPLC (bRPLC) column: XBridge C18, 5 µm 100 
x 2.1 mm analytical column (Waters, Milford, MA); XBridge C18, 5 µm 2.1 x 20 mm Guard 
column (Waters, Milford, MA). Total 24 fractions were generated by concatenation of 96 bRPLC 
fractions.  Peptide samples were analyzed on Q-Exactive instrument (Thermo scientific) interfaced 
with Proxion nanoflow LC system. Peptides were fractionated by reverse-phase HPLC on a 75 µm 
x 15 cm PicoFrit column with a 15 µm emitter (PF3360-75-15-N-5, New Objective) in-house 
packed with Magic C18AQ ( 5 µm, 120Å) using 0-60% acetonitrile/0.1% formic acid gradient over 
90 min at 300 nl/min. ESI voltage 2.4 kV. Survey scans (full ms) were acquired from 350-1,800 
m/z with up to 15 peptide masses (precursor ions) individually isolated with a 2 Da window with 
offset 0.5 Da and fragmented (MS/MS) using a collision energy of 30 and 30 s dynamic exclusion. 
Precursor and the fragment ions were analyzed at 70,000 and 35,000 resolution (at m/z =200), 
respectively.  
 
Identification of Chinese Hamster proteins 
Peptide sequences were identified from isotopically resolved masses in MS and MS/MS spectra 
extracted with and without deconvolution using Thermo Scientific MS2 processor and Xtract 
software. Data was searched against Cricetulus griseus database (RefSeq annotation of C. griseus 
GCF_000419365.1, downloaded 1st of September 2014) with oxidation on methionine, 
deamidation on residues N and Q , (as different variable modifications)  and carbamidomethyl on 
cysteine (fixed), 6-plex TMT on lysine and N-term (fixed) as modifications using Sequest software 
interfaced in the Proteome Discoverer 1.4 (Thermo scientific) workflow. Mass tolerances on 
precursor and fragment masses were 25 ppm and 0.05 Da, respectively. Only protein with at least 
one unique peptide identified with FDR<0.01 was included in the dataset. 
 
Identification of significantly enriched pathways 
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Only proteins detected in both proteome runs (4187 proteins) were used for analysis. The relative 
proteins concentrations were used to calculate the significance using unpaired two sample student t-
test assuming unequal variance using R. The fold change ratio was calculated for each protein using 
the mean value across the biological replicates. The nearest homologous protein in human, rat or 
mouse was found, as given above for the RNA sequencing data. A protein was set to be 
differentially expressed if the fold change were higher than ± 2.0 with a p-value < 0.05. The p-
value, fold change ratio and the Ensembl-ID’s were introduced to IPA and the list of significantly 
enriched pathways was exported.  
 
CHO specific secretion network 
Based on literature search a secretion network was manually built around the presence of secretion 
relevant genes in the CHO genome. Network was visualized in Cytoscape version 3.2.1(Shannon et 
al.  2003). Color of nodes were set based on log2(foldchange) from Clone 1-11 versus Clone 12-14. 
Thickness of lines encircling nodes were increased by p-value when < 0.05.  
 
miRNA sequencing data analysis 
miRNA library preparation was carried out by AROS Biotechnology by the TruSeq Small RNA 
Sample Preparation Kit (cat RS-200-0012, Illumina) using the same totalRNA samples used for 
mRNA sequencing. Only biological triplicates from Clone 1, 7 and 13 were used for miRNA 
sequencing. RNA PCR primer, index 1 sequence was removed from the raw sequencing data using 
CLC genomic workbench (version 7.5) and the miRNAs were search against miRBase (Release 21) 
for Cricetulus griseus, Rattus norvegicus, Homo sapiens and Mus musculus . miRNAs having a 
Pearson correlation > 0.8 to the productivity and p-value < 0.05 (student t-test) between Clone 1 
versus clone 8 and clone 8 versus clone 13 were chosen for cloning. miRNA stemloop sequence 
was extracted from miRBase (Griffiths-Jones et al.  2006) and synthesized as two complimentary 
oligoes. The oligoes were inserted as decriebed elsewhere (Jadhav et al.  2013) into the BLOCK-
iT
TM
 Pol II miR expression system (Invitrogen Inc., Carlsbad, CA) downstream of GFP. Primers 
used for the 4 insertion events: let-7d-fw TGCTGTCGGTTTGTAGGCAGTGTAATTAG 
CTGATTGTACCGCGGTGCTGACAATCACTAACTCCACTGCCATCAAAACAAGGC. let-7d-
rv CCTGGCCTTGTTTTGATGGCAGTGGAGTTAGTGATTGTCAGCACCGCGGTACAATC 
AGCTAATTACACTGCCTACAAACCGAC. let-7d-fw TGCTGCTCCTAGGAAGAGGTAGTAG 
GTTGCATAGTTTTAGGGCAGGGATTTTGCCCACAAGGAGGTAACTATACGACCTGCTG
CCTTTCTTAGGGCCTT. let-7d-rv CCTGAAGGCCCTAAGAAAGGCAGCAGGTCGTATAGT 
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TACCTCCTTGTGGGCAAAATCCCTGCCCTAAAACTATGCAACCTACTACCTCTTCCTAG









Gene synthesis and transient overexpression 
The CHO genes encoding: PDI, PDIA3, PDIA6, FKBP2, FKBP11, NRF2, TGIF2, Bach1, LAMN1 
and MCDF2 were synthesised (Genescript, NJ, USA) further codon optimized for CHO. Calr was 
not synthesized but amplified from cDNA extracted from CHO DXB11 cells. The genes were 
subsequently PCR amplified using Phusion polymerase master mix (New England Biolabs) and 
inserted into a pTT22 backbone with puromycine selection using In-Fusion™ cloning (Clontech, 
CA, USA) following manufacturer’s instructions (see Supplementary Figure 8). Correct insertion 
was validated using Sanger sequencing. All transient transfections were performed using the 
Nucleofector II (Lonza, Basel, Switzerland) with Nucleofector Kit V using program U-024. 2 
million exponentially growing Clone 1 or Clone 7 cells were spun down for 8 min at 100 x g and 
resuspended in Nucleofector Solution (including supplement) and the molar equivalent of 4µg of 
DNA from a 6kb plasmid was added. After transfection the cells were left to grow for 48 or 72 
hours in 4.5 ml of HyClone CDM4CHO media (Thermo). The viable cell density was measured at 
0, 24, 48 and 72 hours using the Vicell XR system (Beckman Coulter) and RNA was extracted from 
approximately 2mio viable cells at the end of the experiment. Transfection efficiency was estimated 
using GFP Transfection Efficiency Assay (Chemometec, Allerod, Denmark) using samples 
transfected with miRNA vectors containing emGFP. Cells were counted every 24 hours and 
samples were extracted at 0h and 72h for ELISA and chromogenic activity using an in-house 
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Estimation of the specific productivity 
The integral of viable cells (IVC) for the first 72 hours of growth where calculated as below, where 
X is viable cell density as measured by Vicell XR system (Beckman Coulter) and t is the amount of 




× (𝑡𝑖+1 − 𝑡𝑖)
𝑛
 
The specific productivity of the transfectants was calculated as below using the product titer at two 





qRT-PCR validation of transgene expressing in transfectants 
Expression level from transgene and endogenous versions of the gene were measured using SYBR 
green qPCR. RNA was extracted 72h hours after transfection using 1.5x10
6
 cells using TRIzol 
(Invitrogen) and Direct-zol™ RNA MiniPrep Kit (Zymo Research, CA, USA) following the 
manufacturer’s instructions. 1.5µg of RNA from each sample was used for cDNA synthesis using 
the iScript cDNA Synthesis Kit. Relevant reactions were set up using QuantiFast® SYBR® Green 
PCR kit and run on a Mx3000P qPCR System. Expression levels were plotted following the ΔΔCt 
method normalized to gapdh. Primers used for detection of endogenous genes: Fkbp2 (Forward: 
GGACCACTGTCCCATCAAGT and reverse: TGAAAACAAAGGGCTGGTTC), BiP (Forward: 
CCTATTCCTGGGTTGGTGTG and reverse: TTGGAGGTGAGCTGGTTCTT), Calr (Forward: 
GGAACCTGCCGTCTATTTCA and reverse: CCCGTAGAATTTGCCAGAAC), gapdh (Forward: 
AACTTTGGCATTGTGGAAGG and reverse: ACACGTTGGGGGTAGGAACA), PDI (Forward: 
CTCAAGTGAGGTGGCTGTCA and reverse: CGTGATTCCAAAAGGGATGT), PDIA3 
(Forward: GCTTGCCCCTGAGTATGAAG and reverse: TAAGGGTTGGGTAGCCACTG), 
PDIA6 (Forward: GTACCCAAACCCTCCAATCC and reverse: TCTTCTGAAGCTGGCTGACA)  
Primers used for detection of transgenes: F8 (transgene position 1676-1695 and 1752-1775), Fkbp2 
(Forward: GCACAGGACAGGTCATCAAA and reverse: CTTTTCTCCCTCGCACATTC), 
GFP(miRNA) (Forward: AAGTCGTGCTGCTTCATGTG and reverse: GAACGGCATCAAGGT 
GAACT), PDI (Forward: CTGCAGCCGAAACACTGA and reverse: CACATCCTTAAAGAA 
TCCGATGA), PDIA3 (Forward: TCCCTTCTCCATACGAGGTG and reverse: CAGTTTCTTG 
TTGGCAGGACT), PDIA6 (Forward: GGAGGATTCGGATCACCAG and reverse: CAGCAG 
TGCGAATTTCATCT) 
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Stable overexpression in cell pools 
GFP and the linked miRNA (let-7f-2 and negative control miRNA) were moved from the BLOCK-
iT
TM
 Pol II miR expression plasmids into the pTT22 plasmid backbone with puromycine selection 
using In-Fusion™ cloning (Clontech, CA, USA) following manufacturer’s instructions. Correct 
insertion was validated using Sanger sequencing. 10e7 of exponentially growing FVIII producing 
cells (Clone 1) were transfected with 10µg of plasmid containing let-7f-2 miRNA/negative control 
miRNA/ PDIA6/FKBP2/ empty pTT22 vector respectively, with three independent electroporation 
reactions (GenePulser Xcell, Biorad). Furthermore, 10e7 of 26.27.1E7 cells (in-house CHO-K1-SV 
cell line producing the model antibody B72.3 (Colcher et al.  1981)) and C7 cells (in-house CHO-
K1 cell line (Ley et al.  2015) producing Erythropoietin) were transfected with 10µg of let-7f-2 
miRNA/negative control miRNA vector respectively with three independent electroporation 
reactions. All plasmids were linearized prior to transfection with ApaLI (New England Biolabs).  
 
The puromycine concentration was slowly raised until the GFP transfection rates (in relevant cell 
lines) were >80% measured using the GFP Transfection Efficiency Assay (Chemometec, Allerod, 
Denmark). The FVIII cells were grown in HyClone CDM4CHO media (Thermo) supplemented 
with Penicillin/Streptomycin (Gibco), MTX and the final puromycine concentration was 5.0 µg/ml. 
26.27.1E7 pools were grown in CD CHO medium (Gibco), supplemented with 
Penicillin/Streptomycin (Gibco), MSX and 8.0 µg/ml puromycine. C7 pools were grown in in-
house made Q-CM105 media with 4mM gln, lipid mix, Vitamin K, Soy hydrolysates and 5.5 µg/ml 
puromycine. 
The stable pools were grown in an orbital shaker at 36.5˚C at a shaking speed of 250 rpm and 8.0% 
CO2 as 15ml cultures in 50 ml tubes (Cultiflask 50, Sartorius AG, Germany). Samples were drawn 
each day of cultivation, spun down at 15,000 xg and stored at -80 C° until analysis. Antibody titer 
analysis was performed on undiluted samples using Dip and Read™ Protein A (ProA) Biosensors 
measured on an Octet RED96 (ForteBio, CA, USA) following manufacturer’s instructions. EPO 
titer analysis was done on samples diluted 10E-5 using Human Erythropoietin Quantikine IVD 
ELISA Kit (R&D Systems, MN, USA) following manufacturer’s instructions. The EPO titer in 
mIU/ml was converted to mg/l by the correlation 150 units/µg (R&D Systems, MN, USA). FVIII 
quantification was carried out as described earlier and made relative to the value of the highest 
producing sample. 
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Chapter 5 – Insights into CHO Proteomics 
In this chapter, a review is presented, which was published as chapter 19 in the book: Cell 
Engineering, Animal Cell Culture (ISBN: 978-3-319-10319-8). The review concerns the current 
knowledge within proteomics to study cell culture and discuss in detail the state-of-the-art of 
proteomics methods used today. 
  
 
     
     
   
      
    
           
         
         
           
         
            
        
             
            
       
            
          
         
           
         
         

         
      
        
         
 
 
         
  
 
         
         
        
     




            
           
          
           
              
          
         
       
         






     
     










      


     
   
   
   




      




      
      




     


    

















    
          
             
              
         
           
            
      
           
             
         
          
           
         
            
        
 
            
         
              
              
          
        
          
         
             
         
            
        
          
    
         
         
         
         
            
        
            
            
            
             
          
            
             
 
           
               
          
           
          
            
         
          
             
           
       
             
              
              
            
             
         
            
              
           
         
             
     
               
            
  
    
             
           
             
          
            
              
          
            
           
             
 
          
             
          
        
           
         
   
    
           
             
          
         
       
            
              
        
            
           
          
         
  
             
     
         
         
             
           
          
          
         
           
                
          
         
         
         
          
            
          
          
            
          
             
       
    
           
           
           
             
           
            
              
             
           
        
          
            
             
            
            
           
              
           
          
         
            
           
            
           
            
            
           
            
            
       
         
           
             
           
         
           
            
           
            
          
          
         
            
            
          
             
        
       
            
    
          
                
            
           
           
             
             
            
           
        
  
          
          
           
          
            

            
            
           
            
             
         
          
         
           
           
           
         
    
            
            
            
           
            
            
            
         
    
         
            
         
           
           
        
       
            
         
           
           
          
             
            
             
 
 
           
           
             
            
         
            
          
              
       
            
          
          
           
          
           
          
          
           
   
             
    
            
         
             
          

           
           
          
         
 
            
           
         
            
           
            
        
            
          
               
        
    
        





   
   
 
   
  
    
 
 











   
  

   
  
    
 
 






























   
   
  
  















   










   















             
  
   
  









    
   
  

















   
  
  
   























































   
   





   






    
  
   

  
   
    
   
  











   
     
  
   
 

   
   
   
  
   
 
   







   
   
  
   






















   
  
 












   
  
  










   
  
  











   
  
   











             
       
           
        
          
            
       
         
            
            
          
           
             
            
          
          
        
         
           
            
           
    
              
         
         
        
          
         
          
           
           
         
             
             
  
   

  
   
   
 
   
 
  
   
  
 





    
             

        
            
          
             
           
           
        
       
      

          
            
        
             
         
            
       
         
          
             
         
        
         
            
         
  
          
          
            
         
           
          
         
         
        
             
         
            
          
         
             
        
           
        
             
       
          
         
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  
         
             
              
          
       
         
           
          
           
           
          
          
         
            
          
            
           
           
             
             
                
             
             
            
            
            
          
         
         
           
          
          
         
        
  
             
          
          
          
        
  
           
         
           
          
          
          
        
        
         
         
          
           
            
             
            
          
         
  
          
        
          
          
          
             
          
             
           
          
        
           
           
             
            
    
           
         
           
             
          
              
           
           
         
           
          
           
          
        
              
                
               
               
    
             
    
          
          
          
           
          
          
            
          
            
           
       
           
         
          
             
           
             
               
        
    
         
        

         
        
        
        
         
           
         
          
         
           
           
         
        
        
         
        
         
        
           
      
        
           
        
           
          
            
          
   

                 
          
   
               
         
  
              
           
  
             
               
               
            
   
               
             
      
               
             
 
               
        
                 
           
  
              
            

             
             
           

                 
              
           
       
               
            
         
            
 
                 
            
     
               
         

            
           
               
          
      
                  
     
              
               
    
               
            
         
        
    
                 
           
        
             
          
 
            
       
             
        
                
            
  
               
          
  
                
           
     
               
          
       
              
         
              
   
                
             

            
              
         

               
             
         
               
             

               
            
      
               
           
             
   
                
            

                 
                 
          
    
             
                 
          
   
               
            
         
               
            
     
             
            
             
       
             
            
    
             
    
             
          
                
           
            

             
             
     
              
          
  
               
        
             
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Chapter 6 – System wide analysis of CHO omics data 
In this chapter, a review will be presented on the topic of generating a genome-scale metabolic 
model specific for CHO. Following the rapid increase in genomic, transcriptomics and proteomic 
data from CHO it is now possible to generate a computational model so far only applied to other 
organisms with well-annotated genomes such as human, yeast and E. coli. The current status and 
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
       
 

    
       
      


     






      
        

   


   
       

      
       
        





        
      





     
       


        






         

  
      






     

       





       

      





       
     

   
     
       

       
     






       
      
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Chapter 7 - The CHO omics toolbox 
In this chapter, a free online database (wiki.bio.dtu.dk/CHOomics) is presented, which contain step 
by step directions for completing bioinformatics analyses as the ones presented in this thesis. As the 
community analyzing CHO omics data is tiny, compared to the scientists working with omics data 
from human or mouse, most databases or methods do not always work easily when applied to CHO 
omics data. The intention of introducing these pipelines in the thesis and on the online wiki-page is 
to hopefully reduce the amount of time needed for newcomers to start analyzing omics data from 
CHO. A short paper “Expanding the omics toolbox for CHO – a free online resource for NGS 
tools” is given, which is intended to be submitted as “Communication to the editor” at 
Biotechnology and Bioengineering, allowing potential users of the database to cite the pipelines. 
The pipelines are listed in the appendix. 
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7.1 Manuscript 2: Expanding the omics toolbox for CHO – a free online 
resource for NGS tools 
Christian Schrøder Kaas
1,2
 and Mikael Rørdam Andersen
2 
1 Mammalian Cell Technology, Global Research Unit, Novo Nordisk A/S, Måløv, Denmark.  
2 Network Engineering of Eukaryotic Cell Factories, Technical University of Denmark, Kgs 
Lyngby, Denmark.  
7.1.1 Abstract 
The CHO bioinformatics wiki (wiki.bio.dtu.dk/CHOomics) is an online resource for the Chinese 
hamster (Cricetulus griseus) and Chinese hamster ovary (CHO) cell communities. As the price has 
dropped dramatically for next generation sequencing during the past decade, sequencing of CHO 
genomes and transcriptomes are now becoming routine. In order to answer important biological 
questions from the data, complex bioinformatics pipelines are needed. The CHOomics 
bioinformatics wiki is intended to convey suggestions for how to do routine analyses such as 
finding differentially expressed genes in an RNAseq experiment and locate changes in copy number 
in a genome.  
KEYWORDS: Chinese hamster ovary cell; CHO genome; CHO transcriptome; database 
 
   Chinese Hamster Ovary (CHO) cells, originally isolated by Ted Puck back in 1957 [1], have had a 
long history as a production organism in industry due to their ability to grow in suspension without 
serum and to be scalable to large production volumes. Biopharmaceuticals are currently generating 
sales of approximately 140 billion USD of which the majority of proteins requiring post-
translational modifications are produced CHO cells [2]. Compared to the human genome [3] that 
has been available since 2001, CHO first entered the genomic era a decade later in 2011 [4] with 
several additional genomes being released recently [5-7]. For this reason tools such as standardized 
qPCR primers and databases of validated SNPs are not available yet making omics analysis on 
CHO a bit more time consuming than equivalent work in cell lines extracted from human or mouse 
tissue [8,9].  
   Following the publication of the CHO-K1 genome back in 2011 [4], the online database 
www.CHOgenome.org  was created allowing the user community to blast the genome as well as 
look up the transcripts and amino-acid sequence encoded by the annotated genes [10,11]. As 
valuable as these first steps were, simple descriptions on how to download the CHO or C.griseus 
genome and a run simple analyzes are lacking. In order to help the newcomer to the field of CHO 
omics the website wiki.bio.dtu.dk/CHOomics has been created allowing access to bioinformatics 
pipelines used for CHO omics analyzes. In the database, suggestions are listed in a step-by-step 
 Chapter 7 - The CHO omics toolbox | 131 
manner on how to accomplish the most standard bioinformatics problems in the field. The database 
is organized as a wiki-page allowing all registered users to correct and add information.  
   A “getting started” section is introduced, specifically with the purpose of introducing the genome 
and the annotation file, which are the core essential for the majority of omics analyses to be run. 
Information regarding e.g. how to access and mine the annotation file to generate a list of genes are 
explained. 
   Unfortunately, a CHO-specific SNP database does not exist at the time of writing, but using the 
code listed on the website, suggestions can be given specifically on how to locate SNPs and how to 
apply a hard-filter to the available CHO genomes, which takes into account that approximately 20% 
of the genes in the CHO genomes have been found  to be haploid and thus cannot be mined 
similarly as a strictly diploid genome [6]. 
   In the current version of www.CHOgenome.org only the sequence of the mature transcripts are 
listed, which make qPCR primer design of intron-spanning primers very time-consuming. At the 
wiki, the gene sequence for all the genes in the C. griseus genome can be accessed with annotation 
of intron and exon positions making qPCR design straight forward.  
   The initial focus of the website is to supply the most basic needs that a newcomer to the field 
might have, but the intention is that more sophisticated pipelines can be listed in the future. This 
way, scientists can be inspired with additional methods to be applied to their data and find solutions 
for the most basic problems they might encounter when analyzing CHO omics data.  
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Chapter 8 - Conclusions and Future Perspectives 
   The aim of this thesis was to investigate the impact of FVIII production in CHO cells using NGS 
tools. From sequencing the genomes of the CHO DXB11 cell line, as well as a FVIII transfectant, it 
was found that the DHFR
-/-
 phenotype could be validated from the genome sequence and in addition 
to the dhfr gene, it was found that roughly 20% of all other the genes were also haploid. These 
findings might aid researchers, using genome editing tools such as Crispr/Cas9, to find targets 
within a given pathway that are haploid and thus facilitate knock out. It was concluded that 
chromosome one and four might be more stable in terms of copy number variations compared to the 
other chromosomes. With the advent of the improved C. griseus genome and possibly additional 
CHO genomes published in the years to come, it might be possible to more accurately locate stable 
islands within the CHO genome. These stable regions might present themselves to be suitable safe 
harbors for targeted integration of transgenes. Current protocols for generation of stable cell lines 
largely depends on random integration of transgenes into the CHO genome and simply screen for 
cells with highest productivity, but it is often observed that high producing cell lines are unstable 
over time due to silencing or genome instability. By targeting the transgene into a stable region of 
the genome it might be possible to create stable cell lines sustaining high productivity over longer 
periods of time despite lower gene copy number. Furthermore, the targeted approach allow for 
better comparisons between cell lines when different transgenes may be expressed from the same 
locus under the same conditions.  
   The genome analysis also showed that 907 genes had undergone copy number changes in the 
FVIII transfectant F435 cell line as compared to the CHO DXB11 host cell line. When more CHO 
genomes become available it will be interesting to see whether such extensive rearrangements are a 
common trait among transfectants, or it is found to be a special case, possibly due to the burden put 
onto cells when producing FVIII. It would in particular be interesting to see how many gene copy 
number variations that are found in a genome, if targeted integration is used, and the cell line is not 
subsequently amplified by MTX. CHO has been used in the industry for more than three decades, 
but in the years to come, we might just learn that these cells are more plastic that we even imagined, 
due to the new possibilities within omics for measuring these fluctuations.  
   Using RNAseq data it was presented in this thesis that transgene expression, splicing of introns 
and detection of truncations can reliably be monitored. As the data can furthermore be used for SNP 
detection in the transgene, it will probably soon become standard practice at companies to run 
RNAseq analyses of the most promising clones in order to validate that the transgene is error-free 
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and transcribed as designed. If the Food and Drug Administration should choose to make whole-
genome sequencing, or targeted sequencing of transgene and transcripts, mandatory for production 
cell lines, biotech companies will soon be generating vast quantities of omics data. As NGS data 
can quickly be purged for transgene sequence by simply removing all reads aligning to the 
transgene sequence (or any other region desired to be kept secret), the possibly of donating data 
from private companies to the universities will become less problematic. 
   Using RNAseq and MS it was shown that FVIII production in CHO cells was accomplished at the 
cost of a high metabolic burden and stress. As the endoplasmic-reticulum-associated protein 
degradation pathway was found to be up-regulated there appear to be ample room for improvement 
of folding capacity of CHO for FVIII production. Several chaperones were overexpressed, but they 
did not impact the FVIII productivity significantly. In order to improve the folding capacity, it will 
be needed to test a broader panel of targets, combinations of targets and perhaps even different 
promoter strength for expression of the target chaperones. Such systematic testing will require a 
high throughput setup and screening assay. Given the general challenges in the gene therapy field 
FVIII will most likely be produced as a recombinant drug for the foreseeable future, and thus 
further work on cell line optimization will be carried out especially for future generations of FVIII 
products with longer serum half-life.   
   Within the next few months a CHO consensus genome-scale metabolic model is expected to be 
made public. In the years to come it will be interesting to see the power of the model for predictions 
of cell line engineering targets, as well as the potential for generating specific models for the 
different CHO cell lines. In order to generate a model specific for e.g. CHO DXB11 the omics data 
presented in this thesis could be mined in order to identify cell line specific patterns in 
transcriptome data and genomic copy numbers.  
  The future of CHO omics looks promising; with a better reference genome and annotation coming 
out, as well as a genome-scale metabolic model expanding the omics toolbox to a levels catching up 
with most other model organisms. By improving our understanding of this industrially important 
cell line, the prospect of generating increasingly efficient CHO cell lines for production of complex 
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Appendix  
10.1 Supplementaries for Chapter 2 
10.1.1 Supplementary figures 




Supplementary figure 1 Read depth analysis of the 20661 in the C. griseus genome.  
For most of the genomes distinct peaks can be seen for genes present in one, two and three copies. Shoulders can be 
seen in the graphs for the cell lines sequenced at a lower depth. Only one peak is seen in wild type C. griseus as 
expected. 
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Supplementary figure 2 The normalized sequencing depth of each gene in F435 and CHO DG44.  
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Supplementary figure 3 Distribution of CN across chromosomes for each cell line.  
A) Percentage of haploid genes B) percentage of diploid genes C) Percentage of genes, which are triploid or higher.  
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Supplementary figure 4 Significant GO-terms in correlation to changes in CN 
Visualization of the 135 GO-terms, which are either significantly enriched in genes with CN reductions or amplifcations 
(Fisher's exact test). GO-terms are visualized in dark blue (p-value < 0.01), light blue (p-value < 0.05) or white (p-value 
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10.1.2 Supplementary tables 
The supplementary tables shown below can be downloaded from BMC genomics 
(http://www.biomedcentral.com/content/supplementary/s12864-015-1391-x-s1.xlsx or 
http://bit.ly/DXB11suppl2). Listed below the reader will find subsections of the supplementary 
tables in order to give an overview of what information is stored in each table. 
Supplmentary table 1. SRA 
A list of SRA accession number for the publicly available CHO genomes (including CHO DXB11).  
CHO cell name SRA accesion number Original publication 
CHO DXB11 SRR1561441 Kaas et al, 2015 
CHO DXB11 SRR1561442 Kaas et al, 2015 
CHO DXB11 SRR1561427 Kaas et al, 2015 
CHO DXB11 SRR1561428 Kaas et al, 2015 
CHO-K1 ATCC SRR329939 Xu et al, 2011 
CHO-K1 ATCC SRR329940 Xu et al, 2011 
CHO-K1 ATCC SRR329941 Xu et al, 2011 
CHO-K1 ATCC SRR329942 Xu et al, 2011 
CHO-K1 ATCC SRR329943 Xu et al, 2011 
CHO-K1 ATCC SRR329944 Xu et al, 2011 
CHO-K1 ATCC SRR329945 Xu et al, 2011 
CHO-K1 ATCC SRR329946 Xu et al, 2011 
CHO-K1 ATCC SRR329947 Xu et al, 2011 
CHO-K1 ATCC SRR329948 Xu et al, 2011 
CHO-K1 ATCC SRR329949 Xu et al, 2011 
CHO-K1 ATCC SRR329950 Xu et al, 2011 
CHO-K1 ATCC SRR329951 Xu et al, 2011 
CHO-K1 ATCC SRR329952 Xu et al, 2011 
CHO-K1 ATCC SRR329953 Xu et al, 2011 
CHO-K1 ATCC SRR329954 Xu et al, 2011 
CHO K1 Protein free SRR803173 Lewis et al, 2013 
CHO K1 Protein free SRR803174 Lewis et al, 2013 
CHO K1 Protein free SRR803175 Lewis et al, 2013 
CHO-K1 ECACC SRR803176 Lewis et al, 2013 
CHO-K1 ECACC SRR803177 Lewis et al, 2013 
CHO-K1 ECACC SRR803178 Lewis et al, 2013 
CHO-K1 Serum free SRR803179 Lewis et al, 2013 
CHO-K1 Serum free SRR803180 Lewis et al, 2013 
CHO-K1 Serum free SRR803181 Lewis et al, 2013 
CHO-S SRR803182 Lewis et al, 2013 
CHO-S SRR803183 Lewis et al, 2013 
CHO DG44 SRR803184 Lewis et al, 2013 
CHO DG44 SRR803185 Lewis et al, 2013 
C0101 SRR801491 Lewis et al, 2013 
C0101 SRR801492 Lewis et al, 2013 
C0101 SRR801493 Lewis et al, 2013 
C0101 SRR801494 Lewis et al, 2013 
C0101 SRR801495 Lewis et al, 2013 
C0101 SRR801496 Lewis et al, 2013 
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For download from SRA, customize the link below by the acession number  
ftp://ftp-trace.ncbi.nih.gov/sra/sra-instant/reads/ByRun/sra/SRR/SRR156/SRR1561441/SRR1561441.sra 
 
Supplmentary table 2. SNP geneoverview 
 List of the number of SNPs detected in each gene in the CHO DXB11 and CHO-K1 ATCC genome. Truncated view 
Genbank 
Gene-





SNPs/indels in exon 
(silent) 
SNPs/indels in exon 
(missense/nonsense) 
XP_007626087.1 A1cf CHO_DXB11 5 5 0 0 
XP_007609693.1 A2ml1 CHO_DXB11 149 136 5 8 
XP_007613122.1 A3galt2 CHO_DXB11 12 10 1 1 









SNPs/indels in exon 
(silent) 
SNPs/indels in exon 
(missense/nonsense) 
XP_007626087.1 A1cf K1ATCC 3 3 0 0 
XP_007609693.1 A2ml1 K1ATCC 139 126 6 7 
XP_007613122.1 A3galt2 K1ATCC 11 10 0 1 
XP_007627973.1 A4galt K1ATCC 1 0 0 1 
… 
  
 Appendix | 142 
Supplmentary table 3. Exon SNPs DXB11 











































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplmentary table 4. Exon SNPs K1ATCC 
Overview of all SNPs and indels affecting exonic sequence in CHO-K1 ATCC. Selected rows seen. 



















































































































































































































































































































































































































































































































































































































































































































































































































































































Supplmentary table 5. Sequencing depth 
The absolute CN, the raw depth measured and the normalized CN value for each gene in the C. griseus genome in each 
genome 
Median 2 2 2 2 2 2 2 2 2 2 













A1cf 2 3 2 2 2 3 2 2 2 2 
A2ml1 2 2 2 2 2 2 2 2 2 2 
A3galt2 2 2 2 2 2 2 2 2 2 2 
A4galt 2 2 2 2 2 2 2 2 2 2 
A4gnt 2 2 2 2 1 2 2 2 2 2 
















A1cf 46 38 14 9 12 14 32 18 49 10 
A2ml1 51 16 9 7 6 7 30 16 37 6 
A3galt2 50 17 9 9 9 9 29,5 17 42 7 
A4galt 58 21 13 11 11 12 39 22 53 10 
A4gnt 48 18 12 9 5 7 33 19 50 7 
Aaas 49 24 13 10 11 21 35 22 54 9 
… 
 













A1cf 1,8 3,3 2,3 2 2,7 3,1 1,9 2,1 2 2,5 
A2ml1 2,0 1,4 1,5 1,6 1,3 1,6 1,8 1,9 1,5 1,5 
A3galt2 2,0 1,5 1,5 2,0 2,0 2,0 1,8 2,0 1,8 1,8 
A4galt 2,3 1,8 2,2 2,4 2,4 2,7 2,4 2,6 2,2 2,5 
A4gnt 1,9 1,6 2,0 2,0 1,1 1,6 2,0 2,2 2,1 1,8 
Aaas 1,9 2,1 2,2 2,2 2,4 4,7 2,1 2,6 2,3 2,3 
… 
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Supplmentary table 6. C. griseus overview  





















































































































































































































































































































































































































































































































































































































































































































































































































































Supplmentary table 7. GO-terms 
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Lists all GO-terms with the number of genes found to have reduced or amplified copy number within this particular 
category and the corresponding p-value. 
   
























































- ATP binding 
935 54 57 45 49 68 76 56 58 53 
            
   





























































































            
   


























































- ATP binding 
935 83 65 84 92 99 70 83 63 78 
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10.2 Supplementaries for Chapter 4 
10.2.1 Supplementary figures 
 
Supplementary Figure 1 Read depth distribution of exon 3 for the Xbp1 transcript. Exonuclease activity of 
Ern1 (IRE1α) removes a 26bp intron inside this exon (NW_006879406.1 position 31183-31209) causing a 
frameshift conversion. The ratio of the median read depth inside this region (blue line) was used relative 
to the median for the rest of the exon (red lines) as a measure of Xbp1 induction. 
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Supplementary Figure 2 CHO specific secretion network overlaid with RNAseq data.  
A) Colors indicate log2(foldchange) between IgG producing CHO-K1 cells in exponential growth phase 
versus non-producing control CHO-K1 cells. B) Colors indicate log2(foldchange) between the FVIII 
producing cell lines (Clone 1-11) versus control cell lines (Clone 12-13). 
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Supplementary Figure 3 subnetwork specific for genes relevant for recognition of misfolded proteins 
overlaid with RNAseq data.  
A) Colors indicate log2(foldchange) between IgG producing CHO-K1 cells in exponential growth phase 
versus non-producing control CHO-K1 cells. B) Colors indicate log2(foldchange) between the FVIII 
producing cell lines (Clone 1-11) versus control cell lines (Clone 12-13). 
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Supplementary Figure 4 subnetwork specific for genes relevant for ER-associated protein degradation 
overlaid with RNAseq data.  
A) Colors indicate log2(foldchange) between IgG producing CHO-K1 cells in exponential growth phase 
versus non-producing control CHO-K1 cells. B) Colors indicate log2(foldchange) between the FVIII 
producing cell lines (Clone 1-11) versus control cell lines (Clone 12-13). 
 
 
Supplementary Figure 5 subnetwork specific for genes relevant for ER-Golgi transport overlaid with 
RNAseq data.  
A) Colors indicate log2(foldchange) between IgG producing CHO-K1 cells in exponential growth phase 
versus non-producing control CHO-K1 cells. B) Colors indicate log2(foldchange) between the FVIII 
producing cell lines (Clone 1-11) versus control cell lines (Clone 12-13). 




Supplementary Figure 6 Transgene expression across relevant transient transfectants. 
qRT-PCR expression values relative to GAPDH.  
 
 
A B C D
E F G H
I J K L
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Supplementary Figure 7 Growth characteristics from stable cell pools producing FVIII, IgG or EPO 
respectively.  
A) Doubling time, B) growth curve, C) viability and D) product titer versus hours of cultivation E) specific 
productivity after 72 hours of growth. 
 
Supplementary Figure 8 Primers used for ligation-free cloning of transgenes into the pTT22 plasmid  
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CK105 GGGCCCTCTAGAGGGAATTC rv pTT22 backbone for cloning 
CK106 GTTTCTGCTAGCAAGCTTGC fw pTT22 backbone for cloning 
CK114 CCCTCTAGAGGGCCC ATGATGGATCTGGAACTGCC fw NRF2 into pTT22 
CK115 CTTGCTAGCAGAAAC GCGCTAGCTTATCAATTCTT rv NRF2 into pTT22 
CK116 CCCTCTAGAGGGCCC ATGTCCGTGTCCGAGAGCGC fw bach1 into pTT22 
CK117 CTTGCTAGCAGAAAC GCGCTAGCTTATCACTCATC rv bach1 into pTT22 
CK118 CCCTCTAGAGGGCCC ATGTACAAAGTCGGTCGGCG fw LMAN1 into pTT22 
CK119 CTTGCTAGCAGAAAC GCGCTAGCTTATCAAAAGAAC rv LMAN1 into pTT22 
CK251 CCCTCTAGAGGGCCC ATGCTGAGTCGTTCACTGCT fw PDI into pTT22 
CK252 CTTGCTAGCAGAAAC GACAAAAGTCGCTTCGAAGC rv PDI into pTT22 
CK253 CCCTCTAGAGGGCCC ATGAGGTTTAGTTGCCTGGC fw PDIA3 into pTT22 
CK254 CTTGCTAGCAGAAAC GACAAAAGTCGCTTCGAAGCG rv PDIA3 into pTT22 
CK255 CCCTCTAGAGGGCCC ATGACCGATACCTTTGAGCA fw PDIA6 into pTT22 
CK256 CTTGCTAGCAGAAAC GACAAAAGTCGCTTCGAAGC rv PDIA6 into pTT22 
CK257 CCCTCTAGAGGGCCC  ATGAGGCTGTCTCGTGTCCT fw FKBP2 into pTT22 
CK258 CTTGCTAGCAGAAAC TTATCACAGTTCGCTTCTAC rv FKBP2 into pTT22 
CK259 CCCTCTAGAGGGCCC  ATGTCCCTGCGTCCTCTGCTG fw FKBP11 into pTT22 
CK260 CTTGCTAGCAGAAAC GACCGGCTGTACAGGATTTA rv FKBP11 into pTT22 
CK261 CCCTCTAGAGGGCCC  ATGAGCGACTCCGACCTGGG fw TGIF2 into pTT22 
CK262 CTTGCTAGCAGAAAC TTATCATTTGGCATTCTCAC rv TGIF2 into pTT22 
CK263 CCCTCTAGAGGGCCC  ATGGCTTCACTGTGGCTGCT fw Mcfd2 into pTT22 
CK264 CTTGCTAGCAGAAAC CTTATCACTGCAGACTTTTA rv Mcfd2 into pTT22 
CK302 CCCTCTAGAGGGCCC ATGCTCCTTTCCGTGCCGCT fw Calr into pTT22 
CK303 CTTGCTAGCAGAAAC CTACAGCTCATCCTTGGTCTGGC rv Calr into pTT22 
CK365 CCCTCTAGAGGGCCC ATGGTGAGCAAGGGCGA fw GFP+pC30miRNA forward into pTT22 
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10.2.2 Supplementary tables 
The complete tables can be downloaded from http://bit.ly/SupTables 
Subsections from each of the tables are listed below in order to provide an overview of the 
information content of each table  
Supplementary Table 1 overview of genes correlating positively with FVIII productivity 
Gene logFC FPKM PValue FDR Homolog IPA identifier 
Matk 1.03 0.82 2.37E-11 2.51E-10 ENSG00000007264 MATK 
LOC103162370 1.06 2.67 0.000208 0.000996 ENSG00000049769 PPP1R3F 
LOC103162202 1.27 3.15 7.97E-06 4.74E-05 ENSG00000053438 NNAT 
Pkp2 1.86 0.79 8.97E-22 2.05E-20 ENSG00000057294 PKP2 
LOC103162774 1.09 17.84 4.13E-17 6.83E-16 ENSG00000058091 CDK14 
Tle2 1.40 1.74 1.79E-07 1.30E-06 ENSG00000065717 TLE2 
Fam107b 2.15 11.94 2.96E-71 4.84E-69 ENSG00000065809 FAM107B 
Derl2 1.45 16.89 2.04E-43 1.35E-41 ENSG00000072849 DERL2 
Ebf4 1.54 2.29 1.98E-32 8.04E-31 ENSG00000088881 EBF4 
Cbx7 1.36 2.28 1.21E-40 7.19E-39 ENSG00000100307 CBX7 
… 
Supplementary Table 2 overview of genes correlating negatively with FVIII productivity 
Gene logFC FPKM PValue FDR Homolog IPA identifier 
Abca6 -3.42 0.19 1.38E-39 7.82E-38 ENSRNOG00000046890 ABCA6 
Abcg1 -4.29 0.45 1.47E-26 4.50E-25 ENSMUSG00000024030 ABCG1 
Abi2 -1.00 5.18 5.03E-11 5.17E-10 ENSG00000138443 ABI2 
Abtb2 -1.31 0.59 8.64E-09 7.27E-08 ENSMUSG00000032724 ABTB2 
Acer1 -1.99 0.66 5.83E-10 5.51E-09 ENSRNOG00000047368 ACER1 
Acp2 -1.03 22.79 1.07E-39 6.11E-38 ENSRNOG00000013594 ACP2 
Acsl1 -1.43 23.35 1.32E-31 5.18E-30 ENSRNOG00000010633 ACSL1 
Acsl3 -1.17 21.52 3.60E-43 2.34E-41 ENSRNOG00000014718 ACSL3 
Acsl6 -1.21 0.7 1.37E-16 2.18E-15 ENSRNOG00000026745 ACSL6 
… 














































04 9 51 
GRIN3B,AKT3,GRIN2D,XIAP,BCL2L1,GRIA4,VEGFB,PIK3CB,
BIRC3 
5 TNFR2 Signaling 
3.2
4E-
04 5 21 TRAF2,TNFAIP3,XIAP,NFKBIE,BIRC3 



























03 11 43 
IL18,Ccl7,MMP9,ITGA3,Cxcl3,ACTA2,SDC4,CXCL2,MMP17,I
L33,Glycam1 
9 CD40 Signaling 
2.4
5E-







03 2 4 MOCS3,NFS1 
11 TNFR1 Signaling 
3.6
3E-
03 5 39 TRAF2,TNFAIP3,XIAP,NFKBIE,BIRC3 
12 




03 6 55 TRAF2,AKT3,PTGS2,BCL2L1,NFKBIE,PIK3CB 
13 TWEAK Signaling 
5.5
0E-





























































02 6 67 PARP10,TRAF2,XIAP,ACTA2,NFKBIE,BIRC3 
22 VEGF Signaling 
1.3
2E-






02 7 43 ABCG4,IL18,C3,SREBF1,MMP9,PTGS2,IL33 
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24 PPAR Signaling 
1.4
8E-















02 7 98 AKT3,ITGA3,HSP90B1,PTGS2,BCL2L1,NFKBIE,PIK3CB 
27 IL-8 Signaling 
1.6
6E-
02 9 116 
ANGPT2,AKT3,MMP9,GNG3,PTGS2,VASP,BCL2L1,VEGFB,PI
K3CB 
28 PEDF Signaling 
1.7
0E-






































02 4 44 AKT3,MLH1,PIK3CB,APC2 
35 Relaxin Signaling 
2.4
5E-
















































Role of NFAT in 











02 8 98 AKT3,GNG3,GRIN2D,PDIA3,GNAT1,GRIA4,PRKACB,PIK3CB 
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44 
Role of Tissue 
Factor in Cancer 
2.9
5E-
02 6 64 AKT3,CYR61,ITGA3,CSF1,BCL2L1,PIK3CB 
45 NF-κB Signaling 
3.0
9E-





























02 3 20 AKT3,MMP9,THBS1 
50 












02 8 178 
CALR,GRIN3B,NFATC4,GRIN2D,ACTA2,GRIA4,PRKACB,HTR
3A 
52 IL-6 Signaling 
3.6
3E-























































02 3 13 C3,C1QBP,C1R 
61 ILK Signaling 
4.4
7E-






02 3 38 TRAF2,NFATC4,NFKBIE 
63 Salvage 4.6 5 57 CDA,GRK4,DAPK1,UPRT,GRK6 
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Supplementary Table 4 genes detected by proteomics 
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10.3 Supplementaries for Chapter 6 
The sections below contain detailed descriptions on how to carry out   
10.3.1 Getting started – downloading the genome and annotation file 
This section describes how to download the current version of the CHO genome to your own server 
and prepare for using it as reference genome for analyzing e.g. RNA sequencing data. 
Download of the genome and annotation file 
At Genbank (http://www.ncbi.nlm.nih.gov/genome/annotation_euk/Cricetulus_griseus/101/) there 
are currently two different genome versions available for Cricetulus griseus: The CHO-K1 genome 
(CriGri_1.0, Assembly GCF_000223135.1), and the Chinese Hamster (C_griseus_v1.0, Assembly 
GCF_000419365.1). By searching Genbank for the assembly name, all 52710 scaffolds in the 




Figure 13 Directions for download of the CHO genome at NCBI Genbank 
 
The annotation file compatible with the genome above, which contains information regarding the 
location and orientation of all annotated genes in the CHO genome, can be downloaded from the 
Genbank FTP server by typing the following in your command line environment: 
wget ftp://ftp.ncbi.nlm.nih.gov/genomes/Cricetulus_griseus/GFF/alt_C_griseus_v1.0_scaffolds.gff3.gz 
gunzip alt_C_griseus_v1.0_scaffolds.gff3.gz 
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After unzipping the file it can be opened 




#!processor NCBI annotwriter 
#!genome-build C_griseus_v1.0 
#!genome-build-accession NCBI_Assembly:GCF_000419365.1 
#!annotation-date 2 May 2014 
#!annotation-source NCBI Cricetulus griseus Annotation Release 101 
##sequence-region NW_006834731.1 1 201 
##species http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10029 




By searching for e.g. Dhfr one will find the table below. 
grep "Dhfr" alt_C_griseus_v1.0_scaffolds.gff3 
 
NW_006884452.1 BestRefSeq gene 3849042 3872852 . + . ID=gene24052;... 
NW_006884452.1 BestRefSeq mRNA 3849042 3872852 . + . ID=rna29637;... 
NW_006884452.1 BestRefSeq exon 3849042 3849131 . + . ID=id344549;... 
NW_006884452.1 BestRefSeq exon 3849436 3849485 . + . ID=id344550;... 
NW_006884452.1 BestRefSeq exon 3851818 3851923 . + . ID=id344551;... 
NW_006884452.1 BestRefSeq exon 3859552 3859678 . + . ID=id344552;... 
NW_006884452.1 BestRefSeq exon 3862431 3862546 . + . ID=id344553;... 
NW_006884452.1 BestRefSeq exon 3872015 3872852 . + . ID=id344554;... 
NW_006884452.1 BestRefSeq CDS 3849046 3849131 . + 0 ID=cds26512;... 
NW_006884452.1 BestRefSeq CDS 3849436 3849485 . + 1 ID=cds26512;... 
NW_006884452.1 BestRefSeq CDS 3851818 3851923 . + 2 ID=cds26512;... 
NW_006884452.1 BestRefSeq CDS 3859552 3859678 . + 1 ID=cds26512;... 
NW_006884452.1 BestRefSeq CDS 3862431 3862546 . + 0 ID=cds26512;... 
NW_006884452.1 BestRefSeq CDS 3872015 3872093 . + 1 ID=cds26512;... 
 
Each type of annotation (in this case gene, mRNA, exon and CDS) contain different pieces of 
information regarding the gene, which are listed in column 9 as e.g. for the exon 
ID=id344550;Parent=rna29637;Dbxref=GeneID:100689028,Genbank:NM_001244016.1;Note=The RefSeq transcript 
has 11 substitutions compared to this genomic sequence;exception=annotated by transcript or proteomic 
data;gbkey=mRNA;gene=Dhfr;product=dihydrofolate reductase;transcript_id=NM_001244016.1 
 
Thus, from the annotation file information regarding: the sequencing scaffold, position on scaffold 
and orientation, GenbankID for transcript and protein, CHOgenome.org gene name (Dhfr) and long 
gene name can all be extracted. For more information regarding the gff3 standard see
2
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Correcting headers 
Following genome download your fasta file will contain headers for each sequence 
>gi|614415150|ref|NW_006834823.1| Cricetulus griseus unplaced genomic scaffold, alternate assembly 
C_griseus_v1.0 C26702588, whole genome shotgun sequence 
AGGTT… 
 
In order to get names that are compatible with the annotation file the header will be shortened. 
sed "s/^>.*|ref|/>/g" sequence.fasta | cut -f 1,1 -d'|' > Cgriseus.fasta 
 
The header will now look like 
>NW_006834823.1 
AGGTT… 
Addition of transgene to the annotation file and genome 
In case you are working with data from a transfected cell line the transgene sequence can be added 
to the genome and the positions of the genes to the annotation file. In the example below the 
sequence from human coagulation factor VIII and the selection marker dihydrofolate reductase 
(DHFR) are added. A new sequencing scaffold called P_Plasmid is made based on the known 




This file was then added to the end of the genome file 
P_Plasmid.txt >> Cgriseus.fasta 
 
In order to detect expression level of this scaffold two exon sequences are added to the annotation 
file for each of the two ORF’s following the same nomenclature as the Dhfr example given above. 
HTSeq, which can be used to deduce the expression level scan the genome based on ranges in the 
annotation file listed as exons
3
. For this reason only these two lines are added. 
 
P_Plasmid RefSeq exon 6581 7144 . + 0 ID=id251660;Parent=rna251660;Dbxref=GeneID:251660;gbkey=mRNA;gene= 
dhfr_p;transcript_id= rna251661 
P_Plasmid RefSeq exon 102 1000 . + 0 ID=id251662;Parent=rna251662;Dbxref=GeneID:251662;gbkey=mRNA;gene= 
hFVIII_p;transcript_id= rna251663 
 
RNA and gene ID’s were made up and checked by grep whether they were already in use. The final 
line of the annotation file contain 3 hashtags which indicating that the file is done. The two lines 
above thus needs to be added before that  
grep -v "###" alt_C_griseus_v1.0_scaffolds.gff3 > CHOannotation.gff3 
cat new_annotation.txt >> CHOannotation.gff3 
echo "###" >> CHOannotation.gff3 
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Extraction of information from the annotation file 
In order to gain an overview on the content of the annotation files a list of genes can be extracted.  
cat CHOannotation.gff3 | sed 's/\t/,/g' |  awk -F, '$3=="exon" {gsub(","," ");print $0}' | grep "gene="  > subset  
cat subset | sed 's/^.*gene=//g' | cut -f 1,1 -d';' > genes 
cat subset | sed 's/^.*Genbank://g' | cut -f 1,1 -d';' | cut -f 1,1 -d',' | gawk '{print $1}' > Genbk 
cat subset | sed 's/^.*Parent=//g' | cut -f 1,1 -d';' | cut -f 1,1 -d',' | gawk '{print $1}' > RNAid 
paste genes Genbk RNAid | sort | uniq > Genes 
 
cat CHOannotation.gff3 | sed 's/\t/,/g' |  awk -F, '$3=="CDS" {gsub(","," ");print $0}' | grep "gene="  > subset 
cat subset | sed 's/^.*gene=//g' | cut -f 1,1 -d';' > genes 
cat subset | sed 's/^.*Genbank://g' | cut -f 1,1 -d';' | cut -f 1,1 -d',' | gawk '{print $1}' > Genbk 
cat subset | sed 's/^.*Parent=//g' | cut -f 1,1 -d';' | cut -f 1,1 -d',' | gawk '{print $1}' > RNAid 
paste genes Genbk RNAid | sort | uniq > Proteins 
 
The two files thus contain information about all transcripts and all proteins 
paste Genes Proteins | head -1 
A1cf    XM_007627897.1  rna20866        A1cf    XP_007626087.1  rna20866 
 
By merging the two files above a list of all the genes in the C. griseus genome can be made 
containing both the Genbank information for the coding region and the translated protein made 
from it. The information of the scaffold they are placed on is furthermore included 
cat Genes | gawk '{print $3}' > rna_genes 
cat Proteins | gawk '{print $3}' > rna_protein 
sdiff rna_protein rna_genes | grep -v ">" | gawk '{print $1}' > uniqueRNA 
 
wc -l uniqueRNA > length 
length=`awk '{print $1 }' < length` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
cat uniqueRNA | head -$i | tail -1 > gene 
gene=`awk '{print $1 }' < gene` 
grep -w "$gene" Genes > one 
grep -w "$gene" Proteins > two 
grep -w "$gene" ./CHOannotation.gff3| head -1 | gawk '{print $1}' > scaffold 
paste one two scaffold | gawk '{print $1, $2, $5, $3, $7}' | sed 's/ /\t/g' >> genenames 
done 
printf "\tASDF\n" | awk -F'\t' '$3' genenames > listofgenes.txt 
 
The list will look as the one below containing all splice variants for protein coding transcripts in the 
C. griseus genome 
A1cf    XM_007627897.1  XP_007626087.1  rna20866        NW_006880426.1 
A2ml1   XM_007611503.1  XP_007609693.1  rna3450 NW_006870833.1 
A3galt2 XM_007614932.1  XP_007613122.1  rna7152 NW_006873147.1 
A4galt  XM_007629783.1  XP_007627973.1  rna22847        NW_006881179.1 
A4galt  XM_007629784.1  XP_007627974.1  rna22846        NW_006881179.1 
 
Downloading data from the SRA 
The raw sequencing reads from the currently sequenced CHO genomes such as CHO DG44 and 
CHO DXB11 can be downloaded from the Sequence Read Archive hosted by Genbank
4
.  The 
reads, which are currently publically available, are listed in the table below 
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Table 1 list of raw sequence from CHO genomes publicly available for download at the time of writing  
CHO cell name 
SRA accession 
number Original publication 
 
CHO cell name 
SRA 
accession 
number Original publication 
CHO DXB11 SRR1561441 Kaas et al, 2015 
 
CHO-K1 Protein free SRR803173 Lewis et al, 2013 
CHO DXB11 SRR1561442 Kaas et al, 2015 
 
CHO-K1 Protein free SRR803174 Lewis et al, 2013 
CHO DXB11 SRR1561427 Kaas et al, 2015 
 
CHO-K1 Protein free SRR803175 Lewis et al, 2013 
CHO DXB11 SRR1561428 Kaas et al, 2015 
 
CHO-K1 ECACC SRR803176 Lewis et al, 2013 
CHO-K1 ATCC SRR329939 Xu et al, 2011 
 
CHO-K1 ECACC SRR803177 Lewis et al, 2013 
CHO-K1 ATCC SRR329940 Xu et al, 2011 
 
CHO-K1 ECACC SRR803178 Lewis et al, 2013 
CHO-K1 ATCC SRR329941 Xu et al, 2011 
 
CHO-K1 Serum free SRR803179 Lewis et al, 2013 
CHO-K1 ATCC SRR329942 Xu et al, 2011 
 
CHO-K1 Serum free SRR803180 Lewis et al, 2013 
CHO-K1 ATCC SRR329943 Xu et al, 2011 
 
CHO-K1 Serum free SRR803181 Lewis et al, 2013 
CHO-K1 ATCC SRR329944 Xu et al, 2011 
 
CHO-S SRR803182 Lewis et al, 2013 
CHO-K1 ATCC SRR329945 Xu et al, 2011 
 
CHO-S SRR803183 Lewis et al, 2013 
CHO-K1 ATCC SRR329946 Xu et al, 2011 
 
CHO DG44 SRR803184 Lewis et al, 2013 
CHO-K1 ATCC SRR329947 Xu et al, 2011 
 
CHO DG44 SRR803185 Lewis et al, 2013 
CHO-K1 ATCC SRR329948 Xu et al, 2011 
 
C0101 SRR801491 Lewis et al, 2013 
CHO-K1 ATCC SRR329949 Xu et al, 2011 
 
C0101 SRR801492 Lewis et al, 2013 
CHO-K1 ATCC SRR329950 Xu et al, 2011 
 
C0101 SRR801493 Lewis et al, 2013 
CHO-K1 ATCC SRR329951 Xu et al, 2011 
 
C0101 SRR801494 Lewis et al, 2013 
CHO-K1 ATCC SRR329952 Xu et al, 2011 
 
C0101 SRR801495 Lewis et al, 2013 
CHO-K1 ATCC SRR329953 Xu et al, 2011 
 
C0101 SRR801496 Lewis et al, 2013 
CHO-K1 ATCC SRR329954 Xu et al, 2011         
 
Download of e.g. C0101, run1 = SRR801491 was downloaded from the ftp using the name of the 
file as shown underlined in the link below:  
wget ftp://ftp-trace.ncbi.nih.gov/sra/sra-instant/reads/ByRun/sra/SRR/SRR801/SRR801491/SRR801491.sra 
 
In order to convert the SRA file into paired reads, the SRA file toolkit was downloaded from NCBI
5
 
and run as follows (remember full name path for the SRA file as it otherwise will not work): 
~/sratoolkit.2.3.2-5-centos_linux64/bin/fastq-dump --split-3 /novo/users/csrk/Cgenomes/SRAdumps/SRR801491.sra 
 
Asses and change the quality score of the reads 
By extracting the first 1000 reads from each file Fastqc
6
 can be run quickly to investigate which 
standard for the quality score was used for each sample. 
head -400 K1ATCC_1_1.fastq >  test_1.fastq 
fastqc test_1.fastq  
 
From the output fastqc_report.html it can be seen that the file is in “Illumina 1.9”-encoding. This is 
the case for all reads from the CHO-K1 ATCC and CHO DXB11 genome whereas the rest from the 
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table above is found to be in “Illumina 1.5”-encoding. If this later is shown to cause problems with 






my $count = 0; 
while (<>) { 
    chomp; 
    if ($count++ % 4 == 3) { tr/\x40-\xff\x00-\x3f/\x21-\xe0\x21/; } 
    print "$_\n"; 
} 
 
perl sanger.pl 1rawread_1.fastq > 2rawread_1.fastq 
 
10.3.2 Extraction and analysis of genomic copy numbers from CHO genomes 
Summary: This tutorial describes how the copy number was extracted for each gene in each of the 
sequenced CHO cell lines. I kindly ask you cite: Kaas et al 2015, Sequencing the CHO DXB11 
genome reveals regional variations in genomic stability and haploidy in case you will publish data 
based on this workflow. For the tutorial below it is assumed that the raw reads from all available 
CHO genomes have been downloaded as described above. 
Pre-alignment trimming of reads 
Trim Galore is a usefull tool, which are able to trim the paired reads, while keeping the files 
synchronized so the pairs are broken
8
. It can be downloaded from here
9
  and the required 
packagages cutadapt from here
10
 and fastqc from here
11
. In the code below all low quality bps are 
trimmed from the ends until bps with a quality >30 are found, but all reads that after trimming are 






~/software/Trimgalore/trim_galore --paired -q 30 --length 40 --fastqc --path_to_cutadapt /novo/appl/ngs/cutadapt-
1.2.1/bin/cutadapt --stringency 5 -o ./trimmed_reads DXB11_1.fastq DXB11_2.fastq 
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Figure 14 quality score across the reads before (left) and after (right) trimming. 
Reads were aligned to the C. griseus genome  
The trimmed reads are subsequently aligned to the C. griseus genome using BWA
13
 and 
subsequently converted into a bam-file from a sam-file. First, the genome has to be indexed by 
BWA before alignment. 
bwa index Cgriseus.fa 
After the genome has been indexed the reads are alinged to the genome 
bwa aln Cgriseus.fasta 1BWA_1.fastq > 1BWA_1.sai 
bwa aln Cgriseus.fasta 1BWA_2.fastq > 1BWA_2.sai 
bwa sampe -r "@RG\tID:libA\tSM:sample_EACC\tPL:ILLUMINA" Cgriseus.fasta 1BWA_1.sai 1BWA_2.sai 1BWA_1.fastq 
1BWA_2.fastq | samtools view -Sb - > 2alignment_L.bam 
 
All reads with a minimum mapping quality less than 30 were removed and the file was sorted and 
indexed 
samtools view -u -q 30 2alignment_L.bam | samtools sort - 2alignment_L.sort 
samtools index 2alignment_L.sort.bam 
 
GATK was used in order to remap all the reads in region containing indels 
The RealignerTargetCreater algorithm
14
 was used to realign reads in problematic regions of the 
genome. 
java -Xmx2g -jar GenomeAnalysisTK.jar -T RealignerTargetCreator -R Cgriseus.fasta  -I 2alignment_L.sort.bam -o 
3_L.intervals 
 
java -Xmx2g -jar GenomeAnalysisTK.jar -T IndelRealigner -targetIntervals 3_L.intervals -R Cgriseus.fasta  -I 
2alignment_L.sort.bam -o 3realigned_L.bam 
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Alignments run in parallel were merged into one bam-file 
In the steps above the data from the same sample was split into multiple files and now the files are 
merged from several bam files into one single bam file. This is done using samtools
15
 
samtools merge Cgris_prePicard.bam 3realigned_L.bam 3realigned_L.bam /H3/3realigned_L.bam 
/H4/3realigned_L.bam /H5/3realigned_L.bam 
PCR duplicates were removed using Picard 
PCR remnants are removed using Picard
16
 
java -Xmx2g -jar MarkDuplicates.jar INPUT=Cgris_prePicard.bam OUTPUT=Cgris_postPicard.bam 
ASSUME_SORTED=FALSE METRICS_FILE=/dev/null VALIDATION_STRINGENCY=SILENT REMOVE_DUPLICATES=true 
 
Calculation of the sequencing depth in genome 




genomeCoverageBed -d -ibam Cgris_postPicard.bam > Cgris.genomecoverage 
 
In order to access the given position easily the coverage file need to be split into files each 
containing each contig. This is done by first merging the three columns into one and subsequently 
using awk to create files for each contig   
sed 's/\t/,/g' Cgris.genomecoverage > Cgris.comma.genomecoverage 
awk -F, '{print > $1.txt}' Cgris.comma.genomecoverage 
 
The files are restored into having three columns again containing 1: the name of the contig, 2: the 
position on the contig, 3: the depth at that given position 
for file in *.1 
do 
sed 's/,/\t/g' $file > $file.txt 
rm $file 
done 
Depths are extracted at genomic coding regions 
The listofgenes.txt file made in the section “Extraction of information from the annotation file” is 
used gene by gene to extract the positions in the genome that the coding region of given gene is 
situated (the file pos) and the depth found for each bp in these intervals are merged into one file 
(seq), which subsequently is sorted and the median is extracted.  
echo '#! /usr/bin/env Rscript' > scriptR 
echo 'd<-scan("stdin", quiet=TRUE)' >> scriptR 
echo 'cat((median(d)/(33/2)), min(d), max(d), median(d), mean(d), sd(d), sd(d)/mean(d), sep="\t")' >> scriptR 
chmod a+x scriptR 
 
for (( k = 1 ; k <= 29983 ; k++ )) 
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do 
cat ../listofgenes2 | head -$k | tail -1 > geneinfo 
geneProtein=`awk '{print $3 }' < geneinfo` 
scaffold=`awk '{print $5 }' < geneinfo` 
grep -w "$geneProtein" ../listofgenes2 > data 
grep -w "$geneProtein" ~/annotationK1.gff3 | sed 's/\t/,/g' | awk -F, '$3=="CDS" {gsub(","," ");print $0}' | gawk 
'{print $1, $4-1, $5}' | sed 's/ /\t/g' | sort -k 2 -n > pos 
wc -l pos > length 
length=`awk '{print $1 }' < length` 
cat pos | head -1 | gawk ' {print $2}' > start 
cat pos | tail -1 | gawk ' {print $3}' > slut 
echo "0" > seq 
for (( j = 1 ; j <= $length ; j++ )) 
do 
cat pos | head -$j | tail -1 | gawk '{print $3}' > slutnr 
cat pos | head -$j | tail -1 | awk '{a=$3-$2+1;print a}' > lengthCDS 
slut=`awk '{print $1 }' < slutnr` 
len=`awk '{print $1 }' < lengthCDS` 
cat $scaffold* | head -$slut | tail -$len | gawk '{print $3}' >> seq 
done 
./test1 < seq > median 
wc -l seq | gawk '{print $1}' > seqlength 
paste median data start slut seqlength >> list.txt 
done 
 
Evaluation of data 
The list.txt files from each cell line were merged into a matrix (in excel) and histograms can be 
made for each cell lines showing the distribution of genes across the measured depths 
  
Figure 15 Histogram showing the number of genes found to have copy number of 1,2 and 3. 
To the left the data from CHO DXB11 is shown and to the right the same data is represented for wild type C. griseus 
clearly showing a single peak indicating a whole diploid genome 
 
start end genes mean(sd) 
0.4 0.75 193 0.795 
0.75 1.25 1987 0.335 
1.25 1.75 1269 0.377 
1.75 2.25 8592 0.227 
2.25 2.75 1030 0.211 
2.75 3.25 687 0.206 
 
Different regions from DXB11 were extracted in order to see if the standard deviation for each gene 
were different. It is seen that the genes from 0 depth to 0.75 seem to have pretty high standard 
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deviation across the CDS but the ones which have 1.5 in depth does not seem to be more noisy than 
genes with 2.0. 
 
Merging into one matrix 
The list.txt file generated from each analyzed cell line was renamed by their cell line name and 
merged into one matrix that was subsequently sorted based on the 20661 genes name and not based 
on the 29978 transcripts which my list originally centered on.  
paste Cgris.txt C0101.txt CHO_PF.txt CHO_SF.txt CHO_S.txt DG44.txt DXB11.txt F435.txt K1ATCC.txt K1ECACC.txt | 
gawk '{print $2, $1, $10, $19, $28, $37, $46, $55, $64, $73, $82}' | sed 's/ /\t/g' > depthmatrix 
cat depthmatrix | gawk '{print $1}' | sort | uniq > genes 
wc -l genes > length 
length=`awk '{print $1 }' < length` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
cat genes | head -$i | tail -1 > gene 
gene=`awk '{print $1 }' < gene` 
grep -w "$gene" depthmatrix | sort -k 9 -n | tail -1 >> depthmatrix2  
done 
 
echo "Gene Cgriseus C0101 CHO_PF CHO_SF CHO_S DG44 DXB11 F435 K1ATCC K1ECACC" | sed 's/ /\t/g' > 
depthmatrix.txt 
cat depthmatrix2  >> depthmatrix.txt 
 
The matrix is imported into R and normalized by half the median depth 





The list is extracted into a matrix and normalized based on half of the median for each cell line 
(thus leading to the mean peak having a normalized depth of 2)  






 Appendix | 171 
CHO-K1 ATCC versus CHO DXB11 
It is now possible to plot e.g. CHO-K1 ATCC versus CHO DXB11. col="#00000010" is used as it 
has transparency allowing for dense spots on the plot to be easily seen whereas outliers does not 
dominate the picture. 




Figure 16 copy number distribution in CHO-K1 ATCC versus CHO DXB11 
 
Construction of a phylogenetic tree 
In order to construct a phylogenetic tree a distance matrix is calculated by extracting the number of 
genes that has a normalized copy number that differ by more than 0.95. A heatmap is made 
representing the same data as a phyloenetic tree (without compromising on the distances due to the 
contraints of a 2D drawing) 
distance=distance2=matrix(ncol=ncol(col),nrow=ncol(col),0);for(i in 1:ncol(col)) 
{for(j in 1:ncol(coll)) 
  {col3=coll[which(abs(coll[,j]-coll[,i])>0.95),] 
   distance[i,j]=dim(col3)[1]/dim(coll)[1] 
   distance2[i,j]=dim(col3)[1] 




Box <- function(x, y, color) 
{rect(x, y, x+1, y+1, density = NULL, col = color, border = NULL, lty = par("lty"), lwd = par("lwd"))} 
colfunc <- colorRampPalette(c("green", "white")) 
colfunc2 <- colorRampPalette(c("white", "red")) 
colors=c(colfunc2(50),colfunc(50)) 
plot(100,100, xlim=c(0,12),ylim=c(0,12),xaxt='n',yaxt='n',ylab="",xlab="") 
for(j in 1:ncol(coll)){for(i in 1:ncol(coll)) {Box(j,i,colors[distance[j,i]*100])}} 
for(i in 1:ncol(col)) {text(i+0.5,1,colnames(col)[i],cex=0.4,pos=1)} 
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for(i in 1:ncol(col)) {text(0.5,i+1,colnames(col)[i],cex=0.4,pos=1)} 
 
Figure 17 heatmap showing the distance between sequenced CHO genomes 
 
In order to draw a phylogenetic tree the packagages below are loaded, a function is made able to 
output a distance matrix based on any matrix, 100 phylogenetic trees are drawn using the bootstrap 
algorithm (boot.phylo) and the concensus tree is used to represent the distance matrix. The tree is 










estimate_tr <- function(m)  
{n=t(m) 
distance=distance2=matrix(ncol=ncol(n),nrow=ncol(n),0) 
for(i in 1:ncol(n)) 
  {for(j in 1:ncol(n)) 
   {col3=n[which(abs(n[,j]-n[,i])>0.95),] 
   distance[i,j]=dim(col3)[1]/dim(n)[1]} 




point_est <- estimate_tr(t(coll)) 
treerooted_no = root(point_est, "Cgriseus", resolve.root = TRUE, interactive = FALSE) 
plot(treerooted_no, type="u", main="NJ without bootstrap") 
windows() 
bs <- boot.phylo(point_est, t(coll), estimate_tr, trees=TRUE, B=100,block = 1)   
con <- consensus(bs$trees[[1]], p=0.5) 
treerooted = root(con, "Cgriseus", resolve.root = TRUE, interactive = FALSE) 
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Figure 18 Phylogenetic tree showing the relationship between sequenced genomes based on copy number 
variations 
 
CNVs based on chromosomal loci 
It would be interessting to investigate the genomic location of the genes across the chromosomes. 
The C. griseus genome had been sequenced sorted by chromosomes
18
. This genome was 
downlaoded from NCBI
19
 and headers were extracted using grep from the fasta file.  
grep "^>" CHOchromosomes.fa > scaffolds.txt 
head -2 scaffolds.txt 
>gi|537274396|gb|KE662775.1| Cricetulus griseus strain 17A/GY chromosome 1 unlocalized genomic scaffold 
chr1_scaffold_0, whole genome shotgun sequence 
>gi|537274281|gb|KE662776.1| Cricetulus griseus strain 17A/GY chromosome 1 unlocalized genomic scaffold 
chr1_scaffold_1, whole genome shotgun sequence 
 
It was seen that the chromosome and scaffold name is listed in the header and this information was 
filtered out and the based on the paper “unplaced scaffold” were attributed to chromosome 9/10 
(here just called 9). Chromosome X were called 0 
 
cat scaffolds.txt | sed 's/^.*gb|//g' | cut -f 1,1 -d'|' > scaffolds 
cat scaffolds.txt | sed 's/^.*chromosome //g' | sed 's/^.*Crice//g' | cut -f 1,1 -d'u' | sed 's/t/9/g' | sed 's/X/0/g' > 
chromosome 
paste scaffolds chromosome > ~/Cgenomes/borth/chromosomeoverview 
 
In order to get the chromosome number for each gene in the C. griseus genome, the 29978 
transcripts listed in the C. griseus genome needs to be blasted against the chromosome sorted 
genome. But first the sequences for those transcripts needs to be downloaded from Genbank. This 
was done by extracting the names of the genes from the C. griseus annotation file (see the section 
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The file Genbankdownload.txt used below: 




wc -l GCmangler2.txt > length 
length=`awk '{print $1 }' < length` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
cat GCmangler2.txt | head -$i | tail -1 > data 
Genbank=`cat data | gawk '{print $1}'` 
cat ~/software/perlGenbankdownload.txt | sed "s/XM_007627897.1/$Genbank/g" |  sed "s/XX/'/g" |  sed 's/YY/"/g' > 
perlscript.pl 
chmod a+x ./perlscript.pl 
./perlscript.pl 
head -1 seq | sed 's/^.*|ref|/>/g' | cut -f 1,1 -d'|' > ./$Genbank.fasta 
grep -v "^>" seq >>  ./$Genbank.fasta 
done 
 
Having all these files in one folder the files were blasted against the C. griseus chromosomes one by 
one and the name of the contig it was found on was extracted and then used to search the list of 




 and the CHOchromosomes.fa file was indexed 
formatdb -i CHOchromosomes.fa -o T -p F 
 
Subsequently all transcripts annotated from the C.griseus genome was blasted against to find the 
chromosome name. 
for file in *.fasta  
do  
blastall -i $file -d ./CHOchromosomes.fa -p blastn -o $file.out  
grep -A2 'Sequences producing significant alignments:' $file.out | tail -1 | gawk '{print $1}' > contig 
grep -A2 'Sequences producing significant alignments:' $file.out | tail -1 | gawk '{print $2}' > Eval 
grep -A2 'Sequences producing significant alignments:' $file.out | tail -1 | gawk '{print $3}' > Eval2 
head -1 $file | sed 's/^.//' > genbankname 
chromosome=`awk '{print $1 }' < contig` 
grep -w "$chromosome" ./chromosomeoverview | gawk '{print $2}' > chromosome 
genbankname=`awk '{print $1 }' < genbankname` 
grep -w "$genbankname" ./listofgenes.txt | head -1 > data 
paste genbankname contig chromosome Eval Eval2 data >> col 
rm contig 
rm genbankname  






Some none-protein-coding genes were removed and a list of the gene names were extracted 
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printf "\tASDF\n" | awk -F'\t' '$10' col.txt > col2.txt  
cat ./col2.txt | gawk '{print $6}' | sort | uniq > genes 
 
The list of gene names were gone through one by one in order to weed out the spleice vatiants.  
wc -l genes > length 
length=`awk '{print $1 }' < length` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
cat genes | head -$i | tail -1 > gene 
gene=`awk '{print $1 }' < gene` 
grep -w "$gene" col2.txt | sort -k 4 -n | tail -1 >> col3.txt 
done 
 
Finally a list contaning just the gene name and the suggested chromosome number was made 
cat ./col3.txt | gawk '{print $3}' > chr 
cat ./col3.txt | gawk '{print $6}' > gens 
paste gens chr | sort | uniq > ~/chroverview.txt 
 
This list was imported into R and the number of genes found on each chromosome were plotted 
versus the lengt of each chromosome as listed in the original paper. A correlation of 0.95 were 
found indicating that most genes are probably correctly placed 
chroverview = read.table("chroverview.txt") 
rownames(chroverview)=chroverview[,1] 









Figure 19 C. griseus chromosomes  
Left: Chromosome length versus number of genes as found in R from input data. Right: Figure from
22
 showing bivariate 
flow cytometric analysis of C. griseus chromosomes prior to isolation and sequencing. 
 
The distribution of copy number in CHO-K1 ATCC versus CHO DXB11 were plotted for each 
chromosome 
png("Figure2.png", width = 20, height = 15, units = 'cm', res = 300) 
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par(mfrow = c(3,4));par(mar = c(0.1, 0.1, 0.1, 0.1)) 
plot(coll[,9],coll[,7],ylim=c(0,4),xlim=c(0,4),pch=20,col="#00000010",ylab=" ",xlab=" ",main=" ",xaxt='n',yaxt='n') 
Axis(side=1, labels=FALSE);Axis(side=2, labels=FALSE);Axis(side=3, labels=FALSE);Axis(side=4, labels=FALSE) 
for(i in 1:9) 
{ 
plot(coll[rownames(chroverview[which(chroverview[,2]==i),]),9],coll[rownames(chroverview[which(chroverview[,2]=
=i),]),7],ylim=c(0,4),xlim=c(0,4),pch=20,col="#00000010",ylab=" ",xlab=" ",main=" ",xaxt='n',yaxt='n') 
#text(3,3,chrnames[i+1]) #show chr number on plot 
Axis(side=1, labels=FALSE);Axis(side=2, labels=FALSE);Axis(side=3, labels=FALSE);Axis(side=4, labels=FALSE) 
} 
plot(coll[rownames(chroverview[which(chroverview[,2]==0),]),9],coll[rownames(chroverview[which(chroverview[,2]=
=0),]),7],ylim=c(0,4),xlim=c(0,4),pch=20,col="#00000010",ylab=" ",xlab=" ",main=" ",xaxt='n',yaxt='n') 
#text(3,3,chrnames[1]) #show chr number on plot 





Figure 20 copy number distribution for CHO-K1 ATCC versus CHO DXB11 sorted by chromosome. 
The x- and y-axes and chromosome names have been added manually in powerpoint. 
 
Subsequently the same data was used for creating a phylogenetic tree for each chromosome 
for(k in 0:9) 
{ 
coll2=coll[rownames(chroverview[which(chroverview[,2]==k),]),] 
distance=distance2=matrix(ncol=ncol(col),nrow=ncol(col),0);for(i in 1:ncol(col)) 
{for(j in 1:ncol(coll)) 
  {col3=coll2[which(abs(coll2[,j]-coll2[,i])>0.95),] 
   distance[i,j]=dim(col3)[1]/dim(coll2)[1] 
   distance2[i,j]=dim(col3)[1]} 
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} 
colnames(distance)=colnames(distance2)=rownames(distance)=rownames(distance2)=colnames(coll) 




Figure 21 phylogenetic tree among the CHO genomes evalutaed for each chromosome.  
 
The same information from above can be told in heatmaps. It seems that chromosome 1 and 4 are 
more stable than the other chromosomes.  
Box <- function(x, y, color) 
{rect(x, y, x+1, y+1, density = NULL, col = color, border = NULL, lty = par("lty"), lwd = par("lwd"))} 
chrnames=c("chrX","chr1","chr2","chr3","chr4","chr5","chr6","chr7","chr8","chr9/10") 
 








png("70.png", width = 20, height = 15, units = 'cm', res = 300) 
colfunc <- colorRampPalette(c("white", "white")) 
colfunc2 <- colorRampPalette(c("white", "blue")) 
colfunc3 <- colorRampPalette(c("blue", "green")) 
colfunc4 <- colorRampPalette(c("green", "red")) 
colors=c(colfunc(2),colfunc2(8),colfunc3(10),colfunc4(30)) 
#colors=c(colfunc(70),colfunc2(30)) 
par(mfrow = c(3,4));par(mar = c(0.1, 0.1, 0.1, 0.1)) 
 Appendix | 178 
#plot(1,1,xlim=c(2,11),ylim=c(2,11)) 
#text(6,6,"max 70%",cex=3,pos=1) 
distance=matrix(ncol=ncol(col),nrow=ncol(coll3),0);for(i in 1:ncol(coll3)) 
{for(j in 1:ncol(coll3)) 
  {col3=coll3[which((coll3[,j]-coll3[,i])>0.95),1] 
   distance[i,j]=length(col3)[1]/dim(coll3)[1] 
  } 
} 
plot(100,100, xlim=c(0,12),ylim=c(0,12),xaxt='n',yaxt='n',ylab="",xlab="") 
for(j in 1:ncol(coll)) 
{for(i in 1:ncol(coll)) 
 {Box(j,i,colors[distance[j,i]*100])} 
} 
for(i in 1:ncol(col)) {text(i+0.5,1,c(1:10)[i],cex=1.3,pos=1)} 
for(i in 1:ncol(col)) {text(0.4,i+1.3,c(1:10)[i],cex=1.3,pos=1)} 
text(6,12.5,"All",cex=1.3,pos=1) 
 
for(k in 1:9) 
{ 
coll2=coll3[rownames(chroverview[which(chroverview[,2]==k),]),] 
distance=distance2=matrix(ncol=ncol(col),nrow=ncol(col),0);for(i in 1:ncol(col)) 
  {for(j in 1:ncol(coll3)) 
    {col2=coll2[which((coll2[,j]-coll2[,i])>0.95),1] #CN up 
     distance[i,j]=length(col2)[1]/dim(coll2)[1] 
    } 
  } 
plot(100,100, xlim=c(0,12),ylim=c(0,12),xaxt='n',yaxt='n',ylab="",xlab="") 
for(j in 1:ncol(coll3)) 
{for(i in 1:ncol(coll3)) 
 {Box(j,i,colors[distance[j,i]*100])} 
} 
for(i in 1:ncol(col)) {text(i+0.5,1,c(1:10)[i],cex=1.3,pos=1)} 




distance=distance2=matrix(ncol=ncol(col),nrow=ncol(col),0);for(i in 1:ncol(col)) 
  {for(j in 1:ncol(coll3)) 
    {col1=coll2[which(abs(coll2[,j]-coll2[,i])>0.95),1] #both up and down 
     col2=coll2[which((coll2[,j]-coll2[,i])>0.95),1] #CN up 
     #col3=coll2[which((coll2[,j]-coll2[,i])<(-0.95)),1] #CN down 
   distance[i,j]=length(col2)[1]/dim(coll2)[1] 
   distance2[i,j]=length(col2)[1] 






for(j in 1:ncol(coll3)) 
{for(i in 1:ncol(coll3)) 
 {Box(j,i,colors[distance[j,i]*100])} 
} 
for(i in 1:ncol(col)) {text(i+0.5,1,c(1:10)[i],cex=1.3,pos=1)} 
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Figure 22 Heatmap visualising the CN reductions and amplifications seen between the currently sequenced CHO cell 
lines and C. griseus 
 
Absolute copy numbers 
In order to have provide an absolute copy number for each gene in each cell line it was assumed 
that the distribution was the same for all cell lines but CHO DXB11 were used to guide the cutoff.  
Genes not detected in any cell line: 159 genes had a median depth of 0 in all 10 genomes (including 
C. griseus). Those 159 genes were taken out of the dataset. 
Haploid genes: depth higher than 0 but lower than 1.3 based on local minimum in CHO DXB11 
between the haploid and diploid peak.  Diploid: higher than 1.3 and lower than 2.7 based on local 
minimum in CHO DXB11 between the diploid and triploid. Triploid or higher: depth higher than 
2.7. Finally all genes are assumed to be diploid in C. griseus 
hist(coll[,7],breaks =c(0,1:5000/100,3000),xlim=c(2.3,3),ylim=c(0,2),main="CHO DXB11") 
coll2=coll 
coll2[which(coll[,1]==0),]=2 #159 genes are 0 in C.griseus so they are considered diploid (or not counted) 
for(j in 2:ncol(coll)) 
{ 
coll2[which(coll[,j]==0 & abs(coll[,1]-coll[,j])<=0.95),j]=2 
coll2[which(abs(coll[,1]-coll[,j])>=0.95 & coll[,j]==0),j]=0 
coll2[which(coll[,j]<=1.3 & coll[,j]>0.0),j]=1 
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coll2[which(coll[,j]<=2.7 & coll[,j]>1.3),j]=2 
coll2[which(coll[,j]<=3.5 & coll[,j]>2.7),j]=3 
for(i in 4:159) 
{coll2[which(coll[,j]<=(i+0.5) & coll[,j]>(i-0.5)),j]=i} 
#coll2[which(round(coll2[,j], digits=0)!=coll2[,j]),]=round(coll2[,j], digits=0) 
} 
coll2[,1]=2 #C. griseus are assumed fully diploid 
 
As a test Dhfr is investigated. It is seen that the copy number agree with the known copy number in 


















Raw depth 47 28 13 9 8 0 17 11 49 9 
Normalized 1.8 2.4 2.2 2.0 1.8 0.0 1.0 1.3 2.0 2.3 
Absolute 2 2 2 2 2 0 1 1 2 2 
 
 
Finally a matrix is made summarizing the number of genes with each copy number. The number 




 column are the number of deleted and duplicated genes as found 
















 0 1 2 3 4 N0 ND hap 3+ 
C. griseus 0 0 20661 0 0 0 0 0% 0% 
C0101 37 3544 15088 1318 674 36 1935 17% 10% 
CHO_PF 54 3356 15059 1734 458 23 1448 16% 11% 
CHO_SF 48 3073 15453 1348 739 32 1574 15% 10% 
CHO_S 47 3024 15603 1236 751 23 2002 15% 10% 
DG44 62 4219 13967 1426 987 54 1881 20% 12% 
DXB11 44 3586 15267 1323 441 0 0 17% 9% 
F435 53 3888 14306 1713 701 0 0 19% 12% 
K1ATCC 30 3773 15305 1085 468 36 1374 18% 8% 
K1ECACC 57 4039 13310 2657 598 19 1430 20% 16% 
 
GO-term enrichment 
A list of GO-terms associated with the CHO genome was downloaded from CHOgenome.org 
(http://www.chogenome.org/files/CHO_GO_Functions_12Sep13.txt).  
… 
EGW13817 "Nxf2,Tapl2,Nxf2b" I79_021570 GO_component: GO:0005634 - nucleus [Evidence 
IEA]; GO_process: GO:0051028 - mRNA transport [Evidence IEA] 
… 
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As seen above the list contain multiple genes and multiple GO-terms on the same row. The file 
above was resorted into a file with one GO-term per line (but still multiple genes) using the script 
below 
for ((  i = 1 ;  i <= 11691 ; i++  )) 
do 
cat GOliste.txt | head -$i | tail -1  > genename 
cat genename | gawk '{print $1}' > gene 
cat genename | sed 's/\t/\n/g' | sed 's/;/\n/g' |  sed 's/^ //g' | sed 1d > Goterms 
number=`wc -l Goterms | gawk '{print $1}' ` 
for ((  j = 1 ;  j <= $number ; j++  )) 
do 
cat Goterms | head -$j | tail -1  > namespecific 








A list of all unique genes in the C. griseus genome was generated previously and used one by one to 
search the file made above to make a list with just the genename and the a GO-term 
for ((  i = 1 ;  i <= 20661 ; i++  )) 
do 
cat uniqgenes | head -$i | tail -1  > genename 
gene=`cat genename` 
grep "$gene" namelist | awk '{$1=""}1' | cut -f 1,1 -d'['  | sed 's/^ //g' > Goterms 
number=`wc -l Goterms | gawk '{print $1}' ` 
for ((  j = 1 ;  j <= $number ; j++  )) 
do 
cat Goterms | head -$j | tail -1  > namespecific 




The list was imported into R. The number of genes with different CN was used to find the number 
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Subsequently, every single GO-term was investigated mining how many CN differences were 
detected for each cell line for that GO-term. The Fischer exact test was used to determine whether a 














(𝑎 + 𝑏)! (𝑐 + 𝑑)! (𝑎 + 𝑐)! (𝑏 + 𝑑)!
𝑎! 𝑏! 𝑐! 𝑑! 𝑛!
 
Where a = Number of genes with a specific GO-term AND reduced/amplified, b= number of 
reduced/amplified genes, which did not have this GO-term, c = Number of genes with tis GO-term, 
which did not have a CN change. d = Number of genes, which did not have the GO-term nor a CN 
change. a+b+c+d = the 20661 genes in C. griseus. 
GOlist=matrix(nrow=length(GoUnique),ncol=37,0);rownames(GOlist)=GoUnique;colnames(GOlist)=c("Genes_with_G
O",1:36) 








if(subsub[2]-subsub[1] > 0.95)  { r[i,1] <- 1} else {r[i,1] <- 0} #amp 
if(subsub[2]-subsub[1] < -0.95) { r[i,2] <- 1} else {r[i,2] <- 0} #reduk 
#CHO_PF 
if(subsub[3]-subsub[1] > 0.95)  { r[i,3] <- 1} else {r[i,3] <- 0} 
if(subsub[3]-subsub[1] < -0.95) { r[i,4] <- 1} else {r[i,4] <- 0} 
#CHO_SF 
if(subsub[4]-subsub[1] > 0.95)  { r[i,5] <- 1} else {r[i,5] <- 0} 
if(subsub[4]-subsub[1] < -0.95) { r[i,6] <- 1} else {r[i,6] <- 0} 
#CHO_S 
if(subsub[5]-subsub[1] > 0.95)  { r[i,7] <- 1} else {r[i,7] <- 0} 
if(subsub[5]-subsub[1] < -0.95) { r[i,8] <- 1} else {r[i,8] <- 0} 
#DG44 
if(subsub[6]-subsub[1] > 0.95)  { r[i,9] <- 1} else {r[i,9] <- 0} 
if(subsub[6]-subsub[1] < -0.95) { r[i,10] <- 1} else {r[i,10] <- 0} 
#DXB11 
if(subsub[7]-subsub[1] > 0.95)  { r[i,11] <- 1} else {r[i,11] <- 0} 
if(subsub[7]-subsub[1] < -0.95) { r[i,12] <- 1} else {r[i,12] <- 0} 
#F435 
if(subsub[8]-subsub[1] > 0.95)  { r[i,13] <- 1} else {r[i,13] <- 0} 
if(subsub[8]-subsub[1] < -0.95) { r[i,14] <- 1} else {r[i,14] <- 0} 
#K1ATCC 
if(subsub[9]-subsub[1] > 0.95)  { r[i,15] <- 1} else {r[i,15] <- 0} 
if(subsub[9]-subsub[1] < -0.95) { r[i,16] <- 1} else {r[i,16] <- 0} 
#K1ECACC 
if(subsub[10]-subsub[1] > 0.95)  { r[i,17] <- 1} else {r[i,17] <- 0} 
if(subsub[10]-subsub[1] < -0.95) { r[i,18] <- 1} else {r[i,18] <- 0} 
 } 
# 
  r2=r3=0;for(i in 1:18) 
  { 
  r2[i]=sum(r[,i])  
  a=sum(r[,i]);b=diffgenes[i]-a;c=nrow(subGOlist)-a;d=20661-a-b-c 
  Fischer=matrix(c(a,c,b,d),nrow = 2) 
  r3[i]=fisher.test(Fischer, alternative = "two.sided")$p.value 
  } 




Following evaluation of all GO-terms in all cell lines, a list of all GO-terms which had a p-value < 
0.01 in just one of the 9 cell lines in either enrichment of amplified or reduced genes was made and 
exported for supplementary table 7. 
test=rlist=0 









sGO=r3[order(r3[,31]),20:37] #sort by reduction in CHO DXB11 
names=c("C0101 duplication","C0101 reduction","CHO-K1 PF duplication","CHO-K1 PF reduction","CHO-K1 SF 
duplication","CHO-K1 SF reduction","CHO-S duplication","CHO-S reduction","CHO DG44 duplication","CHO DG44 
reduction","CHO DXB11 duplication","CHO DXB11 reduction","F435 duplication","F435 reduction","CHO-K1 ATCC 




names=c("CHO-K1 PF duplication","CHO-K1 SF duplication","CHO-K1 ECACC  duplication","CHO-K1 ATCC 
duplication","CHO DXB11 duplication","F435 duplication","CHO DG44 duplication","CHO-S duplication","C0101 
duplication ","CHO-K1 PF reduction","CHO-K1 SF reduction","CHO-K1 ECACC  reduction","CHO-K1 ATCC 
reduction","CHO DXB11 reduction","F435 reduction","CHO DG44 reduction","CHO-S reduction","C0101 reduction") 
names=c("CHO-K1 PF","CHO-K1 SF","CHO-K1 ECACC ","CHO-K1 ATCC","CHO DXB11","F435","CHO DG44","CHO-
S","C0101 ","CHO-K1 PF","CHO-K1 SF","CHO-K1 ECACC","CHO-K1 ATCC","CHO DXB11","F435","CHO DG44","CHO-
S","C0101") 
colnames(significantGO2)=names 
write.table(significantGO2,file="Sup_table7.txt",sep="\t") #all genes 
 
Finally the table above were visualized as a heatmap also where p-values < 0.01 were dark blue and 
0.01 < p-values < 0.05 were shown as blue. 
Box <- function(x, y, color) 
{rect(x, y, x+1, y+1, density = NULL, col = color, border = NULL, lty = par("lty"), lwd = par("lwd"))} 
colfunc <- colorRampPalette(c("darkblue", "darkblue")) 
colfunc2 <- colorRampPalette(c("blue", "blue")) 
colfunc5 <- colorRampPalette(c("white", "white")) 
colors=c(colfunc(10),colfunc2(40),colfunc5(950)) 
 
png("SupplFigure4.png", width = 30, height = 30, units = 'cm', res = 300) 
plot(100,100, xlim=c(1,nrow(significantGO2)+60),ylim=c(0,25),xaxt='n',yaxt='n',ylab="",xlab="") 
for(j in 1:nrow(significantGO2)) 
{ 
for(i in 1:9){Box(j+34,i,colors[round(significantGO2[j,i]*1000,0)+1])} 
for(i in 10:18){Box(j+34,i+1,colors[round(significantGO2[j,i]*1000,0)+1])} 
} 
for(i in 1:9) {text(0.5,i+0.5,names[i],cex=0.60,pos=4)} 
for(i in 10:18) {text(0.5,i+1.5,names[i],cex=0.60,pos=4)} 
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Figure 23 Significant GO-terms in correlation to changes in copy number 
Visualization of the 135 GO-terms, which are either significantly enriched in genes with CN reductions or amplifcations 
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10.3.3 Detecting genomic rearrangements from break-spanning reads 




Pre-alignment trimming of reads 
Trim Galore is a usefull tool, which are able to trim the paired reads from a genome resequencing 
experiment, while keeping the files synchronized so the pairs are broken
24
. It can be downloaded 
from here
25
  and the required packagages cutadapt from here
26
 and fastqc from here
27
. In the code 
below all low quality bps are trimmed from the ends until bps with a quality >30 are found, but all 







~/software/Trimgalore/trim_galore --paired -q 30 --length 40 --fastqc --path_to_cutadapt /novo/appl/ngs/cutadapt-
1.2.1/bin/cutadapt --stringency 5 -o ./trimmed_reads DXB11_1.fastq DXB11_2.fastq 
 
 
Figure 24 quality score across the reads before (left) and after (right) trimming. 
Reads were aligned to the C. griseus genome  
The trimmed reads are subsequently aligned to the C. griseus genome using BWA
29
 and 
subsequently converted into a bam-file from a sam-file. First, the genome has to be indexed by 
BWA before alignment. 
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bwa index Cgriseus.fa 
 
After the genome has been indexed the reads are alinged to the genome 
bwa aln Cgriseus.fasta 1BWA_1.fastq > 1BWA_1.sai 
bwa aln Cgriseus.fasta 1BWA_2.fastq > 1BWA_2.sai 
bwa sampe -r "@RG\tID:libA\tSM:sample_EACC\tPL:ILLUMINA" Cgriseus.fasta 1BWA_1.sai 1BWA_2.sai 1BWA_1.fastq 
1BWA_2.fastq | samtools view -Sb - > 2alignment_L.bam 
 
All reads with a minimum mapping quality less than 30 were removed and the file was sorted and 
indexed 
samtools view -u -q 30 2alignment_L.bam | samtools sort - 2alignment_L.sort 
samtools index 2alignment_L.sort.bam 
 
GATK was used in order to remap all the reads in region containing indels 
The RealignerTargetCreater algorithm
30
 was used to realign reads in problematic regions of the 
genome. 
java -Xmx2g -jar GenomeAnalysisTK.jar -T RealignerTargetCreator -R Cgriseus.fasta  -I 2alignment_L.sort.bam -o 
3_L.intervals 
 
java -Xmx2g -jar GenomeAnalysisTK.jar -T IndelRealigner -targetIntervals 3_L.intervals -R Cgriseus.fasta  -I 
2alignment_L.sort.bam -o 3realigned_L.bam 
Alignments run in parallel were merged into one bam-file 
In the steps above the data from the same sample was split into multiple files and now the files are 
merged from several bam files into one single bam file. This is done using samtools
31
 
samtools merge Cgris_prePicard.bam 3realigned_L.bam 3realigned_L.bam /H3/3realigned_L.bam 
/H4/3realigned_L.bam /H5/3realigned_L.bam 
PCR duplicates were removed using Picard 
PCR remnants are removed using Picard
32
 
java -Xmx2g -jar MarkDuplicates.jar INPUT=Cgris_prePicard.bam OUTPUT=4Picard_L.bam.bam 
ASSUME_SORTED=FALSE METRICS_FILE=/dev/null VALIDATION_STRINGENCY=SILENT REMOVE_DUPLICATES=true 
 
In the 4Picard_L.bam file made above, a certain number of paired reads do not align to the same 
genomic scaffolds in close proximity to each other. Some of these will be noise, but with proper 
filtering it should be possible to hypothesize regarding genomic rearrangements using these 
anomalous reads. This can be carried out using the program SVdetect
33
. 
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Detect break-spanning reads 
The SVDetect BAM_preprocessingPairs script found in the SVdetect library was used to pre-
process the bam file made above 
perl ./SVDetect_r0.8b/scripts/BAM_preprocessingPairs.pl 4Picard.bam 
 
Giving the output: 
Total : 62889376 pairs analysed 
-- 251915 pairs whose one or both reads are unmapped 
-- 62637461 mapped pairs 
---- 746850 abnormal mapped pairs 
------ 542994 pairs mapped on two different chromosomes 
------ 443784 pairs with incorrect strand orientation and/or pair order 
------ 179904 pairs with incorrect insert size distance 
---- 61890611 correct mapped pairs 
 
The bam file was converted to a sam file  
samtools view -h -o 4Picard.ab.sam 4Picard.ab.bam 
 
Prepare chromosome list for SVdetect 
A list of the chromosomes and their length (called sortedlist.txt) is required to run SVdetect. Such a 
list was extracted from the header of the sam file generated above 
 
grep "^@SQ" DXB11_new.ab.sam > headerraw 
sed 's/SN://g' headerraw | sed 's/LN://g' | gawk '{print $2, $3}' | sed 's/ /\t/g'> chr_len 
 
length=`wc -l chr_len | awk '{print $1 }'` 
for (( j = 1 ; j <= $length ; j++ )) 
do 
echo $j >> numbers 
done 
 
paste numbers chr_len > sortedlist.txt 
 
Yielding a list looking like this: 
1       NW_003717424.1  209 
2       NW_003613580.1  8779783 
3       NW_003613581.1  8081566 
4       NW_003613582.1  6666273 
5       NW_003613583.1  6533376 
... 
4390    NW_003712234.1  219 
4391    NW_003713686.1  216 
4392    NC_007936.1     16284 
 
Calculate paired read distance 
Calculate the paired end distance using Picard 
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Figure 25 Paired read distance 
Left: Paired read distance distribution for the CHO DXB11 genome re-sequencing data showing 250±70bp of distance. 
Right: Mean paired read distance for each of the CHO-K1 ATCC SRA files.  
 
By removing the first 11 lines in the output file (./histogram.numerical.txt) the data could be loaded 
into R and the mean (250), median (236) and stdev (70) was found. It was furthermore seen in the 
data that 99% of the reads had an insert size less than 505 bp 
R 




From fastqc of my treated reads it was found that my paired reads were on average 86bp in length. 
SVdetect advice is 2µ+2stdev used for cutoff for rearrangements: 2x (250 + 86 x2) + 2x 70 = 984 = 
1000bp will be used as cutoff.  
 
In order to compare to another genome, the distance for each dataset on the SRA from the CHO-K1 
ATCC genome was analysed. From CHO-K1 ATCC a subset of SRR329941-5 was taken, which all 
had a distance of 175±7bp 
Make the SVdetect config file 




mates_orientation=FR #always use this for paired reads 
read1_length=86 # data found from fastqc output 
read2_length=86 
mates_file=/novo/omicsmanager/processed01/1099/data/pipe2del/SVdetect/4Picardtest/4Picard.ab.sam #full path to 
file containing reads with irregular paired read distance 
cmap_file=/novo/omicsmanager/processed01/1099/data/pipe2del/SVdetect/4Picardtest/sortedlist.txt #full path to list 
of chromosomes and their length 




split_mate_file=0 #see next section for details. If one uses a genome with >24 chromosomes the software cannot 
handle to make this file itself. Set this to 0 and make it manually as explained in the next section.  
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window_size=1000 #This is important. This is the distance that is checked and set as cutoff. Reads with insert sizes 
larger than this are accepted 




split_link_file=0 #same reason as above. Due to >24 chromosomes this need to be 0 and made manually 
nb_pairs_threshold=18 #number of reads needed to validate a specific rearrangement. The median depth of 18 is 
used as a position on each copy of a given chromosome is 9 but each position is covered by 9 reads but also 9 more 
spanning with the insert size twice the length = a depth of 18 is picked in order to be able to recognize haploid 
rearrangements  
strand_filtering=1 #analyse the distribution of forward and reverse reads. Checks that a rearrangements are not only 
backed by forward reads only on one side but an equal distribution of forward and reverse reads as expected 
</filtering> 
 
Create the sam.all files due to the fragmentation of the CHO genome 
If you run the cofig file above with split_mate_file=1 it will try to open all contigs at the same time 
(make perfect sense in the well assembled human genome, but not in a 4000+ contig CHO) = the 
program crashes with a “too many open files”-error.  
After contacting the programmer, a solution was found by making the sam.all files by extracting all 
lines in the sam file that is relevant for a given scaffold and place it in the “mates”-folder. When this 
is done the program works fine if run with split_mate_file=0 (they have already been split) 
cat sortedlist.txt | gawk '{print $2}' > chrlist 
wc -l chrlist > length 
length=`awk '{print $1 }' < length` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
cat chrlist | head -$i | tail -1 > scaffold 
scaffold=`awk '{print $1 }' < scaffold` 




perl ./SVDetect_r0.8b/bin/SVDetect linking -conf ./configfile.txt  
perl  ./SVDetect_r0.8b/bin/SVDetect filtering -conf /./configfile.txt 
perl  ./SVDetect_r0.8b/bin/SVDetect links2SV -conf ./configfile.txt 
perl  ./SVDetect_r0.8b/bin/SVDetect links2circos -./configfile.txt  
perl  ./SVDetect_r0.8b/bin/SVDetect links2bed -conf configfileDXB11.txt 
 
Filtering the SVdetect output 
   10,028 rearrangement events were predicted in CHO DXB11 compared to CHO-K1 ATCC. 
Example output below from an intra-chromosomal structural variant (same scaffold the distance is 
just off) and the orientation of each end is the same (indicate a deletion). 48% of the rearrangements 
were found to be either in the first 10% or the last 10% of the scaffolds, which could be genuine due 
to the assembly of the genome. 
INTRA NORMAL_SENSE - chrNW_003614308.1 4390-4898 - chrNW_003614308.1 7976-8846 11414 99% - - 1.000 -- 
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   In an interesting study by Mijuskovic et al
34
, filtering was suggested based on 1) remove 
sequenced PCR duplicates using Picard, 2) remove reads with low mapping quality, 3) 
rearrangement found in the parental genome (running SVdetect in this case on the CHO-K1 genome 
using the raw CHO-K1 reads and filtering out all all rearrangements found in the parental reads) 
and 4) remove rearrangement within regions with simple repeats (suing repeatmasker). Using this 
strategy the number of SV’s in their case went from 11262 to 513. In the case above it was reduced 
from 10,028 to 365, but validation of rearrangements using PCR did not prove to be succesfull. 
Even if that had been the case the amount of filtering required make the final list questionable for 
exactly how many false negatives are being ignored.  
   It is possible to detect rearrangement in complex genomes using software such as SVdetect, but 
due to repetitive sequences it would probably not yield a realistic result of the number of 
rearrangement events that has occoured.  
10.3.4 SNP detection in two CHO genomes 
Summary: This tutorial describes how to locate SNPs from in a CHO genome aligned to the C. 
griseus reference sequence. I kindly ask you cite: Kaas et al 2015, Sequencing the CHO DXB11 
genome reveals regional variations in genomic stability and haploidy in case you will publish data 
based on this workflow.  
Pre-alignment trimming of reads 
Trim Galore is a usefull tool, which are able to trim the paired reads from a genome resquencing 
experiment, while keeping the files synchronized so the pairs are broken
35
. It can be downloaded 
from here
36
  and the required packagages cutadapt from here
37
 and fastqc from here
38
. In the code 
below all low quality bps are trimmed from the ends until bps with a quality >30 are found, but all 







~/software/Trimgalore/trim_galore --paired -q 30 --length 40 --fastqc --path_to_cutadapt /novo/appl/ngs/cutadapt-
1.2.1/bin/cutadapt --stringency 5 -o ./trimmed_reads DXB11_1.fastq DXB11_2.fastq 
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Figure 26 quality score across the reads before (left) and after (right) trimming. 
Reads were aligned to the C. griseus genome  
The trimmed reads are subsequently aligned to the C. griseus genome using BWA
40
 and 
subsequently converted into a bam-file from a sam-file. First the genome has to be indexed by 
BWA before alignment. 
bwa index Cgriseus.fa 
After the genome has been indexed the reads are alined to the genome 
bwa aln Cgriseus.fasta 1BWA_1.fastq > 1BWA_1.sai 
bwa aln Cgriseus.fasta 1BWA_2.fastq > 1BWA_2.sai 
bwa sampe -r "@RG\tID:libA\tSM:sample_EACC\tPL:ILLUMINA" Cgriseus.fasta 1BWA_1.sai 1BWA_2.sai 1BWA_1.fastq 
1BWA_2.fastq | samtools view -Sb - > 2alignment_L.bam 
 
All reads with a minimum mapping quality less than 30 were removed and the file was sorted and 
indexed 
samtools view -u -q 30 2alignment_L.bam | samtools sort - 2alignment_L.sort 
samtools index 2alignment_L.sort.bam 
 
GATK was used in order to remap all the reads in region containing indels 
The RealignerTargetCreater algorithm
41
 was used to realign reads in problematic regions of the 
genome. 
java -Xmx2g -jar GenomeAnalysisTK.jar -T RealignerTargetCreator -R Cgriseus.fasta  -I 2alignment_L.sort.bam -o 
3_L.intervals 
 
java -Xmx2g -jar GenomeAnalysisTK.jar -T IndelRealigner -targetIntervals 3_L.intervals -R Cgriseus.fasta  -I 
2alignment_L.sort.bam -o 3realigned_L.bam 
 








 Appendix | 192 
Alignments run in parallel were merged into one bam-file 
In the steps above the data from the same sample was split into multiple files and now the files are 
merged from several bam files into one single bam file. This is done using samtools
42
 




PCR duplicates were removed using Picard and raw SNPs located 
PCR remnants are removed using Picard
43
 
java -Xmx2g -jar MarkDuplicates.jar INPUT=Cgris_prePicard.bam OUTPUT=Cgris_postPicard.bam 




 bam file was sorted based on genome 







 were used to locate SNPs 
samtools mpileup -uf Cgriseus.fasta Cgris_postPicard.genomesort.bam | bcftools view -bvcg - > 3SNPs.raw.bcf 
 
The bcf file was converted into vcf using bcftools 
bcftools view 3SNPs.raw.bcf > name.vcf 
Filtering based on background 
The raw vcf-file from C. griseus was used to remove background SNPs found in C. griseus. 
The vcf files were fist zipped and indexed 
bgzip DXB11.vcf 




 was used to filter out the background SNPs found in C. griseus reads against the C. 
griseus genome. 
perl vcftools_0.1.12a/perl/vcf-isec -c DXB11.raw.vcf.gz Cgris.vcf.gz > DXB_uCgris.vcf 
 
Hard filter  
In order to filter away false positives a hard filter was applied which first filtered away all indels or 
SNPs found within 5bp of each other. This should remove SNPs found in regions problematic to 
align. Secondly homozygous SNPs were found by using the DP4-depths to find SNPs with more 
than 80% of the reads showing change and the sum of reference forward, reference reverse, allele 
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forward and allele reverse being higher than the standard deviation from the haploid peak: median 
were in the case of DXB11 33 => ¼ x 33 = 8.25 and ¾ x 33 = 24.75. 8 were chosen as minimum 
for a homozygous SNP and 25 as minimum for a heterologous SNP. This was validated as realistic 




cp DXB_uCgris.vcf name.vcf 
grep "^#" name.vcf > header 
grep -v "^#" name.vcf > file1 
cat file1 | gawk '{print $2}' > file2.1 
cat file2.1 | sed 1d > file2.down 
echo "1" >> file2.down 
echo "1" > file2.up 
head -n -1 file2.1 >> file2.up 
paste file2.1 file2.up | awk '{a=$2-$1; print a;}' | awk ' { if($1>=0) { print $1} else {print $1*-1 }}' > file2.diff1  
paste file2.1 file2.down | awk '{a=$2-$1; print a;}' | awk ' { if($1>=0) { print $1} else {print $1*-1 }}' > file2.diff2 
paste file1 file2.diff1 file2.diff2 > file2 
awk '$11 > 5' file2 | awk '$12 > 5' > file3 
#Only SNPS are looked at right now 
grep -v "INDEL" file3 | cut -f1-10 > file4 
cat file4 | gawk '{print $8}' | sed 's/^.*DP4=//g' | cut -f 1,1 -d';' | sed 's/,/\t/g' > file5 
cat file5 | awk '{a=$3+$4; b=$1+$2+$3+$4; c=((a/b)); print a,b,c}' | sed 's/ /\t/g'> file6 
paste  file4 file6 | awk '$12 >= 8' | awk '$6 > 30' | awk '$13 > 0.80' > file7.homo 
paste  file4 file6 | awk '$12 >= 24' | awk '$6 > 30' > file7.hetero  
cat file7* | sort | uniq  > file8 
grep "^#" name.vcf > header 
cat file8 | cut -f1-10 >> header 
cp header DXB_SNP_uCgris.vcf  
#Only indels are looked at right now 
grep "INDEL" file3 | cut -f1-10 > file4 
cat file4 | gawk '{print $8}' | sed 's/^.*DP4=//g' | cut -f 1,1 -d';' | sed 's/,/\t/g' > file5 
cat file5 | awk '{a=$3+$4; b=$1+$2+$3+$4; c=((a/b)); print a,b,c}' | sed 's/ /\t/g'> file6 
paste  file4 file6 | awk '$12 >= 8' | awk '$6 > 30' | awk '$13 > 0.80' > file7.homo 
paste  file4 file6 | awk '$12 >= 24' | awk '$6 > 30' > file7.hetero   
cat file7* | sort | uniq  > file8 
grep "^#" name.vcf > header 
cat file8 | cut -f1-10 >> header 
cp header DXB_indel_uCgris.vcf 
 
Finding functional consequences  
The vcf-files from above with SNPs and indels were imported into CLC Genomic workbench 
(version 7.0.4) and functional consequences were found using the “Amino acid changes” function 
after importing the Cgriseus.gff3 annotation file as tracks. The output from the program was 
exported as csv files.  
The csv files were reorganized 
The Indel file contained an extra column so each output was treated differently. All lines containing 
“SNPs” which were identical to the reference were removed 
Indel output: 
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cat K1_indel_uCgris_AAC.csv | sed 's/""/"-"/g' | sed 's/","/\t/g' | sed 's/,/YYY/g' | sed 's/"//g' | gawk '{print 
$6,$1,$2,$3,$4,$5,$7,$9,$20,$24,$38,$33,$34}' | sed 's/ /,/g' | awk -F, '$1=="No" {print $0}' |  sed 's/,/\t/g' | cut -
f2-14 | sed 's/YYY/,/g' > K1_indel.txt 
 













































cat K1_SNP_uCgris_AAC.csv | sed 's/""/"-"/g' | sed 's/","/\t/g' | sed 's/; /;/g' | sed 's/,/YYY/g' | sed 's/"//g' | gawk 
'{print $6,$1,$2,$3,$4,$5,$7,$9,$19,$23,$37,$32,$33}' | sed 's/ /,/g' | awk -F, '$1=="No" {print $0}' |  sed 's/,/\t/g' 
| cut -f2-14 | sed 's/YYY/,/g' > K1_SNP.txt 
 








































Filtering the output based on genes 
The output was then filtered based on each gene making the output more easily searchable  
 
echo "K1ATCC" > name 
name=`awk '{print $1 }' < name` 
wc -l ~/Cgenomes/CHOK1_version1.1/listofgenes2 > length 
length=`awk '{print $1 }' < length` 
for ((  i = 22055;  i <= $length ; i++  )) 
do 
cat ~/Cgenomes/CHOK1_version1.1/listofgenes2 | head -$i | tail -1 | gawk '{print $3}' > protein 
protein=`awk '{print $1 }' < protein` 
grep -w "$protein" database > hits 
wc -l hits > length2 
length2=`awk '{print $1 }' < length2` 
for ((  j = 1 ;  j <= $length2 ; j++  )) 
do 
cat hits | head -$j | tail -1 > subset 
scaffold=`awk '{print $1 }' < subset` 
pos=`awk '{print $2 }' < subset` 
ref=`awk '{print $4 }' < subset` 
allele=`awk '{print $5 }' < subset` 
echo "$scaffold.$pos$ref>$allele" > mutation 
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gawk '{print $3}' subset  > type 
gawk '{print $6}' subset  > length 
gawk '{print $7}' subset  > zygosity 
gawk '{print $8}' subset  > depth 
gawk '{print $9}' subset  > DP4 
gawk '{print $10}' subset  > CDSconcequence 
cat subset | sed "s/^.*$protein:c/$protein/" | gawk '{print $1}' | cut -f 1,1 -d';' > coding 
grep "$protein:p" subset | sed "s/^.*$protein:p/$protein/" | gawk '{print $1}' | cut -f 1,1 -d';' > proteinmut 
paste name type length zygosity depth DP4 CDSconcequence mutation coding proteinmut >> SNPs 
done 
grep -w "$protein" SNPs > overview 
wc -l overview | gawk '{print $1}' > rnumber 
gawk '{print $5}' overview | grep "-" | wc -l > intronnumber 
gawk '{print $5}' overview | grep "No" | wc -l > exon_nochange 
gawk '{print $5}' overview | grep "Yes" | wc -l > AAchange 
#paste exon_nochange AAchange | awk '{a=$2+$1;print a;}' > exonnumber 
paste protein name rnumber intronnumber exon_nochange AAchange >> Proteinoverview 
done 
cat SNPs | tr '[' ' ' | tr ']' ' ' | sed 's/.1. /.1./g' > SNP 
 
The first couple of SNPs rearranged based on the code above (see full table in Supplementary table 









Making an output of the changed genes 
In order to obtain a fasta file with a genome as that of the reference, but containing the filtered 
indels and SNPs the method below can be used to create a new pseudo-genome 
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./vcf-sort DXB11.vcf > DXB11sorted.vcf  
bgzip DXB11sorted.vcf 
tabix -p vcf DXB11sorted.vcf.gz 
cat CHOK1_ver1.1.fasta | ./vcf-consensus DXB11sorted.vcf.gz > testout.fa 
Frameshifting mutations 
In order to get lists of the genes having homozygous frameshift mutations in CHO DXB11 and K1:  
cat DXB_indel.txt | grep "Homozygous" | gawk '{print $12}' | grep "fs" | sed 's/:p./\t/g' > DXBfs 
cat K1_indel.txt | grep "Homozygous" | gawk '{print $12}' | grep "fs" | sed 's/:p./\t/g' > K1fs 
sdiff DXBfs K1fs | grep "<" | gawk '{print $1, $2}' > DXBfrunique 
sdiff DXBfs K1fs | grep "|" | gawk '{print $1, $2}' >> DXBfrunique 
 
wc -l DXBfrunique > length 
length=`awk '{print $1 }' < length` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
cat DXBfrunique | head -$i | tail -1 > protein 
protein=`awk '{print $1 }' < protein` 
grep -w "$protein" ~/Cgenomes/CHOK1_version1.1/listofgenes2 > hits 
paste protein hits >> frameshiftDXB11 
done 
 
10.3.5 Extracting differentially expressed genes from an RNA sequencing experiment 
In this section a pipeline is presented for obtaining a list of differentially expressed genes from raw 
reads obtained from RNA sequencing (RNAseq) data 
Pre-alignment trimming of reads 
Trim Galore is a usefull tool, which are able to trim the paired reads, while keeping the files 
synchronized so the pairs are broken
51
. It can be downloaded from here
52
  and the required 
packagages cutadapt from here
53
 and fastqc from here
54
. In the code below all low quality bps are 
trimmed from the ends until bps with a quality >30 are found, but all reads that after trimming are 






~/software/Trimgalore/trim_galore --paired -q 30 --length 40 --fastqc --path_to_cutadapt /novo/appl/ngs/cutadapt-
1.2.1/bin/cutadapt --stringency 5 -o ./trimmed_reads DXB11_1.fastq DXB11_2.fastq 
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Figure 27 quality score across the reads before (left) and after (right) trimming. 
Alignment to the genome 
The alignment of RNAseq reads to the genome is slightly different from genomic data as the 
RNAseq data have had the introns removed and this are only expected to align to exonic sequence. 
The genome was indexed using the bowtie-algorithm so it would work with tophat  
bowtie-build Cgriseus.fasta Cgriseus 
 
The index was tested by looking for a specific sequence only found in the LRP1-gene 
bowtie -c Cgriseus tatccaggggtccagaaggtgcactttggactggctgacg 
 
0 -  NW_003614353.1  616991  CGTCAGCCAGTCCAAAGTGCACCTTCTGGACCCCTGGATA 
IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII        0 
# reads processed: 1 
# reads with at least one reported alignment: 1 (100.00%) 
# reads that failed to align: 0 (0.00%) 
Reported 1 alignments to 1 output stream(s) 
 
This output shows that the genome index was successfully searched and only a single hit was found 
as expected. 
The reads are aligned as below  
tophat -o F3901 #output directory  
-p 32 #number of threads to run on the supercomputer 
--segment-mismatches 3 #number of mismatches that is tolerated for each read   
--segment-length 25  #the read can be split in two (specie sites) but min 25bp on each side 
--mate-inner-dist 80 #distance between the two paired reads (consult sequencing company) 
--mate-std-dev 50  #the standard dev of the above distance so 80+50 is OK 
--transcriptome-index /F3901/transcriptome_idx #generates a transcriptome file that can be used with other samples 
with the same genome 
-G ./Cgriseus.gtf #the genome annotation that is used to lead the assembly.  
./bowtie_index/Cgriseus #where to look for the bowtie-indexed genome 
F390_1_comm_1.fq #input fastq file 1  
F390_1_comm_2.fq #input fastq file 2 
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Count the number of reads aligning to each gene 
Expression values will be deduced using htseq-count
56
, which counts the number of reads aligning 
to the exonic sequence. 
First the accepted_hits.bam file made by tophat is sorted using samtools and subsequently converted 
into a sam file 
 
samtools sort -n accepted_hits.bam accepted_hits.nsort 
samtools view accepted_hits.nsort.bam > accepted_hits.nsort.sam 
 
Then the accepted_hits.nsort.sam file is used to look for exonic sequence based on the position in 
the annotation file. 
htseq-count --stranded=no --idattr=gene_name --samout=htseq-cout.accepted_hits.sam --mode=intersection-
nonempty accepted_hits.nsort.sam ./feature/Cgriseus.gtf > 01.1.htseq.txt 
 










Import into R and normalization of the data 
In R the datafiles above are imported and technical replicates sequenced on different lanes but from 
the same library are simply added together (as e.g. T1+S1) in case to generate a table of 32 columns 
and 26632 rows. 
 
T1=as.matrix(read.table("01.1.htseq.txt",header = TRUE, row.names=1)) 




colnames(col)=c(1.1, 1.2, 1.3, 2.1, 2.2, 2.3, 3.1, 3.2, 3.3, 4, 5, 6.1, 6.2, 6.3, 7.1, 7.2, 7.3, 8.1, 8.2, 8.3, 9, 10, 11, 
12.1, 12.2, 12.3, 13.1, 13.2, 13.3, 14.1, 14.2, 14.3) 
 
Based on the review by Dillies et al
57
 the samples were normalized based on the algorithm used in 
EdgeR
58
. First the group is define, which is the samples are actually biological replicates. In this 
rame column 1-3 is sample1, 4-6 is sample 2…  
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group <- factor(c(rep.int(1, 3),rep.int(2, 3),rep.int(3, 3),4,5,rep.int(6, 3),rep.int(7, 3),rep.int(8, 
3),9,10,11,rep.int(12, 3),rep.int(13, 3),rep.int(14,  3))) 
 
Subsequently the samples are normalized 
.libPaths(c("C:\\R\\Rpackages", .libPaths())) #if you want to install the  
source("http://bioconductor.org/biocLite.R");biocLite("edgeR") 
library(edgeR) 
x <- DGEList(counts=col,group=group) 
plot(aveLogCPM(x, normalized.lib.sizes=TRUE, prior.count=2, dispersion=0.05)) 
y <- calcNormFactors(x) 
z <- estimateCommonDisp(y) #overall dispersion of the dataset (inter-library variability) 
w <- estimateTagwiseDisp(z) #dispersion per tag (gene), 
 




Figure 28 Multidimensional scaling of the 32 RNAseq samples 
 
From supplementary table 6 from recent paper
59









Due to alternative spleicing the same CHO gene identifier is listed with different lengths but as 
htseq counts for the entire gene the longest will be picked. The list (called names.txt) is imported 
into R and used for normalization for each gene in order to arrieve to arrive at Fragments Per 
Kilobase of transcript per Million mapped reads (FPKM) values instead of CPM (Counts per 

























Pearson's correlation coefficient 
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Identifying differentially expressed genes 
From the dataset seen above the difference between sample 1 compared to a control (here sample 
12) is used for calculating the p-values and fold-changes between samples 
et <- exactTest(w, pair=c(12,1))  
write.table(topTags(et,n=25029),file="pvals.csv");pvals = read.csv("pvals.csv",sep=" ") 
head(pvals) 
 
Figure 29 All genes in the genome with the log2(fold-change) for sample 1 vs sample 12, the log2(CPM) and the 
probability that the difference is random 
 
The differentially expressed genes can be isolated from the matrix by assigning cut-off such as fold-







jpeg("Degenes.jpg", width=10, height=10, units="in", res=500) 




The list of genes are exported to a tabular seperated file 
write.table(DE3,file="FPKM.txt", sep="\t") 
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Figure 30 visulization of the differentially expressed genes 
10.3.6 Analyzing miRNA sequencing data 
This section contains a step-by-step guide for data analysis of miRNA sequencing data for 
identification of differentially expressed miRNAs. 
Extraction of the miRNAs 
RNA was extracted from 2x10
6
 cells using TRIzol (Invitrogen) and the RNeasy Cleanup kit 
(Qiagen) following the manufacturer’s instructions. RNA integrity was confirmed on an Agilent 
2100 Bioanalyzer using total RNA nano chips (Agilent Technologies, Santa Clara, Ca, USA). RNA 
concentration was measured using a NanoDrop spectrophotometer (NanoDrop Technologies). 
Multiplexed cDNA library generation and next-generation sequencing were performed by AROS 
Applied Biotechnology (Aarhus, Denmark) pooling the 9 miRNA libraries together with two CHO 
genomes on two lanes in an Illumina Hiseq 2000. 
  
Identification of adapter 
Between 6e6 and 10e7 reads per miRNAseq library were sequenced with ~50bp per read. Due to 
the short nature of a mature miRNA ~30bp of the read will thus be standardized adapter found 
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flanking the miRNA as a result of the library preparation. The reads were analysed using fastqc 




Figure 31 top: Number of sequenced reads from each sample and sequencing lane. Bottom: Output from fastqc showing 
the overrepresentation of RNA PCR primer, index 1. 
 
Online a list of the full primer sequence was found
61





Extraction and counting miRNAs in CLC genomic workbench version 7.5 
The general tutorial for smallRNAseq analysis using CLC genomic workbench was followed6263.  
 The raw reads were imported (import | Illumina) 
 New | Trim adapter list | Add row | Insert name and sequence of RNA PCR primer, index 1 
| Action = Discard when not found 
 Toolbox | Transcriptomics Analysis | Small RNA Analysis | Extract and Count 
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Figure 32 Left: Distribution of miRNAseq length after filtering. Middle: Distribution of miRNAseq length after filtering 




From the initial filter with only RNA PCR primer, index 1 the distribution was completely 
skewed to “miRNAs” with a length of 24bp and not 22bp as expected (see Figure XX.C). From 
the count data it was seen that the vast majority of 24bp fragments were a single species of  
GGAATACCGGGTGCTGTAGGCTTT. This sequence was blasted and found to be 100% identical 
with Homo sapiens RNA, 5S ribosomal pseudogene 500 (NG_033696.1). This sequence must 
somehow have contaminated the library during preperation enriching for miRNAs. This 24bp 
sequence was added to the filter as with the RNA PCR primer (but with Action = Discard when 
found). And following trimming a distribution appeared centred around 22bp as expected. 
 
Identifying miRBase miRNAs using CLC genomic workbench version 7.5 
 Toolbox | Transcriptomics Analysis | Small RNA Analysis | Download miRBase 
 Toolbox | Transcriptomics Analysis | Small RNA Analysis | Annotate and Merge Counts 
 Click: use miRBase, select downloaded miRBase from above. 
 From miRBase species: Cricetulus griseus, Rattus norvegicus, Homo sapiens and Mus 
musculus were chosen 
 Standard settings were used regarding mature length variants 
 
A table is generated showing the expression value with the name  
Feature ID 
Expression 
values Name Resource 
let-7a-1 (Homo sapiens) 0 let-7a-1 
Homo 
sapiens 
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The tables were exported as csv files and merged into one table in excel with 748 miRNAs 








































Importing data into R and normalizing 
The merged table was inserted into a notepad file and all #N/A’s were replaced with 0’s. The 
file was imported into R and the reads from the sample but sequenced on different sequencing 
lanes were pooled into one column. 
 










F445_1 F445_2 F445_3 K28_1 K28_2 K28_3 K66_1 K66_2 K66_3 
let-7a-1//let-7a-3_hs 13 8 17 21 18 12 17 10 17 
let-7a-1//let-7c-2_mm 374 269 367 363 250 201 169 195 216 
let-7a-2//let-7a_mm//cg 0 0 0 0 0 0 3513 0 0 
let-7a-2//let-7a_mm//rn//cg 10589 19021 0 18618 0 12229 3544 5291 0 
 







group <- factor(c(rep.int(1, 3),rep.int(2, 3),rep.int(3, 3))) 
x <- DGEList(counts=coll,group=group) 
y <- calcNormFactors(x) 
z <- estimateCommonDisp(y) #overall dispersion of the dataset (inter-library variability) 
w <- estimateTagwiseDisp(z) #dispersion per tag (gene) 





F445_1 F445_2 F445_3 K28_1 K28_2 K28_3 K66_1 K66_2 K66_3 
let-7a-1//let-7a-3_hs 18,9 13,3 20,0 18,6 17,6 16,7 24,5 12,3 19,4 
let-7a-1//let-7c-2_mm 543,7 447,6 432,5 321,5 245,0 279,0 243,8 239,5 245,9 
let-7a-2//let-7a_mm//cg 0,0 0,0 0,0 0,0 0,0 0,0 5.067,1 0,0 0,0 
let-7a-2//let-7a_mm//rn//cg 15393,1 31648,7 0,0 16488,1 0,0 16972,9 5111,9 6498,3 0,0 
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Finding differentially expressed miRNAs  
 
et <- exactTest(w, pair=c(1,3)) 
topTags(et,n=20) 
detags <- rownames(topTags(et)$table) 
cpm(w)[detags, order(w$samples$group)]  #extract de differentially expressed  
summary(de <- decideTestsDGE(et, p=0.05)) #gener der er op og ned 
detags <- rownames(w)[as.logical(de)]  
png("Figure1.png", width = 20, height = 15, units = 'cm', res = 300) 
plotSmear(et, de.tags=detags, cex =1) #plot with DE genes 




Figure 33 Visalization of the 11 miRNAs which are differentially downregulated, the 22 miRNAS which are 
differentially upregulated and the 715 miRNAs which are similar in F435 compared to K66.    
Finding miRNAs correlating to FVIII productivity 
The relative productivities of FVIII from the experiment where the total RNA was purified was 
imported and subsequently the information was used to calculate the spearman correlation 
between the expression of each miRNA and the FVIII productivity. This revealed 32 miRNAs, 






F445_1 F445_2 F445_3 K28_1 K28_2 K28_3 K66_1 K66_2 K66_3 
100% 87% 98% 20% 19% 20% 0% 0% 0% 
 
 
cortotal=1;for(i in 1:nrow(total)) 




In order to filter the results even further it was investigated whether there was a significant 
difference in expression between the three clones. After this filter there were 8 miRNAs, which 
correlated positively with productivity and 12 miRNAs correlating negatively with the productivity. 
 
cortotal2=cortotal3=1 
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cor3a=cor2a[which(cor2a[,10]<0.05 & cor2a[,11]<0.05),] 
 




Figure 34 The expression of mir-34b_cg correlating positively with the productivity.   
 
Genome position of the miRNA 
Using blast the genomic position of the miRNAs can be found. In my particular case the target 
miRNAs chosen are all either found in introns of genes, which appear to be silent or in intergenic 
space. A lot could have been interpreted from the results if the miRNA was found to be excised 
from the intron of a gene with a known function. 
10.3.7 Identification of potential targets for Crispr/Cas9 induced knock outs 
The aim of this section was to generate a method for locating potential Crispr/Cas9 sites for knock-
out of genes in C. griseus genome  
 
The idea in short: 
1. Create list of the target regions (exon 1-6 of all genes in the genome) 
2. Make a list of all 16bp combinations (sense and antisense), which have the NGG motif 
3. Create a C. griseus transcriptome list containing the transcribed regions of the genome 
4. Search the C. griseus genome / transcriptome for off-target binding of each potential 
Crispr/Cas9 target site in order to generate an alignment score for each target 
 
Extraction of coding region from all genes in the genome 
From the C. griseus annotation file a list of all genes was extracted previously. One gene at the time 
the list of exons were extracted from the gff3 annotation file and based on the orientation of the 
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gene exons one was taken from end or beginning. These coordinates were used to extract the region 
from the genome and export it as a fasta file. 
cat ./listofgenes | gawk '{print $3, $1, $2}' | sed 's/ /\t/g' | uniq > Genelist 
wc -l Genelist > ./length 
length=`awk '{print $1 }' < ./length` 
for ((  i = 1;  i <= $length ; i++  )) 
do 
cat Genelist | head -$i | tail -1 > ./geneinfo 
cat ./geneinfo | gawk '{print $1}' > ./genename 
genesearch_CDS=`awk '{print $1 }' < ./geneinfo` 
CHOname=`awk '{print $2 }' < ./geneinfo` 
genesearch_mRNA=`awk '{print $3 }' < ./geneinfo` 
grep -w "$genesearch_CDS" ../annotation.gff3 > stuff 
cat stuff | sed 's/\t/,/g' | awk -F, '$3=="CDS" {gsub(","," ");print $0}' | gawk '{print $1, $4, $5}' | sed 's/ /\t/g' > 
exon 
 length2=`wc -l exon | awk '{print $1 }'` 
 for ((  j = 1;  j <= $length2 ; j++  )) 
 do 
 cat exon | head -$j | tail -1 > exon.bed 
 /novo/appl/ngs/BEDTools-Version-2.16.2/fastaFromBed -fi ../Cgriseus.fasta -bed exon.bed -fo ./output.fasta 
 echo ">$CHOname-$genesearch_mRNA-exon$j" > $CHOname-$genesearch_mRNA-$j.fasta 











All the files are sorted into folders 
#organize into folders 
for ((  i = 1;  i <= 10 ; i++  )) 
do 
mkdir exon$i 
mv *.$i.fasta ./exon$i/ 
done 
mkdir exon_rest 
mv *.fasta ./exon_rest 
 
Find all potential target sites  







The length of the exon is found and a running window is made of all 33bp ranges (in this case 153). 
A 33bp window was chosen in order to know a bit about the base pairs flanking the 16bp target site. 
All of these results are reverse complimented to make sure targets on both strands are found. Finally 
only targets which has a “GG” in position at position 15 and 16 of the final guide RNA are included 
ending up with 29 targets in this exon 
length=`sed 1d $file | wc -m` 
 Appendix | 208 
for ((  i = 0 ;  i <= $length ; i++  )) 
do 
sed 1d $file | sed "s/^.\{$i\}//" | cut -c 1-33 >> sample.txt 
done 
head --lines=-34 sample.txt > sample2.txt 
perl -0777ne's/\n //g; tr/ATGCatgcNn/TACGtacgNn/; print scalar reverse $_;' sample2.txt | sed 1d >> sample2.txt  










Extract the genes in the CHO genome in order to find mRNA targets 
In order to not just find the number of off-targets in the genome but also which off-targets are in 
transcribed regions of the genome all ranges ±50bp of an mRNA annotated region are fished out 
(the same way as exon 1) 
 
cat /novo/users/csrk/Cgenomes/CHOK1_version1.1/listofgenes | gawk '{print $1}' | uniq > Genelist 
plus=+ 
wc -l Genelist > ./length 
length=`awk '{print $1 }' < ./length` 
for ((  i = 1;  i <= $length ; i++  )) 
do 
cat Genelist | head -$i | tail -1 > ./geneinfo 
cat ./geneinfo | gawk '{print $1}' > ./genename 
genename=`awk '{print $1 }' < ./geneinfo` 
grep -w "$genename" ../annotationK1.gff3 | sed 's/\t/,/g' |  awk -F, '$3=="mRNA" {gsub(","," ");print $0}' > gene 
orientation=`cat gene | gawk '{print $7}' | head -1` 
cat gene | gawk '{print $1, $4-50, $5+50}' | sed 's/ /\t/g' |  sed 's/ /\t/g' | sort -n -k 2 | tail -1 > coordinates 
/novo/appl/ngs/BEDTools-Version-2.16.2/fastaFromBed -fi ../CHOK1_ver1.1.fasta -bed ./coordinates -fo ./output.fasta 
orientation=`cat gene | gawk '{print $7}' | head -1` 
echo " " >> mRNA.fasta 
echo ">$genename" >> mRNA.fasta 
if [ "$orientation" == "$plus" ] 
then 
 sed 1d output.fasta >> mRNA.fasta 
else 
 sed 1d output.fasta > temp.txt 




This ended up with 148 errors where the genes were within 50bp of the start/end of scaffold. The 
output file was split into individual fasta files and each were counted in order to find the files, 
which were to be rerun with the script above without the extra ±50bp 
 
csplit -z mRNA.fasta '/^>/' '{*}' --suffix="%02d.fa" --prefix=RNA- -s 
for file in RNA-* 
do 
head -1 $file > name 
sed 1d $file | wc -m > number 
echo "$file" > filename 
paste name number filename>> list.txt 
done 
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The genome and the new transcriptome were indexed making them searchable with bowtie (which 
is made for NGS analysis and thus optimized for aligning short reads better than e.g. blastn) 
bowtie-build Cgriseus.fasta Cgriseus 
bowtie-build mRNA.fasta mRNA 
Search these targets against the CHO genome / transcriptome 
For each of the 29 target sequences the 34bp sequence extracted above is trimmed to the 13bp target 
sequence and a 3bp cap is inserted to the end 
 
TCACCAAGAGGGGCCATAAATTCTGTGGTGACC => GCCATAAATTCTGNGG 
 
The new guide sequence is then searched against the mRNA database (shown) and subsequently the 
same way against the genome (not shown). The output show all target hits, the scaffold (or gene 
name) and the position of the start of the alignment. The final column show a list of the mismatches. 
All targets, which have mismatches in pos 15 and 16 (the final GG’s) are removed. The number of 
targets with 1, 2 and 3 mismatches are counted and the targets which have 1 (shown below) and 2 
(not shown) are extracted.   
 
Output from  
0 - LOC103158597 28290 CCNCAGAATTTATGGC IIIIIIIIIIIIIIII 3 0:A>C,13:A>N,15:T>C 
0 - LOC100774700 9295 CCNCAGAATTTATGGC IIIIIIIIIIIIIIII 0 0:A>C,8:G>A,13:C>N 
0 - Kctd16 127312 CCNCAGAATTTATGGC IIIIIIIIIIIIIIII 0 0:A>C,8:C>A,13:T>N 
 
 
Each guide sequence are scored based on the arbitrary score: 10 points for each off-target gene with 
0 mismatches, 5 points for each off-target gene with 1 mismatch, 2 points for each genome off-
target with 0 mismatches and 1 point for each genomic off-target with 1 mismatch. All guide 
sequences are sorted so that the target with the lowest score are listed in the top the output. 
motif=NGG 
length=`sed 1d finalcandidates | wc -l` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
head -$i finalcandidates | tail -1 > oligo 
cat oligo | sed "s/^.\{12\}//" | cut -c 1-13 > temp2 
temp2=`cat temp2` 
blastmotif="$temp2$motif" 
echo "$temp2$motif" >  candidate 
bowtie -c ./libs/mRNA $blastmotif -v 3 -a > results 
cat results | grep -v "14:" | grep -v "15:" > correcthits 
cat correcthits | gawk '{print $8}' | awk -F ':' '{print NF-1, NR}' | gawk '{print $1}' | sed 's/1/FXX1/g' | sed 
's/2/FXX2/g' | sed 's/3/FXX3/g' > number 
grep "1" number | wc -l > 1RNA 
grep "2" number | wc -l > 2RNA 
grep "3" number | wc -l > 3RNA 
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##extract hits 
paste correcthits number | grep "FXX1"  > sub1hits 
length2=`cat sub1hits | wc -l` 
rm sample2  
for ((  j = 1 ;  j <= $length2 ; j++  )) 
 do 
 head -$j sub1hits | tail -1 > sample 
 ori=`cat sample | gawk '{print $2}'`   
if [ "$ori" == "$plus" ] 
   then 
    cat sample | gawk '{print $3, $4+1, $4+16, 0}' >> sample2 
   else 
    cat sample | gawk '{print $3, $4+16, $4+1, 0}' >> sample2 
   fi 
done 
cat sample2 | sed 's/ /;/g' | awk '$1=$1' RS= OFS=, > 1mmRNAhits 
…#similar code as above for searching the genomic sequence 
paste 1RNA 2RNA 1genome 2genome | awk '{a=$1*10; b=$2*5; c=$3*2; d=a+b+c+$4; print d}' > oligoscore 
paste genename oligo candidate 1RNA 2RNA 3RNA 1genome 2genome 3genome oligoscore 1mmRNAhits >> 
some_results 
paste genename oligo candidate 1RNA 2RNA 3RNA 1genome 2genome 3genome oligoscore 1mmRNAhits 2mmRNAhits 
1mmGhits 2mmGhits >> all_results 
done 
cat some_results | sort -k 6 -n > results_minimal_$file.txt 
cat all_results | sort -k 6 -n > results_all_$file.txt 
done 
 
Convert output to excel 
Finally the output is converted from a txt file to an excel file 
converter_all script 








for file in results_all_* 
do 
sed 's/\t\t/\t0\t/' $file > temp 
./converter_all < temp 
name=`echo "$file" | sed 's/....$//' | sed 's/^............//'` >> names 
mv output.xlsx $name.xlsx 










RNA_targets_1mismatch  49 
RNA_targets_2mismatch  908 
genome_targets_0mismatch  5 
genome_targets_1mismatch 146 
genome_targets_2mismatch  2793 
score  431 
RNA_hits_0 Aadac;116;131;0.Acp5;8012;7997;0.Srpk1;34003;33988;0 




10.3.8 Primer design for qRT-PCR in CHO 
Due to RNA sequencing data
65
 being released before the genome sequence of CHO-K1
66
 the 
Genbank entries for each gene as stated on CHOgenome.org are only based on mature RNA and not 
the entire mRNA sequence containing introns. Thus, designing qRT-PCR primers spanning introns 
in order to desinguish between DNA and cDNA is not very straight forward. For this reason the 
mRNA regions of the genome including introns were extracted using the code below and used to 
create 29978 Genbank files, which can be opened in e.g. Vector NTI. 
 
A list of all genes in the C. griseus genome was extracted from the annotation file 
cat annotationK1.gff3 | sed 's/\t/,/g' |  awk -F, '$3=="exon" {gsub(","," ");print $0}' | grep "gene=" > sca 
cat sca | sed 's/^.*gene=//g' | cut -f 1,1 -d';' > genes 
cat sca | sed 's/^.*Genbank://g' | cut -f 1,1 -d';' | cut -f 1,1 -d',' | gawk '{print $1}' > Genbk 
cat sca | sed 's/^.*product=//g' | cut -f 1,1 -d';' | sed 's/ /;/g' > genenames 
cat sca | sed 's/^.*Parent=//g' |   cut -f 1,1 -d';' > RNAid 
cat sca | gawk '{print $1}' > seqscaffold 
paste genes Genbk RNAid genenames seqscaffold  | sort | uniq > exon_Genbank 
 
cat annotationK1.gff3 | sed 's/\t/,/g' |  awk -F, '$3=="CDS" {gsub(","," ");print $0}' | grep "gene=" > sca 
cat sca | sed 's/^.*gene=//g' | cut -f 1,1 -d';' > genes 
cat sca | sed 's/^.*Genbank://g' | cut -f 1,1 -d';' | cut -f 1,1 -d',' | gawk '{print $1}' > Genbk 
cat sca | sed 's/^.*product=//g' | cut -f 1,1 -d';' | sed 's/ /;/g' > genenames 
cat sca | sed 's/^.*Parent=//g' |   cut -f 1,1 -d';' > RNAid 
paste genes Genbk RNAid genenames | sort | uniq > CDS_Genbank 
 
paste CDS_Genbank | gawk '{print $3}' | sort | uniq > RNACDS  
paste exon_Genbank | gawk '{print $3}'  | sort | uniq > RNAexon 
sdiff RNACDS RNAexon | grep -v ">" | grep -v "|" | gawk '{print $1}' > unique_proteinrna 
 
wc -l unique_proteinrna > length 
length=`awk '{print $1 }' < length` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do  
cat unique_proteinrna | head -$i | tail -1 > gene 
gene=`awk '{print $1 }' < gene` 
grep -w "$gene" CDS_Genbank > temp1 
grep -w "$gene" exon_Genbank > temp2 
paste temp1 temp2 | gawk '{print $1, $6, $2, $3, $9}' | sed 's/ /\t/g' >> genenames 
done 
printf "\tASDF\n" | awk -F'\t' '$3' genenames | sort | uniq > listofgenes  
 
The list looks like this and thus contain all Genbank entries for RNA tarnscripts, CDS region and 
the sequencing scaffold the gene was found on for all splice variants 
A1cf XM_007627897.1 XP_007626087.1 rna20866 NW_006880426.1 
A2ml1 XM_007611503.1 XP_007609693.1 rna3450 NW_006870833.1 
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A3galt2 XM_007614932.1 XP_007613122.1 rna7152 NW_006873147.1 
A4galt XM_007629783.1 XP_007627973.1 rna22847 NW_006881179.1 
A4galt XM_007629784.1 XP_007627974.1 rna22846 NW_006881179.1 
A4gnt XM_007634050.1 XP_007632240.1 rna27323 NW_006883256.1 
 
Next step is to extract the regions from the genome using FastaFromBed from BEDTools. This is 
done by first finding the coordinates in the genome from the annotation file for each gene and then 
using the coordinates to extract a fasta file using only this sequence from the genome. 
cat /novo/users/csrk/Cgenomes/CHOK1_version1.1/listofgenes | gawk '{print $3, $1, $2}' | sed 's/ /\t/g' | uniq > 
Genelist 
plus=+ 
wc -l Genelist > ./length 
length=`awk '{print $1 }' < ./length` 
for ((  i = 1;  i <= $length ; i++  )) 
do 
cat Genelist | head -$i | tail -1 > ./geneinfo 
cat ./geneinfo | gawk '{print $1}' > ./genename 
geneCHO=`awk '{print $2 }' < ./geneinfo` 
geneCHOname=`awk '{print $1 }' < ./geneinfo` 
genesearch=`awk '{print $3 }' < ./geneinfo` 
grep -w "$genesearch" ../annotationK1.gff3 | sed 's/\t/,/g' |  awk -F, '$3=="mRNA" {gsub(","," ");print $0}' > gene 
orientation=`cat gene | gawk '{print $7}' | head -1` 
cat gene | gawk '{print $1, $4-1, $5}' | sed 's/ /\t/g' |  sed 's/ /\t/g' | sort -n -k 2 | tail -1 > coordinates 
/novo/appl/ngs/BEDTools-Version-2.16.2/fastaFromBed -fi ../CHOK1_ver1.1.fasta -bed ./coordinates -fo ./output.fasta 
orientation=`cat gene | gawk '{print $7}' | head -1` 
echo " " >> mRNA.fasta 
if [ "$orientation" == "$plus" ] 
then 
  echo ">$geneCHO-$geneCHOname-p" >> mRNA.fasta 
 sed 1d output.fasta >> mRNA.fasta 
else 
  echo ">$geneCHO-$geneCHOname-m" >> mRNA.fasta 
 sed 1d output.fasta > temp.txt 




The mRNA.fasta file is then split into individual files given the name from the fasta header 
csplit -z mRNA.fasta '/^>/' '{*}' --suffix="%02d.fa" --prefix=mRNA- -s 
for file in *.fa 
do 
name=`head -1 $file | sed 's/^>//g'` 
mv $file $name.fasta 
done 
 
To fish out the exon coordinates the R-script below is used to make the coordinates relative 
echo '#! /usr/bin/env Rscript' > Rminus  
echo 'RNA=as.matrix(read.table("RNA"))' >> Rminus 
echo 'exon=as.matrix(read.table("exon"))' >> Rminus 
echo 'exonminus=cbind((RNA[1,2]-exon[,2]+1),(RNA[1,2]-exon[,1]+1))' >> Rminus 
echo 'write.table(exonminus,file="output.txt",sep="\t")' >> Rminus 
chmod a+x Rminus 
 
echo '#! /usr/bin/env Rscript' > Rplus  
echo 'RNA=as.matrix(read.table("RNA"))' >> Rplus 
echo 'exon=as.matrix(read.table("exon"))' >> Rplus 
echo 'exonplus=cbind((exon[,1]-RNA[1,1]+1),(exon[,2]-RNA[1,1]+1))' >> Rplus 
echo 'write.table(exonplus,file="output.txt",sep="\t")' >> Rplus 
chmod a+x Rplus 
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The code below is used to fish out the genome coordinates and using the code above the coordinates 
are made relative to the fastafile created above 
cat /novo/users/csrk/Cgenomes/CHOK1_version1.1/listofgenes | gawk '{print $3, $1, $2}' | sed 's/ /\t/g' | uniq > 
Genelist 
plus=+ 
wc -l Genelist > ./length 
length=`awk '{print $1 }' < ./length` 
for ((  i = 1;  i <= $length ; i++  )) 
do 
cat Genelist | head -$i | tail -1 > ./geneinfo 
cat ./geneinfo | gawk '{print $1}' > ./genename 
geneCHO=`awk '{print $2 }' < ./geneinfo` 
genesearch_tran=`awk '{print $3 }' < ./geneinfo` 
genesearch_CDS=`awk '{print $1 }' < ./geneinfo` 
grep -w "$genesearch_tran" ../annotationK1.gff3 > stuff1 
grep -w "$genesearch_CDS" ../annotationK1.gff3 > stuff2 
cat stuff1 | sed 's/\t/,/g' | awk -F, '$3=="mRNA" {gsub(","," ");print $0}' | gawk '{print $4, $5}' > RNA 
cat stuff2 | sed 's/\t/,/g' | awk -F, '$3=="CDS" {gsub(","," ");print $0}' | gawk '{print $4, $5}' > exon 
orientation=`head -1 stuff1 | gawk '{print $7}'` 
if [ "$orientation" == "$plus" ] 
then 
 ./Rplus 
 cat output.txt | sed 's/^"/exon/g' | sed 's/"\t/\t/g' | sed 1d > $geneCHO-$genesearch_CDS-p.txt 
else 
 ./Rminus 




Finally the genes with only one exon needs to have the name changed. 
for file in *.txt 
do 
cat $file | sed 's/exonV1/exon1/g' > temp 
mv temp $file 
done 
 
In order to merge the coordinates in the txt file with the fasta file into one annotated Genbank file a 
script was written by my colleague Thomas P. Boesen 
#!/usr/bin/env ruby 
def process_file(name) 
  puts 'Processing: ' + name 
  name =~ /-(\w+)[^\/]*$/ 
  locus = $1 
  # READ FILE CONTENT # 
  sequence = '' 
  File.open(name + '.fasta', "r") do |f| 
    f.each_line do |line| 
      sequence += line.strip unless line.start_with? '>' 
    end 
  end 
#  puts "Seq length: #{sequence.length}" 
  exons = [] 
  File.open(name + '.txt', 'r') do |f| 
    f.each_line do |line| 
      if line =~ /^(\w+)\s+(\d+)\s+(\d+)/ 
        exons.push({:label => $1, :start => Integer($2), :end => Integer($3)}) 
      end 
    end 
  end 
#  exons.each {|exon| 
#    puts "Exon: #{exon[:label]} #{exon[:start]} #{exon[:end]} #{sequence[exon[:start]..exon[:end]]}" 
#  } 
  # GENERATE GENBANK FILE # 
  File.open(name + '.genbank', 'w'){|file| 
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    file.write "LOCUS       " + locus.ljust(17) + "#{sequence.length}".rjust(6) + " bp    DNA     circular     26-MAR-
2015\n" 
    file.write "SOURCE      \n" 
    file.write "  ORGANISM  \n" 
    file.write "FEATURES             Location/Qualifiers\n" 
    exons.each {|exon| 
      file.write "     misc_feature    #{exon[:start]}..#{exon[:end]}\n" 
      file.write "                     /vntifkey=\"21\"\n" 
      file.write "                     /label=#{exon[:label]}\n" 
    } 
    file.write "ORIGIN\n" 
    iBase = 0 
    while iBase < sequence.length 
      file.write "#{iBase+1}".rjust(9) + " #{sequence[iBase..iBase+9]} #{sequence[iBase+10..iBase+19]} 
#{sequence[iBase+20..iBase+29]} #{sequence[iBase+30..iBase+39]} #{sequence[iBase+40..iBase+49]} 
#{sequence[iBase+50..iBase+59]}\n" 
      iBase += 60 
    end 
    file.write "//\n" 
  } 
end 
def process_dir (name) 
  files = Dir.glob(name + '/*.txt') 
  files.each {|file| 
    process_file file[0..-5] 





Output opened in Vector NTI 
 
Figure 35 overview of the expon location in calreticulin (NP_001231051).  
 
Using the files above qPCR primers were designed using Primer3 (http://bioinfo.ut.ee/primer3-
0.4.0/). 
10.3.9 Validation of primers against the CHO genome, transcriptome and mature 
transcriptome 
























The script below imports the list above and uses bowtie to align the oligoes to the CHO genome to 
find potential off-targets  
cat input.txt | tr '\015' '\012' | sort -n | uniq | sed 1d > input 
length=`wc -l input | gawk '{print $1}'` 
for ((  i = 1 ;  i <= $length ; i++  )) 
do 
oligo=`head -$i input | tail -1 | gawk '{print $2}'` 
echo $oligo > name 
head -$i input | tail -1 | gawk '{print $1}' > primername 
bowtie -c ~/Cgenomes/CHOK1_version1.1/Crispr/libs/Cgriseus $oligo -v 2 -a > results1 
bowtie -c ~/Cgenomes/CHOK1_version1.1/Crispr/libs/mRNA $oligo -v 2 -a > results2 
bowtie -c ~/Cgenomes/CHOK1_version1.1/Crispr/libs/mRNAs_mature $oligo -v 2 -a > results3 
cat results1 | gawk '{print $8}' | awk -F ':' '{print NF, NR}' | gawk '{print $1}' | sed 's/0/FXX0/g' | sed 's/1/FXX1/g' | 
sed 's/2/FXX2/g' > number 
grep "0" number | wc -l > 0g 
grep "1" number | wc -l > 1g 
grep "2" number | wc -l > 2g 
paste number results1 | grep -v "FXX2"  > sub1 
length2=`cat sub1 | wc -l` 
rm sample2  
for ((  j = 1 ;  j <= $length2 ; j++  )) 
 do 
 head -$j sub1 | tail -1 > sample 
 ori=`cat sample | gawk '{print $2}'`   
if [ "$ori" == "$plus" ] 
 then 
  cat sample | sed 's/FXX0/0/g' | sed 's/FXX1/1/g' | gawk '{print $4, $5+1, $5+16, $1}' >> sample2 
 else 
  cat sample | sed 's/FXX0/0/g' | sed 's/FXX1/1/g' | gawk '{print $4, $5+16, $5+1, $1}' >> sample2 
 fi 
done 
cat sample2 | sed 's/ /;/g' | awk '$1=$1' RS= OFS=, > 0mm_g 
# 
cat results2 | gawk '{print $8}' | awk -F ':' '{print NF, NR}' | gawk '{print $1}' | sed 's/0/FXX0/g' | sed 's/1/FXX1/g' | 
sed 's/2/FXX2/g' > number 
grep "0" number | wc -l > 0r 
grep "1" number | wc -l > 1r 
grep "2" number | wc -l > 2r 
paste number results2 | grep -v "FXX2"  > sub1 
length2=`cat sub1 | wc -l` 
rm sample2  
for ((  j = 1 ;  j <= $length2 ; j++  )) 
 do 
 head -$j sub1 | tail -1 > sample 
 ori=`cat sample | gawk '{print $2}'`   
if [ "$ori" == "$plus" ] 
 then 
  cat sample | sed 's/FXX0/0/g' | sed 's/FXX1/1/g' | gawk '{print $4, $5+1, $5+16, $1}' >> sample2 
 else 
  cat sample | sed 's/FXX0/0/g' | sed 's/FXX1/1/g' | gawk '{print $4, $5+16, $5+1, $1}' >> sample2 
 fi 
done 
cat sample2 | sed 's/ /;/g' | awk '$1=$1' RS= OFS=, > 0mm_r 
# 
cat results3 | gawk '{print $8}' | awk -F ':' '{print NF, NR}' | gawk '{print $1}' | sed 's/0/FXX0/g' | sed 's/1/FXX1/g' | 
sed 's/2/FXX2/g' > number 
grep "0" number | wc -l > 0g 
grep "1" number | wc -l > 1g 
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grep "2" number | wc -l > 2g 
paste number results3 | grep -v "FXX2"  > sub1 
length2=`cat sub1 | wc -l` 
rm sample2  
for ((  j = 1 ;  j <= $length2 ; j++  )) 
 do 
 head -$j sub1 | tail -1 > sample 
 ori=`cat sample | gawk '{print $2}'`   
if [ "$ori" == "$plus" ] 
 then 
  cat sample | sed 's/FXX0/0/g' | sed 's/FXX1/1/g' | gawk '{print $4, $5+1, $5+16, $1}' >> sample2 
 else 




cat sample2 | sed 's/ /;/g' | awk '$1=$1' RS= OFS=, > 0mm_r2 
paste primername name 0g 1g 2g 0r 1r 2r 0r2 1r2 2r2 0mm_g 0mm_r 0mm_r2 >> list.txt 
done 
 
Finally the output is converted to an excel file 
echo '#! /usr/bin/env Rscript' > converter_all 
echo 'col=as.matrix(read.table("stdin"))' >> converter_all 




targets","mRNA_offtargets","mRNA_mature_offtargets")' >> converter_all 
echo 'write.xlsx(col,"./output.xlsx")' >> converter_all 
chmod a+x converter_all 
 
for file in list.txt 
do 
sed 's/\t\t/\t0\t/' $file > temp 
./converter_all < temp 
name=`echo "$file" | sed 's/....$//' >> names 
mv output.xlsx $name.xlsx 




From the output (list.xlsx) it can be seen how well each oligo fares concerning off-target binding. 
From the binding positions found in the last 3 columns it can be calculated what the amplicon 
length will be using gDNA or cDNA as template. 
Primername CK369 CK370 
Primerseq GGAACCTGCCGTCTATTTCA CCCGTAGAATTTGCCAGAAC 
Genome_0mm 1 1 
Genome_1mm 0 0 
Genome_2mm 0 0 
RNA+intron_0mm 1 1 
RNA+intron_1mm 0 0 
RNA+intron_2mm 0 0 
RNA-intron_0mm 0 0 
RNA-intron_2mm 0 0 
RNA-intron_3mm 0 0 
Genome_off-targets NW_006879744.1;597082;597067;0 NW_006879744.1;597539;597524;0… 
mRNA_offtargets Calr;115;100;0 Calr;572;557;0,Daam1;18574;18559;3… 
mRNA_mature_offtargets NM_001244122.1;66;51;0 NM_001244122.1;170;155;0 
 
